# Calculation results of IVW methods2

  


| exposure | method | nsnp | b | se | pval | adjust\_FDR | lo\_ci | up\_ci | or | or\_lci95 | or\_uci95 |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| GCST004246-Alzheimer's disease | Inverse variance weighted | 4 | 0.947417 | 0.029944 | \#\#\#\#\#\#\#\# | \#\#\#\#\#\#\#\# | 0.888727 | 1.006107 | 2.579039 | 2.432033 | 2.734932 |
| GCST007319-Alzheimer's disease \(late onset\) | Inverse variance weighted | 10 | 0.016217 | 0.000673 | \#\#\#\#\#\#\#\# | \#\#\#\#\#\#\#\# | 0.014898 | 0.017536 | 1.01635 | 1.01501 | 1.017691 |
| GCST002245-Alzheimer's disease \(late onset\) | Inverse variance weighted | 12 | 0.979058 | 0.046035 | \#\#\#\#\#\#\#\# | 4.96E-98 | 0.888829 | 1.069286 | 2.661946 | 2.43228 | 2.913299 |
| GCST007320-Alzheimer's disease or family history of Alzheimer's disease | Inverse variance weighted | 56 | 0.01515 | 0.000859 | 1.11E-69 | 2.36E-67 | 0.013467 | 0.016833 | 1.015266 | 1.013558 | 1.016976 |
| GCST007600-Alzheimer's disease | Inverse variance weighted | 6 | 0.734583 | 0.046815 | 1.74E-55 | 3.56E-53 | 0.642826 | 0.82634 | 2.084612 | 1.901847 | 2.28494 |
| GCST003262-Post bronchodilator FEV1 | Inverse variance weighted | 176 | 0.279157 | 0.019826 | 5.03E-45 | 9.67E-43 | 0.240298 | 0.318017 | 1.322015 | 1.271628 | 1.3744 |
| GCST001026-Alzheimer's disease \(late onset\) | Inverse variance weighted | 4 | 0.942266 | 0.067481 | 2.61E-44 | 4.86E-42 | 0.810003 | 1.074529 | 2.565788 | 2.247915 | 2.928612 |
| GCST003264-Post bronchodilator FEV1/FVC ratio | Inverse variance weighted | 196 | 1.049571 | 0.090403 | 3.67E-31 | 6.09E-29 | 0.872382 | 1.22676 | 2.856425 | 2.392603 | 3.410161 |
| GCST006904-Cerebral amyloid deposition \(PET imaging\) | Inverse variance weighted | 21 | 7.369593 | 0.681784 | 3.11E-27 | 4.90E-25 | 6.033296 | 8.705891 | 1586.988 | 417.0876 | 6038.377 |
| GCST007321-Family history of Alzheimer's disease | Inverse variance weighted | 7 | 0.022232 | 0.002214 | 9.80E-24 | 1.47E-21 | 0.017894 | 0.026571 | 1.022481 | 1.018055 | 1.026927 |
| GCST001025-Alzheimer's disease | Inverse variance weighted | 2 | 0.865198 | 0.094784 | 6.97E-20 | 9.12E-18 | 0.679421 | 1.050975 | 2.375477 | 1.972735 | 2.860439 |
| GCST005316-Intelligence \(MTAG\) | Inverse variance weighted | 434 | -0.39798 | 0.045414 | 1.89E-18 | 2.43E-16 | -0.487 | -0.30897 | 0.671673 | 0.61447 | 0.734201 |
| GCST002817-Alzheimer's disease in APOE e4- carriers | Inverse variance weighted | 2 | 0.961421 | 0.112681 | 1.44E-17 | 1.80E-15 | 0.740567 | 1.182275 | 2.615411 | 2.097124 | 3.261787 |
| GCST006568-Highest math class taken \(MTAG\) | Inverse variance weighted | 691 | -0.43051 | 0.058559 | 1.96E-13 | 2.36E-11 | -0.54529 | -0.31573 | 0.650177 | 0.579676 | 0.729254 |
| GCST007511-Alzheimer's disease \(late onset\) | Inverse variance weighted | 4 | 0.88555 | 0.120989 | 2.49E-13 | 2.95E-11 | 0.648412 | 1.122688 | 2.424318 | 1.912502 | 3.073104 |
| GCST006571-Educational attainment \(MTAG\) | Inverse variance weighted | 862 | -0.44245 | 0.062821 | 1.88E-12 | 2.14E-10 | -0.56558 | -0.31932 | 0.642459 | 0.56803 | 0.72664 |
| GCST006570-Cognitive performance \(MTAG\) | Inverse variance weighted | 380 | -0.41565 | 0.059845 | 3.77E-12 | 4.07E-10 | -0.53294 | -0.29835 | 0.659912 | 0.586874 | 0.742039 |
| GCST006250-Intelligence | Inverse variance weighted | 342 | -0.00141 | 0.000203 | 4.44E-12 | 4.71E-10 | -0.0018 | -0.00101 | 0.998596 | 0.998199 | 0.998993 |
| GCST006269-General cognitive ability | Inverse variance weighted | 249 | -0.00146 | 0.000232 | 2.75E-10 | 2.82E-08 | -0.00192 | -0.00101 | 0.998538 | 0.998085 | 0.998992 |
| GCST006442-Educational attainment \(years of education\) | Inverse variance weighted | 1009 | -0.37122 | 0.062603 | 3.03E-09 | 3.01E-07 | -0.49392 | -0.24852 | 0.689891 | 0.610227 | 0.779955 |
| GCST006569-Self-reported math ability \(MTAG\) | Inverse variance weighted | 472 | -0.35959 | 0.062799 | 1.03E-08 | 9.73E-07 | -0.48267 | -0.2365 | 0.697965 | 0.617132 | 0.789386 |
| GCST003676-Educational attainment \(years of education\) | Inverse variance weighted | 89 | -0.56287 | 0.123423 | 5.10E-06 | 0.000407 | -0.80478 | -0.32096 | 0.56957 | 0.447185 | 0.72545 |
| GCST007141-Low density lipoprotein cholesterol levels | Inverse variance weighted | 160 | 0.645374 | 0.145782 | 9.56E-06 | 0.000744 | 0.359643 | 0.931106 | 1.906701 | 1.432817 | 2.537314 |
| GCST006572-Cognitive performance | Inverse variance weighted | 126 | -0.42677 | 0.099578 | 1.82E-05 | 0.001382 | -0.62195 | -0.2316 | 0.652611 | 0.536898 | 0.793261 |
| GCST006940-Neurociticism | Inverse variance weighted | 103 | 0.001602 | 0.000379 | 2.38E-05 | 0.001784 | 0.000859 | 0.002345 | 1.001603 | 1.000859 | 1.002348 |
| GCST007434-Metastasis in stage I-III microsatellite instability low/stable colorectal cancer \(time to event\) | Inverse variance weighted | 17 | 0.007806 | 0.001963 | 6.98E-05 | 0.004749 | 0.003959 | 0.011653 | 1.007836 | 1.003966 | 1.011721 |
| GCST006574-Highest math class taken | Inverse variance weighted | 208 | -0.32618 | 0.082322 | 7.42E-05 | 0.00496 | -0.48754 | -0.16483 | 0.721672 | 0.614138 | 0.848035 |
| GCST004988-Breast cancer | Inverse variance weighted | 197 | -0.08767 | 0.023034 | 0.000141 | 0.009163 | -0.13282 | -0.04253 | 0.916059 | 0.875623 | 0.958363 |
| GCST004233-LDL cholesterol levels | Inverse variance weighted | 41 | -0.25703 | 0.06759 | 0.000143 | 0.009163 | -0.3895 | -0.12455 | 0.773346 | 0.677392 | 0.882892 |
| GCST004570-Iron status biomarkers \(iron levels\) | Inverse variance weighted | 3 | -0.25466 | 0.069149 | 0.000231 | 0.014624 | -0.39019 | -0.11913 | 0.775181 | 0.676927 | 0.887695 |
| GCST005931-Glioma | Inverse variance weighted | 3 | -0.13156 | 0.036196 | 0.000278 | 0.01723 | -0.20251 | -0.06062 | 0.876725 | 0.816682 | 0.941183 |
| GCST005932-Glioblastoma | Inverse variance weighted | 3 | -0.10592 | 0.029155 | 0.00028 | 0.01723 | -0.16306 | -0.04877 | 0.899499 | 0.84954 | 0.952397 |
| GCST005232-Neuroticism | Inverse variance weighted | 77 | 0.001278 | 0.000368 | 0.000507 | 0.029153 | 0.000558 | 0.001999 | 1.001279 | 1.000558 | 1.002001 |
| GCST007615-C-reactive protein levels | Inverse variance weighted | 36 | -1.39524 | 0.410642 | 0.00068 | 0.038684 | -2.20009 | -0.59038 | 0.247774 | 0.110793 | 0.554117 |
| GCST004435-Monokine induced by gamma interferon levels | Inverse variance weighted | 2 | 0.259817 | 0.078717 | 0.000965 | 0.052954 | 0.105531 | 0.414103 | 1.296693 | 1.1113 | 1.513014 |
| GCST007143-Total cholesterol levels | Inverse variance weighted | 184 | 0.485408 | 0.15024 | 0.001234 | 0.065408 | 0.190937 | 0.779879 | 1.624838 | 1.210383 | 2.181209 |
| GCST002650-Coffee consumption \(cups per day\) | Inverse variance weighted | 4 | 0.322924 | 0.100846 | 0.001364 | 0.071068 | 0.125266 | 0.520582 | 1.38116 | 1.13345 | 1.683006 |
| GCST001808-Tumor biomarkers | Inverse variance weighted | 7 | 0.132285 | 0.041352 | 0.001379 | 0.071205 | 0.051235 | 0.213334 | 1.141433 | 1.05257 | 1.237798 |
| GCST006476-Neuroticism | Inverse variance weighted | 206 | 0.000818 | 0.000256 | 0.00139 | 0.071205 | 0.000316 | 0.001319 | 1.000818 | 1.000316 | 1.00132 |
| GCST005867-Menarche \(age at onset\) | Inverse variance weighted | 8 | -0.16084 | 0.050848 | 0.00156 | 0.077361 | -0.26051 | -0.06118 | 0.851425 | 0.770661 | 0.940652 |
| GCST006480-Glioblastoma \(age-stratified\) | Inverse variance weighted | 4 | -0.08607 | 0.027464 | 0.001725 | 0.082622 | -0.1399 | -0.03224 | 0.917528 | 0.869444 | 0.968272 |
| GCST000653-Age-related macular degeneration | Inverse variance weighted | 2 | 0.216074 | 0.06896 | 0.001728 | 0.082622 | 0.080912 | 0.351236 | 1.241194 | 1.084276 | 1.420822 |
| GCST004389-Circulating chemerin levels | Inverse variance weighted | 4 | -0.50294 | 0.16187 | 0.00189 | 0.086696 | -0.8202 | -0.18567 | 0.604751 | 0.440343 | 0.830545 |
| GCST006573-Self-reported math ability | Inverse variance weighted | 310 | -0.23406 | 0.07559 | 0.001959 | 0.088541 | -0.38222 | -0.0859 | 0.791314 | 0.682347 | 0.917683 |
| GCST006478-Worry | Inverse variance weighted | 83 | 0.481061 | 0.157411 | 0.002243 | 0.097782 | 0.172535 | 0.789587 | 1.617789 | 1.188313 | 2.202486 |
| GCST007709-General factor of neuroticism | Inverse variance weighted | 160 | -0.40762 | 0.134228 | 0.002391 | 0.103535 | -0.67071 | -0.14453 | 0.665232 | 0.511347 | 0.865427 |
| GCST002474-Glioma \(high-grade\) | Inverse variance weighted | 2 | -0.12487 | 0.041153 | 0.002412 | 0.103708 | -0.20553 | -0.0442 | 0.882616 | 0.814219 | 0.956758 |
| GCST006630-Diastolic blood pressure | Inverse variance weighted | 55 | -0.05891 | 0.019661 | 0.002731 | 0.114273 | -0.09745 | -0.02038 | 0.942788 | 0.907148 | 0.979828 |
| GCST002721-Trans fatty acid levels | Inverse variance weighted | 22 | -3.46395 | 1.159465 | 0.002812 | 0.115268 | -5.7365 | -1.1914 | 0.031306 | 0.003226 | 0.303797 |
| GCST000043-Type 1 diabetes | Inverse variance weighted | 4 | 0.037358 | 0.012543 | 0.002897 | 0.116406 | 0.012774 | 0.061941 | 1.038064 | 1.012856 | 1.0639 |
| GCST004873-Endometriosis | Inverse variance weighted | 2 | -0.06968 | 0.02422 | 0.004018 | 0.153416 | -0.11715 | -0.0222 | 0.932696 | 0.889453 | 0.97804 |
| GCST006944-Experiencing mood swings | Inverse variance weighted | 48 | 0.002008 | 0.000703 | 0.004303 | 0.160338 | 0.000629 | 0.003386 | 1.00201 | 1.00063 | 1.003392 |
| GCST006661-Male-pattern baldness | Inverse variance weighted | 145 | -0.06937 | 0.024338 | 0.004371 | 0.161879 | -0.11707 | -0.02166 | 0.932986 | 0.889525 | 0.97857 |
| GCST000506-Lung adenocarcinoma | Inverse variance weighted | 4 | -0.19444 | 0.068853 | 0.004744 | 0.172579 | -0.32939 | -0.05948 | 0.823299 | 0.719363 | 0.942251 |
| GCST007590-Hippocampal volume | Inverse variance weighted | 3 | 0.004285 | 0.001551 | 0.005744 | 0.201785 | 0.001244 | 0.007325 | 1.004294 | 1.001245 | 1.007352 |
| GCST006292-Response to antipsychotic treatment in schizophrenia | Inverse variance weighted | 2 | 0.009081 | 0.003294 | 0.005842 | 0.201977 | 0.002624 | 0.015538 | 1.009122 | 1.002628 | 1.015659 |
| GCST008152-Weight | Inverse variance weighted | 11 | -0.32838 | 0.11914 | 0.005847 | 0.201977 | -0.56189 | -0.09486 | 0.720093 | 0.570131 | 0.909499 |
| GCST002155-Osteoarthritis \(hip\) | Inverse variance weighted | 2 | 0.258028 | 0.09384 | 0.005966 | 0.202638 | 0.074102 | 0.441953 | 1.294374 | 1.076916 | 1.555743 |
| GCST000565-Angiotensin-converting enzyme activity | Inverse variance weighted | 2 | -0.00254 | 0.000922 | 0.005984 | 0.202638 | -0.00434 | -0.00073 | 0.997468 | 0.995666 | 0.999273 |
| GCST006948-Feeling nervous | Inverse variance weighted | 37 | 0.00164 | 0.000597 | 0.005999 | 0.202638 | 0.00047 | 0.00281 | 1.001642 | 1.00047 | 1.002814 |
| GCST007899-Fasting blood glucose | Inverse variance weighted | 7 | 0.450977 | 0.165182 | 0.00633 | 0.209232 | 0.12722 | 0.774735 | 1.569845 | 1.135666 | 2.170016 |
| GCST002355-Serum uric acid levels | Inverse variance weighted | 3 | 0.808678 | 0.299302 | 0.006895 | 0.219637 | 0.222046 | 1.39531 | 2.244938 | 1.248628 | 4.036226 |
| GCST002646-Infant length | Inverse variance weighted | 10 | -0.26085 | 0.096959 | 0.007139 | 0.225064 | -0.45089 | -0.07081 | 0.770397 | 0.637062 | 0.931639 |
| GCST004067-Hip circumference adjusted for BMI | Inverse variance weighted | 66 | -0.22002 | 0.082292 | 0.007502 | 0.234132 | -0.38132 | -0.05873 | 0.802499 | 0.682961 | 0.94296 |
| GCST007182-Two-hour glucose in pregnancy \(gestational week 30-32\) | Inverse variance weighted | 2 | -0.09014 | 0.034391 | 0.008768 | 0.265548 | -0.15755 | -0.02273 | 0.913805 | 0.854238 | 0.977525 |
| GCST007326-Number of sexual partners | Inverse variance weighted | 72 | -0.33254 | 0.127252 | 0.008969 | 0.268997 | -0.58195 | -0.08312 | 0.717103 | 0.558808 | 0.920238 |
| GCST004212-Height | Inverse variance weighted | 12 | -2.86661 | 1.101505 | 0.009256 | 0.27359 | -5.02556 | -0.70766 | 0.056892 | 0.006568 | 0.492797 |
| GCST006252-Childhood steroid-sensitive nephrotic syndrome | Inverse variance weighted | 2 | -0.04485 | 0.017365 | 0.009805 | 0.287056 | -0.07888 | -0.01081 | 0.956144 | 0.924149 | 0.989246 |
| GCST000667-Smoking behavior | Inverse variance weighted | 3 | -0.04883 | 0.018983 | 0.01011 | 0.293182 | -0.08603 | -0.01162 | 0.952346 | 0.917563 | 0.988448 |
| GCST006943-Feeling miserable | Inverse variance weighted | 40 | 0.001928 | 0.00076 | 0.011199 | 0.30738 | 0.000438 | 0.003419 | 1.00193 | 1.000438 | 1.003424 |
| GCST000666-Smoking behavior | Inverse variance weighted | 4 | -0.03836 | 0.0152 | 0.011607 | 0.317148 | -0.06815 | -0.00857 | 0.962364 | 0.934116 | 0.991466 |
| GCST005209-Hodgkin's lymphoma | Inverse variance weighted | 4 | 0.124882 | 0.049655 | 0.011903 | 0.320966 | 0.027559 | 0.222206 | 1.133015 | 1.027942 | 1.248828 |
| GCST007483-Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | Inverse variance weighted | 17 | 0.604648 | 0.24154 | 0.012304 | 0.326057 | 0.131229 | 1.078067 | 1.830609 | 1.140229 | 2.938994 |
| GCST004521-Autism spectrum disorder or schizophrenia | Inverse variance weighted | 44 | 0.118133 | 0.047699 | 0.013263 | 0.345517 | 0.024643 | 0.211623 | 1.125394 | 1.024949 | 1.235683 |
| GCST007342-Depression | Inverse variance weighted | 55 | -0.28611 | 0.115921 | 0.01358 | 0.349413 | -0.51332 | -0.05891 | 0.751178 | 0.598507 | 0.942793 |
| GCST002672-Febrile seizures | Inverse variance weighted | 5 | -0.0621 | 0.02516 | 0.013583 | 0.349413 | -0.11141 | -0.01278 | 0.939791 | 0.89457 | 0.987297 |
| GCST007602-Smoking behaviour \(cigarettes smoked per day\) | Inverse variance weighted | 3 | -0.36355 | 0.147608 | 0.013781 | 0.352447 | -0.65286 | -0.07423 | 0.695206 | 0.520555 | 0.928454 |
| GCST003846-Caffeine metabolism \(plasma 1,3,7-trimethylxanthine \(caffeine\) level\) | Inverse variance weighted | 6 | -0.00256 | 0.001042 | 0.013949 | 0.352447 | -0.0046 | -0.00052 | 0.997442 | 0.995407 | 0.999481 |
| GCST005830-Hand grip strength | Inverse variance weighted | 75 | 4.331559 | 1.762899 | 0.014008 | 0.352447 | 0.876277 | 7.78684 | 76.06277 | 2.401942 | 2408.695 |
| GCST001917-Ovarian cancer in BRCA1 mutation carriers | Inverse variance weighted | 3 | -0.10706 | 0.043589 | 0.014045 | 0.352447 | -0.19249 | -0.02162 | 0.898473 | 0.824901 | 0.978608 |
| GCST001275-Liver enzyme levels \(alanine transaminase\) | Inverse variance weighted | 2 | 0.013407 | 0.005474 | 0.01432 | 0.35622 | 0.002678 | 0.024137 | 1.013497 | 1.002681 | 1.02443 |
| GCST005957-Waist-to-hip ratio adjusted for BMI \(age &lt;50\) | Inverse variance weighted | 3 | -0.44422 | 0.181471 | 0.014369 | 0.35622 | -0.7999 | -0.08854 | 0.641323 | 0.449372 | 0.915268 |
| GCST005180-Homeostasis model assessment of beta-cell function | Inverse variance weighted | 4 | 0.773016 | 0.316222 | 0.014504 | 0.35811 | 0.153221 | 1.392811 | 2.16629 | 1.165583 | 4.026152 |
| GCST005276-Dementia with Lewy bodies | Inverse variance weighted | 2 | 1.311901 | 0.538562 | 0.014853 | 0.363822 | 0.256319 | 2.367483 | 3.713225 | 1.292165 | 10.6705 |
| GCST000817-Height | Inverse variance weighted | 106 | -0.1342 | 0.055168 | 0.014993 | 0.364337 | -0.24233 | -0.02607 | 0.874417 | 0.7848 | 0.974268 |
| GCST005124-Urinary magnesium-to-creatinine ratio | Inverse variance weighted | 2 | -0.27967 | 0.11544 | 0.015407 | 0.370236 | -0.50594 | -0.05341 | 0.75603 | 0.60294 | 0.947991 |
| GCST007487-Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | Inverse variance weighted | 20 | 0.586431 | 0.242252 | 0.015489 | 0.370236 | 0.111617 | 1.061246 | 1.797562 | 1.118085 | 2.889969 |
| GCST000808-Alzheimer's disease \(late onset\) | Inverse variance weighted | 2 | 0.831649 | 0.346432 | 0.016368 | 0.385554 | 0.152641 | 1.510656 | 2.297103 | 1.164907 | 4.529702 |
| GCST000700-Vertical cup-disc ratio | Inverse variance weighted | 5 | -1.91559 | 0.799204 | 0.016536 | 0.388024 | -3.48203 | -0.34915 | 0.147255 | 0.030745 | 0.705289 |
| GCST007515-Type 2 diabetes | Inverse variance weighted | 11 | 0.292527 | 0.122539 | 0.016977 | 0.392387 | 0.052349 | 0.532704 | 1.339808 | 1.053744 | 1.703532 |
| GCST002321-Lipid traits | Inverse variance weighted | 5 | 1.84043 | 0.774684 | 0.017515 | 0.398821 | 0.322049 | 3.358811 | 6.299248 | 1.379953 | 28.75499 |
| GCST006718-Alcohol use disorder \(consumption score\) | Inverse variance weighted | 4 | 4.741197 | 2.0018 | 0.017862 | 0.402255 | 0.817668 | 8.664725 | 114.5713 | 2.265212 | 5794.853 |
| GCST003185-Nicotine dependence | Inverse variance weighted | 2 | -0.5927 | 0.251206 | 0.018303 | 0.407876 | -1.08507 | -0.10034 | 0.552831 | 0.33788 | 0.90453 |
| GCST002289-Coronary artery disease | Inverse variance weighted | 2 | -0.27369 | 0.116006 | 0.018311 | 0.407876 | -0.50106 | -0.04632 | 0.760568 | 0.605887 | 0.954738 |
| GCST001907-Multiple myeloma \(hyperdiploidy\) | Inverse variance weighted | 2 | -0.08871 | 0.038024 | 0.019653 | 0.429041 | -0.16323 | -0.01418 | 0.915115 | 0.849394 | 0.985921 |
| GCST003961-Hippocampal volume | Inverse variance weighted | 2 | 0.004761 | 0.002041 | 0.019679 | 0.429041 | 0.00076 | 0.008763 | 1.004773 | 1.000761 | 1.008801 |
| GCST003926-Renal underexcretion gout | Inverse variance weighted | 5 | 0.042992 | 0.018449 | 0.019788 | 0.429877 | 0.006832 | 0.079152 | 1.04393 | 1.006856 | 1.082368 |
| GCST005829-Hand grip strength | Inverse variance weighted | 18 | 5.847574 | 2.516138 | 0.020124 | 0.434113 | 0.915945 | 10.7792 | 346.3931 | 2.499135 | 48011.89 |
| GCST001485-Hippocampal volume | Inverse variance weighted | 3 | 0.000391 | 0.000169 | 0.021124 | 0.451698 | 5.86E-05 | 0.000723 | 1.000391 | 1.000059 | 1.000723 |
| GCST002602-Vitamin D levels | Inverse variance weighted | 2 | -0.02471 | 0.01075 | 0.021508 | 0.454409 | -0.04578 | -0.00364 | 0.975589 | 0.955248 | 0.996363 |
| GCST007093-Osteoarthritis | Inverse variance weighted | 12 | 0.299714 | 0.130561 | 0.0217 | 0.456729 | 0.043814 | 0.555613 | 1.349473 | 1.044789 | 1.743009 |
| GCST006942-Feeling lonely | Inverse variance weighted | 5 | 0.006166 | 0.002707 | 0.022753 | 0.470985 | 0.00086 | 0.011472 | 1.006185 | 1.00086 | 1.011538 |
| GCST000546-Leprosy | Inverse variance weighted | 5 | -0.05844 | 0.025772 | 0.023355 | 0.481828 | -0.10895 | -0.00793 | 0.943234 | 0.896771 | 0.992104 |
| GCST003605-EGFR mutation-positive lung adenocarcinoma | Inverse variance weighted | 4 | -0.08972 | 0.039614 | 0.023515 | 0.481842 | -0.16737 | -0.01208 | 0.914184 | 0.84589 | 0.987992 |
| GCST000664-Vitamin D levels | Inverse variance weighted | 3 | -0.08177 | 0.036142 | 0.023676 | 0.481842 | -0.1526 | -0.01093 | 0.921488 | 0.85847 | 0.989132 |
| GCST003724-Bipolar disorder | Inverse variance weighted | 4 | 0.143504 | 0.063776 | 0.024441 | 0.486296 | 0.018503 | 0.268506 | 1.154312 | 1.018675 | 1.308008 |
| GCST000550-Metabolite levels | Inverse variance weighted | 5 | 0.10302 | 0.046038 | 0.025241 | 0.494158 | 0.012785 | 0.193255 | 1.108514 | 1.012867 | 1.213193 |
| GCST007516-Type 2 diabetes \(adjusted for BMI\) | Inverse variance weighted | 9 | 0.2863 | 0.128057 | 0.02537 | 0.494158 | 0.035308 | 0.537292 | 1.331492 | 1.035938 | 1.711366 |
| GCST001277-Liver enzyme levels \(gamma-glutamyl transferase\) | Inverse variance weighted | 19 | 0.002456 | 0.001102 | 0.025816 | 0.497552 | 0.000296 | 0.004616 | 1.002459 | 1.000296 | 1.004626 |
| GCST003468-Chronic lymphocytic leukemia | Inverse variance weighted | 11 | -0.06226 | 0.028058 | 0.026482 | 0.505621 | -0.11726 | -0.00727 | 0.939636 | 0.889357 | 0.992757 |
| GCST008151-Waist circumference | Inverse variance weighted | 4 | -0.43972 | 0.199201 | 0.027285 | 0.512997 | -0.83015 | -0.04928 | 0.644217 | 0.435982 | 0.95191 |
| GCST008160-Waist circumference | Inverse variance weighted | 4 | -0.43972 | 0.199201 | 0.027285 | 0.512997 | -0.83015 | -0.04928 | 0.644217 | 0.435982 | 0.95191 |
| GCST006698-Parental longevity \(both parents in top 10%\) | Inverse variance weighted | 5 | -19.4316 | 8.813726 | 0.027475 | 0.514997 | -36.7065 | -2.15668 | 3.64E-09 | 1.14E-16 | 0.115708 |
| GCST005116-Male-pattern baldness | Inverse variance weighted | 27 | 0.057552 | 0.026161 | 0.027812 | 0.51972 | 0.006277 | 0.108826 | 1.05924 | 1.006296 | 1.114969 |
| GCST003427-Alzheimer disease and age of onset | Inverse variance weighted | 6 | 0.061949 | 0.028563 | 0.030091 | 0.538636 | 0.005966 | 0.117932 | 1.063908 | 1.005984 | 1.125167 |
| GCST000381-Biomedical quantitative traits | Inverse variance weighted | 2 | 0.043403 | 0.020016 | 0.030129 | 0.538636 | 0.004171 | 0.082634 | 1.044358 | 1.00418 | 1.086145 |
| GCST006891-Dentate gyrus molecular layer volume | Inverse variance weighted | 5 | 0.001969 | 0.000913 | 0.031092 | 0.552776 | 0.000179 | 0.003758 | 1.001971 | 1.000179 | 1.003765 |
| GCST002829-Urate levels in overweight individuals | Inverse variance weighted | 8 | 0.075405 | 0.035316 | 0.032751 | 0.572245 | 0.006185 | 0.144625 | 1.07832 | 1.006204 | 1.155606 |
| GCST001290-Height | Inverse variance weighted | 5 | -0.35471 | 0.166502 | 0.03314 | 0.576323 | -0.68106 | -0.02837 | 0.701375 | 0.506082 | 0.972029 |
| GCST000582-Mean corpuscular hemoglobin concentration | Inverse variance weighted | 2 | -0.30748 | 0.144657 | 0.033536 | 0.576999 | -0.59101 | -0.02396 | 0.735295 | 0.553766 | 0.976329 |
| GCST006810-Self-reported risk-taking behaviour | Inverse variance weighted | 16 | -0.33087 | 0.155871 | 0.033777 | 0.576999 | -0.63638 | -0.02536 | 0.718297 | 0.529205 | 0.974954 |
| GCST000880-Menarche \(age at onset\) | Inverse variance weighted | 19 | -0.00311 | 0.001473 | 0.034945 | 0.581743 | -0.00599 | -0.00022 | 0.996899 | 0.994025 | 0.999781 |
| GCST006898-Hypothyroidism | Inverse variance weighted | 6 | -0.08378 | 0.039928 | 0.035874 | 0.58972 | -0.16204 | -0.00552 | 0.919632 | 0.850407 | 0.994491 |
| GCST002647-Height | Inverse variance weighted | 113 | -0.10468 | 0.050002 | 0.036309 | 0.593683 | -0.20268 | -0.00667 | 0.900616 | 0.81654 | 0.993349 |
| GCST002762-Optic cup area | Inverse variance weighted | 10 | -0.60976 | 0.293113 | 0.037499 | 0.601293 | -1.18426 | -0.03526 | 0.543481 | 0.305972 | 0.965356 |
| GCST002922-Multiple myeloma and monoclonal gammopathy | Inverse variance weighted | 3 | -0.099 | 0.04768 | 0.037863 | 0.603062 | -0.19245 | -0.00555 | 0.905743 | 0.824934 | 0.994469 |
| GCST002442-Blood metabolite ratios | Inverse variance weighted | 39 | -0.08358 | 0.04031 | 0.03814 | 0.605909 | -0.16258 | -0.00457 | 0.919821 | 0.849945 | 0.995442 |
| GCST006871-Total hippocampal volume | Inverse variance weighted | 8 | 0.000263 | 0.000127 | 0.039344 | 0.617176 | 1.28E-05 | 0.000513 | 1.000263 | 1.000013 | 1.000513 |
| GCST004941-Dehydroepiandrosterone sulphate levels | Inverse variance weighted | 2 | -0.491 | 0.238291 | 0.039351 | 0.617176 | -0.95805 | -0.02395 | 0.612016 | 0.383641 | 0.976338 |
| GCST004386-Diastolic blood pressure | Inverse variance weighted | 3 | 0.053547 | 0.026055 | 0.039868 | 0.618965 | 0.002478 | 0.104615 | 1.055006 | 1.002481 | 1.110283 |
| GCST001213-Type 2 diabetes | Inverse variance weighted | 5 | -0.1983 | 0.096673 | 0.040243 | 0.620851 | -0.38778 | -0.00882 | 0.820123 | 0.678562 | 0.991218 |
| GCST002738-Psoriasis | Inverse variance weighted | 9 | -0.07063 | 0.034443 | 0.040293 | 0.620851 | -0.13814 | -0.00313 | 0.931804 | 0.870977 | 0.99688 |
| GCST007430-Peak expiratory flow | Inverse variance weighted | 54 | 0.179826 | 0.087837 | 0.040632 | 0.624507 | 0.007666 | 0.351986 | 1.197009 | 1.007695 | 1.421888 |
| GCST001227-Systolic blood pressure | Inverse variance weighted | 8 | -0.02309 | 0.011292 | 0.04092 | 0.625676 | -0.04522 | -0.00095 | 0.977179 | 0.955789 | 0.999048 |
| GCST004004-Mean corpuscular volume | Inverse variance weighted | 8 | -3.37403 | 1.651574 | 0.04106 | 0.625676 | -6.61112 | -0.13695 | 0.034251 | 0.001345 | 0.872016 |
| GCST007335-Age at first sexual intercourse | Inverse variance weighted | 14 | -0.3633 | 0.178284 | 0.041573 | 0.629532 | -0.71274 | -0.01387 | 0.695377 | 0.4903 | 0.98623 |
| GCST003217-Triglycerides | Inverse variance weighted | 5 | 6.202123 | 3.045539 | 0.041704 | 0.629967 | 0.232866 | 12.17138 | 493.7964 | 1.262212 | 193180.6 |
| GCST000728-Behcet's disease | Inverse variance weighted | 2 | -0.07499 | 0.036912 | 0.042193 | 0.634053 | -0.14734 | -0.00264 | 0.927752 | 0.863002 | 0.99736 |
| GCST000611-Height | Inverse variance weighted | 7 | -0.19835 | 0.09793 | 0.042823 | 0.63758 | -0.39029 | -0.00641 | 0.820082 | 0.676858 | 0.993613 |
| GCST001463-Adiponectin levels | Inverse variance weighted | 3 | -0.46186 | 0.22847 | 0.043226 | 0.63758 | -0.90966 | -0.01406 | 0.630113 | 0.402662 | 0.986043 |
| GCST001930-Breast cancer | Inverse variance weighted | 5 | -0.12293 | 0.060855 | 0.043387 | 0.63758 | -0.2422 | -0.00365 | 0.884329 | 0.784898 | 0.996357 |
| GCST004364-Intelligence | Inverse variance weighted | 8 | -0.00281 | 0.001394 | 0.043485 | 0.63758 | -0.00555 | \#\#\#\#\#\#\#\# | 0.99719 | 0.99447 | 0.999918 |
| GCST007518-Type 2 diabetes \(adjusted for BMI\) | Inverse variance weighted | 9 | 0.263817 | 0.130696 | 0.043534 | 0.63758 | 0.007652 | 0.519981 | 1.301889 | 1.007682 | 1.681996 |
| GCST001101-Corneal curvature | Inverse variance weighted | 2 | -0.25272 | 0.125721 | 0.044416 | 0.644833 | -0.49913 | -0.0063 | 0.776687 | 0.607057 | 0.993715 |
| GCST004201-Gallbladder cancer | Inverse variance weighted | 2 | -0.07023 | 0.034946 | 0.044471 | 0.644833 | -0.13872 | -0.00173 | 0.932181 | 0.870469 | 0.998267 |
| GCST001484-Head circumference \(infant\) | Inverse variance weighted | 2 | -0.35691 | 0.177848 | 0.044769 | 0.646977 | -0.70549 | -0.00833 | 0.699837 | 0.493866 | 0.991708 |
| GCST004241-Triglyceride levels | Inverse variance weighted | 3 | 0.434939 | 0.216975 | 0.04501 | 0.64806 | 0.009669 | 0.86021 | 1.544869 | 1.009715 | 2.363657 |
| GCST006289-Spherical equivalent | Inverse variance weighted | 23 | 0.076823 | 0.038389 | 0.045377 | 0.649039 | 0.001579 | 0.152066 | 1.07985 | 1.001581 | 1.164237 |
| GCST003761-Emphysema distribution in smoking | Inverse variance weighted | 5 | -0.22645 | 0.113205 | 0.045458 | 0.649039 | -0.44834 | -0.00457 | 0.797356 | 0.63869 | 0.995438 |
| GCST000663-Obesity \(early onset extreme\) | Inverse variance weighted | 2 | -0.1706 | 0.085474 | 0.045945 | 0.653042 | -0.33813 | -0.00307 | 0.843161 | 0.713106 | 0.996936 |
| GCST007446-vWF levels | Inverse variance weighted | 10 | 0.635815 | 0.318857 | 0.046147 | 0.653042 | 0.010856 | 1.260774 | 1.888561 | 1.010915 | 3.528152 |
| GCST002041-Blood trace element \(Cu levels\) | Inverse variance weighted | 2 | -0.14458 | 0.072598 | 0.046418 | 0.653042 | -0.28688 | -0.00229 | 0.865382 | 0.750604 | 0.997711 |
| GCST006945-Feeling guilty | Inverse variance weighted | 15 | -0.00198 | 0.001004 | 0.048304 | 0.671885 | -0.00395 | \#\#\#\#\#\#\#\# | 0.99802 | 0.996059 | 0.999985 |
| GCST007092-Osteoarthritis of the hip or knee | Inverse variance weighted | 12 | 0.198741 | 0.100955 | 0.048998 | 0.680005 | 0.000869 | 0.396613 | 1.219866 | 1.000869 | 1.48678 |
| GCST004611-High light scatter reticulocyte count | Inverse variance weighted | 87 | 0.135434 | 0.068926 | 0.049424 | 0.684373 | 0.000339 | 0.27053 | 1.145034 | 1.000339 | 1.310659 |
| GCST001032-Caffeine consumption | Inverse variance weighted | 2 | 0.172782 | 0.088878 | 0.05189 | 0.706523 | -0.00142 | 0.346983 | 1.188608 | 0.998583 | 1.414792 |
| GCST006802-Body mass index | Inverse variance weighted | 17 | -0.25966 | 0.134948 | 0.054333 | 0.718853 | -0.52416 | 0.004834 | 0.77131 | 0.59205 | 1.004846 |
| GCST000450-Matrix metalloproteinase levels | Inverse variance weighted | 2 | -0.05439 | 0.028301 | 0.054627 | 0.718853 | -0.10986 | 0.00108 | 0.947063 | 0.895961 | 1.001081 |
| GCST001783-Platelet count | Inverse variance weighted | 3 | -0.002 | 0.001046 | 0.055279 | 0.720188 | -0.00405 | 4.53E-05 | 0.997998 | 0.995955 | 1.000045 |
| GCST002234-Breast cancer | Inverse variance weighted | 2 | -0.12188 | 0.063656 | 0.055528 | 0.720218 | -0.24665 | 0.002882 | 0.885251 | 0.781415 | 1.002886 |
| GCST001548-Male-pattern baldness | Inverse variance weighted | 6 | -0.04372 | 0.02298 | 0.057096 | 0.729495 | -0.08876 | 0.00132 | 0.95722 | 0.915062 | 1.00132 |
| GCST004950-Breast cancer | Inverse variance weighted | 56 | -0.05446 | 0.028628 | 0.057135 | 0.729495 | -0.11057 | 0.001653 | 0.946998 | 0.895325 | 1.001654 |
| GCST000418-Uric acid levels | Inverse variance weighted | 5 | 0.257957 | 0.135905 | 0.057687 | 0.731259 | -0.00842 | 0.524331 | 1.294283 | 0.991618 | 1.689329 |
| GCST002119-Metabolite levels  \(X-11787\) | Inverse variance weighted | 2 | -0.28021 | 0.147973 | 0.058273 | 0.736814 | -0.57023 | 0.00982 | 0.755627 | 0.565393 | 1.009868 |
| GCST006095-Excessive hairiness | Inverse variance weighted | 2 | 0.115182 | 0.060877 | 0.058485 | 0.736814 | -0.00414 | 0.234501 | 1.122078 | 0.995872 | 1.264278 |
| GCST002674-Febrile seizures \(MMR vaccine-related\) | Inverse variance weighted | 4 | -0.05102 | 0.02701 | 0.058908 | 0.737608 | -0.10396 | 0.001921 | 0.95026 | 0.901261 | 1.001923 |
| GCST003665-Metabolite levels \(lipoprotein measures\) | Inverse variance weighted | 13 | 0.172099 | 0.091359 | 0.059596 | 0.7408 | -0.00696 | 0.351162 | 1.187796 | 0.99306 | 1.420718 |
| GCST005667-Central corneal thickness | Inverse variance weighted | 22 | 0.002777 | 0.001474 | 0.059645 | 0.7408 | -0.00011 | 0.005667 | 1.002781 | 0.999887 | 1.005683 |
| GCST002031-Primary tooth development \(number of teeth\) | Inverse variance weighted | 6 | -0.08218 | 0.043676 | 0.059891 | 0.740855 | -0.16778 | 0.003424 | 0.921106 | 0.845536 | 1.00343 |
| GCST008077-LDL cholesterol levels | Inverse variance weighted | 17 | 0.005964 | 0.003201 | 0.06245 | 0.758785 | -0.00031 | 0.012239 | 1.005982 | 0.99969 | 1.012314 |
| GCST002991-Pancreatic cancer | Inverse variance weighted | 5 | -0.1075 | 0.057839 | 0.063072 | 0.75922 | -0.22087 | 0.00586 | 0.898073 | 0.801823 | 1.005877 |
| GCST004826-P wave duration | Inverse variance weighted | 8 | 0.012351 | 0.006647 | 0.063161 | 0.75922 | -0.00068 | 0.02538 | 1.012428 | 0.999323 | 1.025705 |
| GCST000780-Protein C levels | Inverse variance weighted | 4 | 0.085567 | 0.046481 | 0.065637 | 0.775738 | -0.00554 | 0.17667 | 1.089335 | 0.994479 | 1.193238 |
| GCST005908-Height | Inverse variance weighted | 8 | -0.78146 | 0.424965 | 0.065933 | 0.775738 | -1.61439 | 0.051472 | 0.457737 | 0.199012 | 1.052819 |
| GCST002222-LDL cholesterol | Inverse variance weighted | 39 | 0.109183 | 0.059414 | 0.066112 | 0.775738 | -0.00727 | 0.225634 | 1.115366 | 0.992758 | 1.253117 |
| GCST004894-Type 2 diabetes | Inverse variance weighted | 51 | 0.082639 | 0.044994 | 0.066261 | 0.775738 | -0.00555 | 0.170827 | 1.086149 | 0.994466 | 1.186286 |
| GCST007517-Type 2 diabetes | Inverse variance weighted | 9 | 0.233042 | 0.126949 | 0.066401 | 0.775738 | -0.01578 | 0.481863 | 1.262434 | 0.984345 | 1.619087 |
| GCST002042-LDL cholesterol | Inverse variance weighted | 2 | 0.048033 | 0.026217 | 0.066935 | 0.775738 | -0.00335 | 0.099419 | 1.049205 | 0.996653 | 1.104529 |
| GCST005934-Neuropathic pain in head and neck cancer | Inverse variance weighted | 2 | 0.047979 | 0.026251 | 0.067594 | 0.775841 | -0.00347 | 0.099432 | 1.049149 | 0.996533 | 1.104543 |
| GCST000054-Type 1 diabetes | Inverse variance weighted | 2 | 0.046644 | 0.025537 | 0.067766 | 0.775841 | -0.00341 | 0.096697 | 1.047749 | 0.996598 | 1.101526 |
| GCST005047-Type 2 diabetes | Inverse variance weighted | 35 | 0.077392 | 0.042405 | 0.067993 | 0.776987 | -0.00572 | 0.160506 | 1.080465 | 0.994294 | 1.174105 |
| GCST001848-IgG glycosylation | Inverse variance weighted | 13 | 0.036126 | 0.019809 | 0.068189 | 0.777787 | -0.0027 | 0.074951 | 1.036786 | 0.997305 | 1.077831 |
| GCST006119-Protein C levels | Inverse variance weighted | 5 | 0.094817 | 0.052349 | 0.070102 | 0.787066 | -0.00779 | 0.197421 | 1.099458 | 0.992243 | 1.218256 |
| GCST001662-Generalized epilepsy | Inverse variance weighted | 3 | -0.06402 | 0.035352 | 0.070155 | 0.787066 | -0.13331 | 0.005271 | 0.937986 | 0.875193 | 1.005285 |
| GCST006716-Alcohol use disorder \(total score\) | Inverse variance weighted | 8 | 0.002409 | 0.001332 | 0.070605 | 0.788902 | -0.0002 | 0.005021 | 1.002412 | 0.999798 | 1.005033 |
| GCST001923-Glomerular filtration rate | Inverse variance weighted | 2 | 0.020767 | 0.011522 | 0.071475 | 0.793187 | -0.00182 | 0.04335 | 1.020985 | 0.998186 | 1.044303 |
| GCST002592-Neuritic plaque | Inverse variance weighted | 2 | 0.930297 | 0.516664 | 0.071768 | 0.794603 | -0.08236 | 1.942959 | 2.535263 | 0.920936 | 6.979374 |
| GCST002686-Protein C levels | Inverse variance weighted | 2 | 0.08359 | 0.046623 | 0.07299 | 0.798478 | -0.00779 | 0.174971 | 1.087183 | 0.992239 | 1.191211 |
| GCST007926-Medication use \(antihypertensives\) | Inverse variance weighted | 2 | -0.19706 | 0.110054 | 0.07336 | 0.801101 | -0.41277 | 0.018645 | 0.82114 | 0.661816 | 1.01882 |
| GCST003044-Crohn's disease | Inverse variance weighted | 82 | -0.03541 | 0.01979 | 0.073554 | 0.801257 | -0.0742 | 0.003377 | 0.965207 | 0.928485 | 1.003382 |
| GCST000933-C-reactive protein | Inverse variance weighted | 2 | 0.232782 | 0.130128 | 0.073635 | 0.801257 | -0.02227 | 0.487833 | 1.262106 | 0.977978 | 1.628782 |
| GCST001916-Breast Cancer in BRCA1 mutation carriers | Inverse variance weighted | 2 | 0.101266 | 0.056852 | 0.074876 | 0.803314 | -0.01016 | 0.212696 | 1.106571 | 0.989888 | 1.237009 |
| GCST002226-Fat body mass | Inverse variance weighted | 2 | -0.30858 | 0.17355 | 0.075392 | 0.803314 | -0.64874 | 0.031574 | 0.734487 | 0.522703 | 1.032078 |
| GCST002166-Serum protein levels \(sST2\) | Inverse variance weighted | 10 | -0.08899 | 0.050102 | 0.075697 | 0.803418 | -0.18719 | 0.009208 | 0.914853 | 0.829285 | 1.00925 |
| GCST006984-Takayasu arteritis | Inverse variance weighted | 4 | -0.07329 | 0.041274 | 0.075794 | 0.803418 | -0.15418 | 0.00761 | 0.929334 | 0.857115 | 1.007639 |
| GCST004726-Vitamin D levels | Inverse variance weighted | 7 | -0.16368 | 0.092288 | 0.076137 | 0.8048 | -0.34456 | 0.017207 | 0.849015 | 0.70853 | 1.017356 |
| GCST002216-Triglycerides | Inverse variance weighted | 25 | -0.05772 | 0.032591 | 0.076569 | 0.805559 | -0.12159 | 0.006161 | 0.943918 | 0.885508 | 1.00618 |
| GCST002454-Colorectal cancer | Inverse variance weighted | 13 | 0.075227 | 0.04256 | 0.077136 | 0.805939 | -0.00819 | 0.158645 | 1.078129 | 0.991843 | 1.171922 |
| GCST006697-Parental longevity \(combined parental attained age, Martingale residuals\) | Inverse variance weighted | 17 | 4.714234 | 2.667105 | 0.077137 | 0.805939 | -0.51329 | 9.94176 | 111.5234 | 0.598523 | 20780.28 |
| GCST003851-Caffeine metabolism \(plasma 1,7-dimethylxanthine \(paraxanthine\) to 1,3,7-trimethylxanthine \(caffeine\) ratio\) | Inverse variance weighted | 10 | 0.001653 | 0.000936 | 0.077546 | 0.806693 | -0.00018 | 0.003488 | 1.001654 | 0.999818 | 1.003494 |
| GCST002896-Cholesterol, total | Inverse variance weighted | 26 | 0.187202 | 0.107091 | 0.080452 | 0.82851 | -0.0227 | 0.397099 | 1.20587 | 0.97756 | 1.487503 |
| GCST006886-Subiculum volume | Inverse variance weighted | 3 | 0.00282 | 0.001615 | 0.080702 | 0.829692 | -0.00034 | 0.005985 | 1.002824 | 0.999656 | 1.006003 |
| GCST007815-Male-pattern baldness | Inverse variance weighted | 27 | -0.03913 | 0.022504 | 0.082042 | 0.837116 | -0.08324 | 0.004974 | 0.961622 | 0.920129 | 1.004987 |
| GCST003542-Night sleep phenotypes | Inverse variance weighted | 2 | -0.01298 | 0.00747 | 0.082212 | 0.837116 | -0.02762 | 0.001658 | 0.987101 | 0.972754 | 1.00166 |
| GCST006061-Atrial fibrillation | Inverse variance weighted | 100 | 0.046532 | 0.026799 | 0.082506 | 0.837116 | -0.00599 | 0.099058 | 1.047632 | 0.994024 | 1.10413 |
| GCST003629-nicotine metabolite ratio in current smokers | Inverse variance weighted | 4 | 0.091391 | 0.052681 | 0.082777 | 0.837116 | -0.01186 | 0.194646 | 1.095697 | 0.988206 | 1.214881 |
| GCST002424-C-reactive protein levels | Inverse variance weighted | 3 | 0.129911 | 0.075098 | 0.083651 | 0.837116 | -0.01728 | 0.277104 | 1.138728 | 0.982867 | 1.319304 |
| GCST001307-Gamma glutamyl transferase levels | Inverse variance weighted | 3 | 0.185495 | 0.107261 | 0.083741 | 0.837116 | -0.02474 | 0.395726 | 1.203814 | 0.975567 | 1.485462 |
| GCST007637-Diffusing capacity of carbon monoxide | Inverse variance weighted | 2 | 0.232999 | 0.135204 | 0.084833 | 0.837116 | -0.032 | 0.497999 | 1.26238 | 0.968505 | 1.645426 |
| GCST002084-Allergic sensitization | Inverse variance weighted | 7 | -0.09659 | 0.056055 | 0.084859 | 0.837116 | -0.20646 | 0.013276 | 0.907926 | 0.813458 | 1.013365 |
| GCST004209-Cholesterol, total | Inverse variance weighted | 11 | 0.262342 | 0.152421 | 0.085219 | 0.837116 | -0.0364 | 0.561087 | 1.299972 | 0.964252 | 1.752577 |
| GCST008256-Diverticulitis | Inverse variance weighted | 2 | -0.11174 | 0.064978 | 0.085484 | 0.837116 | -0.2391 | 0.015613 | 0.894274 | 0.787336 | 1.015736 |
| GCST006077-Branched-chain amino acid levels \(Isoleucine\) | Inverse variance weighted | 4 | 0.197103 | 0.114663 | 0.085619 | 0.837116 | -0.02764 | 0.421842 | 1.217869 | 0.972742 | 1.524767 |
| GCST004564-Waist circumference adjusted for BMI in active individuals | Inverse variance weighted | 52 | -0.13627 | 0.080128 | 0.089001 | 0.857649 | -0.29332 | 0.020778 | 0.872604 | 0.74578 | 1.020995 |
| GCST004146-Chronic lymphocytic leukemia | Inverse variance weighted | 17 | -0.03608 | 0.021264 | 0.089764 | 0.858446 | -0.07775 | 0.0056 | 0.964566 | 0.925192 | 1.005616 |
| GCST006887-Hippocampal subfield CA1 volume | Inverse variance weighted | 3 | 0.001563 | 0.000923 | 0.090293 | 0.858446 | -0.00025 | 0.003372 | 1.001564 | 0.999754 | 1.003377 |
| GCST007931-Medication use \(HMG CoA reductase inhibitors\) | Inverse variance weighted | 53 | 0.206151 | 0.121777 | 0.090482 | 0.858446 | -0.03253 | 0.444833 | 1.228939 | 0.967992 | 1.56023 |
| GCST004237-Triglyceride levels | Inverse variance weighted | 32 | 0.689004 | 0.407034 | 0.090504 | 0.858446 | -0.10878 | 1.48679 | 1.991731 | 0.896926 | 4.422877 |
| GCST004608-Granulocyte percentage of myeloid white cells | Inverse variance weighted | 111 | 0.100528 | 0.05951 | 0.091173 | 0.858446 | -0.01611 | 0.217168 | 1.105754 | 0.984016 | 1.242553 |
| GCST004135-White blood cell count \(eosinophil\) | Inverse variance weighted | 2 | -1.73225 | 1.02643 | 0.091478 | 0.858446 | -3.74406 | 0.279548 | 0.176885 | 0.023658 | 1.322532 |
| GCST000497-Mean platelet volume | Inverse variance weighted | 8 | 0.783095 | 0.464786 | 0.092017 | 0.858446 | -0.12789 | 1.694077 | 2.188235 | 0.879954 | 5.441619 |
| GCST004609-Monocyte percentage of white cells | Inverse variance weighted | 114 | -0.08134 | 0.048303 | 0.092189 | 0.858446 | -0.17602 | 0.013334 | 0.921879 | 0.838605 | 1.013423 |
| GCST007140-High density lipoprotein cholesterol levels | Inverse variance weighted | 169 | -0.21933 | 0.130582 | 0.093028 | 0.858446 | -0.47527 | 0.03661 | 0.803057 | 0.621717 | 1.037289 |
| GCST000545-Fetal hemoglobin levels | Inverse variance weighted | 2 | -0.13673 | 0.081448 | 0.093206 | 0.858446 | -0.29637 | 0.022909 | 0.872207 | 0.743514 | 1.023174 |
| GCST001610-Renal function-related traits \(BUN\) | Inverse variance weighted | 6 | -2.14352 | 1.278521 | 0.093628 | 0.858446 | -4.64942 | 0.362381 | 0.117241 | 0.009567 | 1.436746 |
| GCST001570-Chronic lymphocytic leukemia | Inverse variance weighted | 4 | -0.05276 | 0.031611 | 0.095125 | 0.858446 | -0.11471 | 0.0092 | 0.94861 | 0.89162 | 1.009242 |
| GCST005897-Low tan response | Inverse variance weighted | 45 | -0.02383 | 0.014285 | 0.095274 | 0.858446 | -0.05183 | 0.004168 | 0.976452 | 0.949493 | 1.004177 |
| GCST006979-Heel bone mineral density | Inverse variance weighted | 673 | 0.059075 | 0.035428 | 0.095424 | 0.858446 | -0.01036 | 0.128514 | 1.060855 | 0.989689 | 1.137138 |
| GCST002630-Systolic blood pressure | Inverse variance weighted | 9 | -0.01058 | 0.006347 | 0.095481 | 0.858446 | -0.02302 | 0.001859 | 0.989474 | 0.977242 | 1.00186 |
| GCST006622-Neonatal cytokine/chemokine levels \(fetal genetic effect\) | Inverse variance weighted | 6 | -0.047 | 0.028202 | 0.095613 | 0.858446 | -0.10227 | 0.008277 | 0.954089 | 0.902782 | 1.008312 |
| GCST007012-Cerebrospinal fluid AB1-42 levels | Inverse variance weighted | 2 | -1.21316 | 0.728766 | 0.095978 | 0.859497 | -2.64154 | 0.215225 | 0.297258 | 0.071252 | 1.240141 |
| GCST000225-Inflammatory bowel disease | Inverse variance weighted | 5 | -0.05995 | 0.036266 | 0.09833 | 0.871318 | -0.13103 | 0.011133 | 0.941814 | 0.877193 | 1.011196 |
| GCST006888-Hippocampal subfield CA3 volume | Inverse variance weighted | 3 | 0.004109 | 0.00249 | 0.098988 | 0.873144 | -0.00077 | 0.00899 | 1.004117 | 0.999228 | 1.00903 |
| GCST002631-Diastolic blood pressure | Inverse variance weighted | 7 | -0.02276 | 0.013806 | 0.099283 | 0.873511 | -0.04982 | 0.004303 | 0.9775 | 0.951403 | 1.004312 |
| GCST008257-Diverticular disease | Inverse variance weighted | 2 | -0.13694 | 0.083125 | 0.099467 | 0.873511 | -0.29987 | 0.025982 | 0.872019 | 0.740915 | 1.026322 |
| GCST007938-Medication use \(anilides\) | Inverse variance weighted | 4 | -0.31532 | 0.19189 | 0.10034 | 0.873511 | -0.69142 | 0.06079 | 0.729559 | 0.500864 | 1.062675 |
| GCST002828-Urate levels in obese individuals | Inverse variance weighted | 3 | 0.068259 | 0.041553 | 0.100451 | 0.873511 | -0.01319 | 0.149704 | 1.070642 | 0.9869 | 1.16149 |
| GCST001698-Serum total protein level | Inverse variance weighted | 2 | -0.76206 | 0.46419 | 0.100652 | 0.874022 | -1.67188 | 0.147751 | 0.466703 | 0.187894 | 1.159224 |
| GCST000249-Basal cell carcinoma | Inverse variance weighted | 2 | 0.077001 | 0.046953 | 0.101009 | 0.874656 | -0.01503 | 0.169029 | 1.080044 | 0.985087 | 1.184154 |
| GCST006924-Loneliness \(MTAG\) | Inverse variance weighted | 9 | 1.102958 | 0.673366 | 0.101426 | 0.875041 | -0.21684 | 2.422755 | 3.013066 | 0.80506 | 11.27689 |
| GCST000303-Glycated hemoglobin levels | Inverse variance weighted | 3 | 0.453206 | 0.276737 | 0.101489 | 0.875041 | -0.0892 | 0.995611 | 1.573349 | 0.914664 | 2.706378 |
| GCST003364-Triglyceride levels | Inverse variance weighted | 3 | 0.119857 | 0.073206 | 0.101577 | 0.875041 | -0.02363 | 0.263342 | 1.127336 | 0.97665 | 1.301271 |
| GCST004574-Skin aging \(microtopography measurement\) | Inverse variance weighted | 4 | -0.15106 | 0.092317 | 0.101777 | 0.875041 | -0.332 | 0.029883 | 0.859798 | 0.717489 | 1.030334 |
| GCST004495-BMI \(adjusted for smoking behaviour\) | Inverse variance weighted | 38 | -0.2288 | 0.140879 | 0.104361 | 0.881471 | -0.50492 | 0.047325 | 0.795489 | 0.603553 | 1.048463 |
| GCST001215-Coffee consumption | Inverse variance weighted | 3 | 0.257978 | 0.159133 | 0.104984 | 0.885383 | -0.05392 | 0.569878 | 1.294311 | 0.947507 | 1.768052 |
| GCST002598-Educational attainment | Inverse variance weighted | 3 | -0.59616 | 0.370528 | 0.107627 | 0.897814 | -1.3224 | 0.130073 | 0.550922 | 0.266496 | 1.138911 |
| GCST001381-Menopause \(age at onset\) | Inverse variance weighted | 15 | -0.02794 | 0.017383 | 0.108026 | 0.898041 | -0.06201 | 0.006134 | 0.97245 | 0.939877 | 1.006153 |
| GCST006421-Cannabis use | Inverse variance weighted | 3 | -0.28351 | 0.176468 | 0.108145 | 0.898041 | -0.62939 | 0.062366 | 0.753134 | 0.532917 | 1.064352 |
| GCST006231-Mean arterial pressure | Inverse variance weighted | 24 | -0.01531 | 0.009537 | 0.108384 | 0.898041 | -0.03401 | 0.003381 | 0.984804 | 0.966566 | 1.003387 |
| GCST004777-Diastolic blood pressure | Inverse variance weighted | 21 | -0.02488 | 0.015517 | 0.108877 | 0.89982 | -0.05529 | 0.005536 | 0.975429 | 0.94621 | 1.005551 |
| GCST001116-Progressive supranuclear palsy | Inverse variance weighted | 5 | -0.02256 | 0.014095 | 0.109489 | 0.903543 | -0.05018 | 0.005067 | 0.977694 | 0.951055 | 1.00508 |
| GCST004144-Thyroid cancer | Inverse variance weighted | 5 | -0.03752 | 0.023452 | 0.109661 | 0.903749 | -0.08348 | 0.008449 | 0.963179 | 0.919907 | 1.008485 |
| GCST000568-Fasting blood glucose | Inverse variance weighted | 9 | 0.399556 | 0.250046 | 0.11006 | 0.905355 | -0.09054 | 0.889647 | 1.491162 | 0.913442 | 2.434269 |
| GCST003072-Cerebrospinal fluid AB1-42 levels | Inverse variance weighted | 2 | 0.247184 | 0.154803 | 0.110318 | 0.905355 | -0.05623 | 0.550598 | 1.280415 | 0.945322 | 1.73429 |
| GCST007445-Factor VIII levels | Inverse variance weighted | 9 | 0.818848 | 0.513957 | 0.11111 | 0.905392 | -0.18851 | 1.826203 | 2.267885 | 0.828194 | 6.210264 |
| GCST002606-Prostate cancer | Inverse variance weighted | 11 | -0.09908 | 0.062248 | 0.111455 | 0.905392 | -0.22108 | 0.022926 | 0.905671 | 0.80165 | 1.023191 |
| GCST001937-Breast cancer | Inverse variance weighted | 47 | -0.04909 | 0.030851 | 0.111555 | 0.905392 | -0.10956 | 0.011376 | 0.952094 | 0.89623 | 1.011441 |
| GCST004878-Sj?gren's syndrome | Inverse variance weighted | 5 | -0.04551 | 0.028616 | 0.111738 | 0.905392 | -0.1016 | 0.010575 | 0.955509 | 0.903393 | 1.010632 |
| GCST006628-Systolic blood pressure | Inverse variance weighted | 36 | 0.022256 | 0.014014 | 0.11227 | 0.905392 | -0.00521 | 0.049724 | 1.022505 | 0.994801 | 1.050981 |
| GCST007018-Serum bilirubin levels in metabolic syndrome | Inverse variance weighted | 7 | 0.081713 | 0.051459 | 0.112306 | 0.905392 | -0.01915 | 0.182573 | 1.085144 | 0.981035 | 1.200302 |
| GCST002388-Serum metabolite levels | Inverse variance weighted | 7 | -0.0489 | 0.030824 | 0.11266 | 0.905392 | -0.10931 | 0.011518 | 0.952278 | 0.896449 | 1.011584 |
| GCST004518-Waist-to-hip ratio adjusted for body mass index | Inverse variance weighted | 2 | 0.428863 | 0.270788 | 0.113248 | 0.905392 | -0.10188 | 0.959606 | 1.53551 | 0.903137 | 2.610668 |
| GCST008156-Hip circumference adjusted for BMI | Inverse variance weighted | 4 | 0.246826 | 0.155871 | 0.113301 | 0.905392 | -0.05868 | 0.552332 | 1.279956 | 0.943008 | 1.737301 |
| GCST004963-Lipoprotein phospholipase A2 activity in cardiovascular disease | Inverse variance weighted | 7 | 0.007966 | 0.005034 | 0.113593 | 0.905392 | -0.0019 | 0.017833 | 1.007998 | 0.9981 | 1.017993 |
| GCST008260-group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP | Inverse variance weighted | 8 | -0.01178 | 0.007462 | 0.114406 | 0.905392 | -0.02641 | 0.002845 | 0.988289 | 0.97394 | 1.002849 |
| GCST005591-Colorectal cancer | Inverse variance weighted | 9 | 0.101415 | 0.064514 | 0.115954 | 0.90635 | -0.02503 | 0.227863 | 1.106736 | 0.975278 | 1.255913 |
| GCST000507-Systemic lupus erythematosus | Inverse variance weighted | 10 | -0.03952 | 0.025167 | 0.116302 | 0.907224 | -0.08885 | 0.009803 | 0.961246 | 0.91498 | 1.009851 |
| GCST002195-Hormone measurements | Inverse variance weighted | 2 | 0.196574 | 0.125677 | 0.117788 | 0.909239 | -0.04975 | 0.4429 | 1.217225 | 0.951465 | 1.557217 |
| GCST007461-Alcohol consumption \(drinks per week\) | Inverse variance weighted | 56 | 0.413113 | 0.264197 | 0.117898 | 0.909239 | -0.10471 | 0.930939 | 1.511516 | 0.900584 | 2.536889 |
| GCST005806-Blood protein levels | Inverse variance weighted | 711 | 0.008263 | 0.005286 | 0.118038 | 0.909239 | -0.0021 | 0.018624 | 1.008297 | 0.997904 | 1.018798 |
| GCST004094-Prostate-specific antigen levels \(conditioned on lead SNPs\) | Inverse variance weighted | 3 | -0.35754 | 0.229197 | 0.118766 | 0.909239 | -0.80677 | 0.091684 | 0.699393 | 0.446298 | 1.096019 |
| GCST001263-Height | Inverse variance weighted | 7 | -0.20593 | 0.132259 | 0.11946 | 0.909239 | -0.46516 | 0.053295 | 0.813888 | 0.628034 | 1.05474 |
| GCST001873-Red blood cell traits | Inverse variance weighted | 3 | 0.100953 | 0.065014 | 0.120473 | 0.909997 | -0.02647 | 0.228379 | 1.106224 | 0.973873 | 1.256562 |
| GCST006870-Hippocampal tail volume | Inverse variance weighted | 7 | 0.000958 | 0.000619 | 0.121349 | 0.911854 | -0.00025 | 0.002171 | 1.000959 | 0.999746 | 1.002173 |
| GCST002086-C-reactive protein | Inverse variance weighted | 3 | 4.921829 | 3.180641 | 0.121759 | 0.912323 | -1.31223 | 11.15589 | 137.2534 | 0.26922 | 69974.48 |
| GCST004625-Monocyte count | Inverse variance weighted | 104 | -0.08272 | 0.053482 | 0.121937 | 0.912323 | -0.18754 | 0.022104 | 0.920609 | 0.828992 | 1.02235 |
| GCST002966-Amino acid levels | Inverse variance weighted | 5 | -0.25535 | 0.16594 | 0.123859 | 0.912323 | -0.58059 | 0.069898 | 0.774649 | 0.559569 | 1.072399 |
| GCST006259-Systolic blood pressure | Inverse variance weighted | 36 | -0.01248 | 0.008114 | 0.124083 | 0.912323 | -0.02838 | 0.003425 | 0.9876 | 0.972018 | 1.003431 |
| GCST005186-Fasting blood glucose | Inverse variance weighted | 18 | 0.293661 | 0.191606 | 0.125366 | 0.915315 | -0.08189 | 0.669208 | 1.341329 | 0.921377 | 1.95269 |
| GCST002364-Urinary metabolites \(H-NMR features\) | Inverse variance weighted | 15 | 0.017928 | 0.01173 | 0.126422 | 0.91652 | -0.00506 | 0.040919 | 1.018089 | 0.99495 | 1.041767 |
| GCST000372-Height | Inverse variance weighted | 5 | 0.163143 | 0.107318 | 0.128466 | 0.923246 | -0.0472 | 0.373487 | 1.177205 | 0.953896 | 1.452791 |
| GCST000652-Age-related macular degeneration | Inverse variance weighted | 2 | 0.018806 | 0.012381 | 0.128798 | 0.923246 | -0.00546 | 0.043073 | 1.018984 | 0.994553 | 1.044014 |
| GCST006890-Dentate gyrus granule cell layer volume | Inverse variance weighted | 4 | 0.002674 | 0.001768 | 0.130478 | 0.927093 | -0.00079 | 0.006139 | 1.002677 | 0.999209 | 1.006158 |
| GCST002337-Amyotrophic lateral sclerosis \(sporadic\) | Inverse variance weighted | 4 | 0.015988 | 0.010575 | 0.13056 | 0.927093 | -0.00474 | 0.036714 | 1.016116 | 0.995273 | 1.037396 |
| GCST006889-Hippocampal subfield CA4 volume | Inverse variance weighted | 4 | 0.00315 | 0.002086 | 0.130943 | 0.927093 | -0.00094 | 0.007238 | 1.003155 | 0.999063 | 1.007264 |
| GCST007269-Pulse pressure | Inverse variance weighted | 183 | -0.01321 | 0.008746 | 0.131042 | 0.927093 | -0.03035 | 0.003936 | 0.986881 | 0.970108 | 1.003943 |
| GCST007225-Varicose veins | Inverse variance weighted | 11 | 0.067691 | 0.044896 | 0.131621 | 0.928827 | -0.0203 | 0.155687 | 1.070035 | 0.9799 | 1.16846 |
| GCST002243-Bladder cancer | Inverse variance weighted | 2 | -0.1277 | 0.084764 | 0.13193 | 0.928827 | -0.29384 | 0.038437 | 0.880118 | 0.745399 | 1.039186 |
| GCST002745-Total bilirubin levels in HIV-1 infection | Inverse variance weighted | 4 | 0.129831 | 0.086397 | 0.13291 | 0.932795 | -0.03951 | 0.29917 | 1.138636 | 0.961263 | 1.348739 |
| GCST001231-Carotid intima media thickness | Inverse variance weighted | 3 | -0.18304 | 0.12186 | 0.133089 | 0.932809 | -0.42188 | 0.055808 | 0.832737 | 0.655811 | 1.057394 |
| GCST007044-Extremely high intelligence | Inverse variance weighted | 18 | -0.00147 | 0.000983 | 0.133568 | 0.932809 | -0.0034 | 0.000452 | 0.998526 | 0.996604 | 1.000452 |
| GCST002703-Prostate-specific antigen levels | Inverse variance weighted | 4 | 0.11827 | 0.078857 | 0.133663 | 0.932809 | -0.03629 | 0.27283 | 1.125548 | 0.964362 | 1.313676 |
| GCST002541-Menarche \(age at onset\) | Inverse variance weighted | 82 | -0.07759 | 0.051814 | 0.134276 | 0.932809 | -0.17914 | 0.023966 | 0.925345 | 0.835987 | 1.024256 |
| GCST007925-Medication use \(vasodilators used in cardiac diseases\) | Inverse variance weighted | 2 | -0.15208 | 0.101573 | 0.134319 | 0.932809 | -0.35117 | 0.046999 | 0.858917 | 0.703867 | 1.048121 |
| GCST004750-Squamous cell lung carcinoma | Inverse variance weighted | 12 | -0.0514 | 0.034349 | 0.134547 | 0.932809 | -0.11872 | 0.015924 | 0.949899 | 0.888054 | 1.016051 |
| GCST004070-Cerebrospinal P-tau181p levels | Inverse variance weighted | 2 | 10.97812 | 7.33694 | 0.134581 | 0.932809 | -3.40228 | 25.35852 | 58578.26 | 0.033297 | 1.03E+11 |
| GCST006611-HDL cholesterol | Inverse variance weighted | 93 | -0.39798 | 0.266374 | 0.135161 | 0.934089 | -0.92007 | 0.124115 | 0.671678 | 0.398492 | 1.132146 |
| GCST007718-Urinary albumin-to-creatinine ratio | Inverse variance weighted | 4 | 0.695021 | 0.465517 | 0.135435 | 0.934089 | -0.21739 | 1.607434 | 2.00375 | 0.804614 | 4.989991 |
| GCST006911-Asthma \(moderate or severe\) | Inverse variance weighted | 12 | 0.093193 | 0.06251 | 0.136003 | 0.934089 | -0.02933 | 0.215713 | 1.097674 | 0.971099 | 1.240747 |
| GCST002315-Thrombin generation potential phenotypes | Inverse variance weighted | 2 | 0.003035 | 0.002041 | 0.137074 | 0.936211 | -0.00097 | 0.007036 | 1.00304 | 0.999034 | 1.007061 |
| GCST004499-BMI in non-smokers | Inverse variance weighted | 25 | -0.21298 | 0.14357 | 0.137957 | 0.936436 | -0.49438 | 0.06842 | 0.808174 | 0.609951 | 1.070814 |
| GCST000672-Paget's disease | Inverse variance weighted | 2 | -0.0416 | 0.028201 | 0.140173 | 0.945821 | -0.09688 | 0.013673 | 0.959252 | 0.907669 | 1.013767 |
| GCST004334-Mean corpuscular hemoglobin | Inverse variance weighted | 4 | -0.06807 | 0.04634 | 0.141867 | 0.95205 | -0.15889 | 0.022759 | 0.934197 | 0.853086 | 1.02302 |
| GCST005846-Heart rate response to recovery post exercise \(10 sec\) | Inverse variance weighted | 8 | -0.19043 | 0.129764 | 0.142232 | 0.95205 | -0.44477 | 0.063905 | 0.826602 | 0.640973 | 1.065991 |
| GCST000527-Ulcerative colitis | Inverse variance weighted | 2 | 0.156914 | 0.107232 | 0.143383 | 0.95506 | -0.05326 | 0.36709 | 1.169895 | 0.948132 | 1.443527 |
| GCST001969-Heart rate | Inverse variance weighted | 15 | 0.016419 | 0.01125 | 0.144411 | 0.960866 | -0.00563 | 0.038468 | 1.016555 | 0.994386 | 1.039218 |
| GCST001984-Graves' disease | Inverse variance weighted | 2 | 0.112834 | 0.077563 | 0.145739 | 0.962317 | -0.03919 | 0.264857 | 1.119446 | 0.961569 | 1.303245 |
| GCST001758-Birth weight | Inverse variance weighted | 4 | -0.22072 | 0.151814 | 0.145981 | 0.962317 | -0.51827 | 0.076837 | 0.801943 | 0.595548 | 1.079866 |
| GCST004347-Glioma | Inverse variance weighted | 3 | -0.08053 | 0.055414 | 0.146157 | 0.962317 | -0.18914 | 0.028081 | 0.922628 | 0.827671 | 1.028479 |
| GCST006575-Takayasu arteritis | Inverse variance weighted | 2 | 0.031391 | 0.021603 | 0.146195 | 0.962317 | -0.01095 | 0.073733 | 1.031889 | 0.989109 | 1.076519 |
| GCST007507-Benign prostatic hyperplasia and lower urinary tract symptoms | Inverse variance weighted | 10 | -0.10628 | 0.073663 | 0.149093 | 0.966906 | -0.25066 | 0.038103 | 0.899176 | 0.778289 | 1.038838 |
| GCST007459-Smoking behaviour \(cigarettes smoked per day\) | Inverse variance weighted | 32 | -0.19875 | 0.138627 | 0.151668 | 0.973634 | -0.47045 | 0.072965 | 0.819759 | 0.624718 | 1.075692 |
| GCST000818-Urate levels | Inverse variance weighted | 7 | 0.000971 | 0.000677 | 0.151899 | 0.973634 | -0.00036 | 0.002298 | 1.000971 | 0.999643 | 1.002301 |
| GCST007266-Adult asthma | Inverse variance weighted | 2 | -0.07863 | 0.055054 | 0.15322 | 0.976109 | -0.18654 | 0.029275 | 0.924381 | 0.829827 | 1.029708 |
| GCST008295-Number of decayed, missing and filled tooth surfaces or use of dentures | Inverse variance weighted | 23 | 0.30775 | 0.215954 | 0.154137 | 0.977949 | -0.11552 | 0.731019 | 1.36036 | 0.890903 | 2.077197 |
| GCST008070-HDL cholesterol levels | Inverse variance weighted | 28 | -0.46524 | 0.32737 | 0.155271 | 0.979425 | -1.10689 | 0.176401 | 0.627982 | 0.330586 | 1.192916 |
| GCST002603-Creatine kinase in statin users | Inverse variance weighted | 2 | -0.16957 | 0.119339 | 0.155351 | 0.979425 | -0.40347 | 0.064338 | 0.84403 | 0.667996 | 1.066453 |
| GCST002921-Multiple myeloma | Inverse variance weighted | 2 | -0.07558 | 0.053343 | 0.156508 | 0.979425 | -0.18014 | 0.02897 | 0.927203 | 0.835157 | 1.029394 |
| GCST001858-Refractive error | Inverse variance weighted | 14 | 0.071176 | 0.050282 | 0.156916 | 0.979425 | -0.02738 | 0.169729 | 1.07377 | 0.972994 | 1.184984 |
| GCST005312-Menopause \(age at onset\) | Inverse variance weighted | 38 | -0.02412 | 0.017061 | 0.157424 | 0.979425 | -0.05756 | 0.009319 | 0.976168 | 0.944064 | 1.009363 |
| GCST006624-Systolic blood pressure | Inverse variance weighted | 80 | 0.018232 | 0.012901 | 0.157583 | 0.979425 | -0.00705 | 0.043518 | 1.018399 | 0.992971 | 1.044478 |
| GCST002830-Urate levels in lean individuals | Inverse variance weighted | 3 | 0.051421 | 0.036672 | 0.160854 | 0.985284 | -0.02046 | 0.123298 | 1.052766 | 0.979753 | 1.131221 |
| GCST006475-Depressed affect | Inverse variance weighted | 40 | 0.30983 | 0.221139 | 0.161196 | 0.985284 | -0.1236 | 0.743263 | 1.363193 | 0.88373 | 2.102787 |
| GCST003359-Serum uric acid levels | Inverse variance weighted | 2 | 0.001278 | 0.000913 | 0.161646 | 0.985284 | -0.00051 | 0.003068 | 1.001279 | 0.999488 | 1.003072 |
| GCST001609-Lung adenocarcinoma | Inverse variance weighted | 3 | -0.07835 | 0.05602 | 0.161951 | 0.985284 | -0.18815 | 0.031453 | 0.924644 | 0.828494 | 1.031953 |
| GCST004572-Iron status biomarkers \(transferrin saturation\) | Inverse variance weighted | 3 | -0.16179 | 0.11572 | 0.162085 | 0.985284 | -0.3886 | 0.065024 | 0.850622 | 0.678006 | 1.067185 |
| GCST007492-Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | Inverse variance weighted | 3 | 0.600254 | 0.429657 | 0.162398 | 0.985284 | -0.24187 | 1.442381 | 1.822581 | 0.785155 | 4.230759 |
| GCST002733-Platelet count | Inverse variance weighted | 3 | 0.002485 | 0.001779 | 0.162399 | 0.985284 | -0.001 | 0.005972 | 1.002488 | 0.998999 | 1.00599 |
| GCST005213-Asthma \(childhood onset\) | Inverse variance weighted | 3 | 0.095505 | 0.068436 | 0.162849 | 0.985284 | -0.03863 | 0.229639 | 1.100215 | 0.962108 | 1.258146 |
| GCST001850-Major depressive disorder | Inverse variance weighted | 2 | -0.06494 | 0.046554 | 0.163042 | 0.985284 | -0.15618 | 0.026307 | 0.937125 | 0.855402 | 1.026656 |
| GCST007502-Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | Inverse variance weighted | 14 | 0.300291 | 0.215654 | 0.163781 | 0.985284 | -0.12239 | 0.722972 | 1.350252 | 0.884803 | 2.060549 |
| GCST003383-Platelet count | Inverse variance weighted | 3 | -0.00304 | 0.002185 | 0.163976 | 0.985284 | -0.00732 | 0.001241 | 0.996964 | 0.992704 | 1.001242 |
| GCST003925-Gout | Inverse variance weighted | 6 | 0.022851 | 0.016442 | 0.164585 | 0.985284 | -0.00937 | 0.055077 | 1.023114 | 0.990669 | 1.056621 |
| GCST001144-Dupuytren's disease | Inverse variance weighted | 6 | 0.039677 | 0.028577 | 0.165012 | 0.985284 | -0.01633 | 0.095688 | 1.040474 | 0.983798 | 1.100415 |
| GCST002275-Asthma \(childhood onset\) | Inverse variance weighted | 3 | -0.03808 | 0.027552 | 0.16689 | 0.985284 | -0.09209 | 0.015918 | 0.962632 | 0.912027 | 1.016045 |
| GCST007132-High density lipoprotein cholesterol levels | Inverse variance weighted | 13 | 0.507371 | 0.367508 | 0.167411 | 0.985284 | -0.21294 | 1.227687 | 1.660919 | 0.808201 | 3.413324 |
| GCST005752-Systemic lupus erythematosus | Inverse variance weighted | 34 | 0.034041 | 0.024695 | 0.16807 | 0.985284 | -0.01436 | 0.082444 | 1.034627 | 0.985741 | 1.085938 |
| GCST001105-Migraine | Inverse variance weighted | 2 | -0.13311 | 0.09661 | 0.168261 | 0.985284 | -0.32246 | 0.056245 | 0.875369 | 0.724361 | 1.057857 |
| GCST008235-Cognitive impairment | Inverse variance weighted | 2 | -1.32789 | 0.964073 | 0.168396 | 0.985284 | -3.21747 | 0.561692 | 0.265036 | 0.040056 | 1.753637 |
| GCST002537-Breast cancer | Inverse variance weighted | 3 | -0.20119 | 0.146117 | 0.16855 | 0.985284 | -0.48757 | 0.085204 | 0.817761 | 0.614114 | 1.08894 |
| GCST006477-Depression | Inverse variance weighted | 47 | -0.00082 | 0.000596 | 0.169296 | 0.985284 | -0.00199 | 0.000349 | 0.999181 | 0.998014 | 1.000349 |
| GCST008105-Diverticular disease | Inverse variance weighted | 2 | -0.2776 | 0.202037 | 0.169438 | 0.985284 | -0.67359 | 0.118391 | 0.757599 | 0.509873 | 1.125685 |
| GCST002458-Serum thyroid-stimulating hormone levels | Inverse variance weighted | 2 | 0.361532 | 0.263309 | 0.169742 | 0.985284 | -0.15455 | 0.877617 | 1.435527 | 0.856798 | 2.405162 |
| GCST007876-Estimated glomerular filtration rate | Inverse variance weighted | 80 | -0.00036 | 0.000261 | 0.169743 | 0.985284 | -0.00087 | 0.000153 | 0.999642 | 0.999132 | 1.000153 |
| GCST007494-Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | Inverse variance weighted | 3 | 0.564173 | 0.411224 | 0.170083 | 0.9853 | -0.24183 | 1.370173 | 1.757994 | 0.785193 | 3.93603 |
| GCST001180-Plasma omega-3 polyunsaturated fatty acid levels \(alphalinolenic acid\) | Inverse variance weighted | 7 | -0.52161 | 0.380553 | 0.170477 | 0.985974 | -1.2675 | 0.224269 | 0.593562 | 0.281536 | 1.251408 |
| GCST000851-Hodgkin's lymphoma | Inverse variance weighted | 2 | -0.0871 | 0.063639 | 0.171125 | 0.986941 | -0.21183 | 0.037636 | 0.916589 | 0.809103 | 1.038354 |
| GCST000756-Magnesium levels | Inverse variance weighted | 4 | 0.328879 | 0.240589 | 0.171633 | 0.98756 | -0.14268 | 0.800434 | 1.38941 | 0.867035 | 2.226508 |
| GCST004349-Glioblastoma | Inverse variance weighted | 5 | -0.04795 | 0.035085 | 0.171759 | 0.98756 | -0.11671 | 0.020821 | 0.953184 | 0.889839 | 1.021039 |
| GCST007725-Serum uric acid levels | Inverse variance weighted | 21 | 0.11026 | 0.08073 | 0.172008 | 0.98756 | -0.04797 | 0.268491 | 1.116568 | 0.953161 | 1.30799 |
| GCST001720-Endometriosis | Inverse variance weighted | 5 | -0.0645 | 0.047278 | 0.172452 | 0.98756 | -0.15717 | 0.02816 | 0.937532 | 0.85456 | 1.02856 |
| GCST000401-Menopause \(age at onset\) | Inverse variance weighted | 3 | 0.038258 | 0.028049 | 0.172575 | 0.98756 | -0.01672 | 0.093234 | 1.038999 | 0.983421 | 1.097719 |
| GCST004983-Parental lifespan | Inverse variance weighted | 3 | -0.76272 | 0.562386 | 0.175027 | 0.989434 | -1.865 | 0.339553 | 0.466395 | 0.154896 | 1.404319 |
| GCST001784-Pulmonary function \(smoking interaction\) | Inverse variance weighted | 2 | 0.979192 | 0.722116 | 0.175098 | 0.989434 | -0.43616 | 2.394539 | 2.662303 | 0.646517 | 10.96314 |
| GCST001465-Adiponectin levels | Inverse variance weighted | 4 | -0.46765 | 0.345211 | 0.175521 | 0.989537 | -1.14426 | 0.208965 | 0.626474 | 0.318459 | 1.232402 |
| GCST002493-Bone mineral density \(paediatric, skull\) | Inverse variance weighted | 5 | 0.080578 | 0.059492 | 0.175599 | 0.989537 | -0.03603 | 0.197182 | 1.083913 | 0.964615 | 1.217966 |
| GCST008103-Bipolar disorder | Inverse variance weighted | 8 | -0.11826 | 0.087412 | 0.176071 | 0.990055 | -0.28959 | 0.053063 | 0.888461 | 0.748568 | 1.054496 |
| GCST004776-Systolic blood pressure | Inverse variance weighted | 19 | -0.01059 | 0.007832 | 0.176422 | 0.990055 | -0.02594 | 0.004763 | 0.989468 | 0.974395 | 1.004774 |
| GCST004131-Inflammatory bowel disease | Inverse variance weighted | 9 | 0.095173 | 0.070414 | 0.176496 | 0.990055 | -0.04284 | 0.233185 | 1.099849 | 0.958066 | 1.262615 |
| GCST003236-Plasma omega-6 polyunsaturated fatty acid levels \(arachidonic acid\) | Inverse variance weighted | 2 | 0.084553 | 0.06266 | 0.17721 | 0.99315 | -0.03826 | 0.207367 | 1.088231 | 0.962462 | 1.230434 |
| GCST006083-Prostate cancer \(advanced\) | Inverse variance weighted | 2 | 0.221699 | 0.164834 | 0.178632 | 0.994506 | -0.10138 | 0.544773 | 1.248195 | 0.903593 | 1.724217 |
| GCST003924-Renal overload gout | Inverse variance weighted | 4 | 0.033289 | 0.024782 | 0.17918 | 0.994506 | -0.01528 | 0.081861 | 1.033849 | 0.984833 | 1.085305 |
| GCST007201-Schizophrenia | Inverse variance weighted | 123 | -0.03498 | 0.026054 | 0.179436 | 0.994506 | -0.08604 | 0.016089 | 0.965627 | 0.917554 | 1.016219 |
| GCST006914-Sleep duration | Inverse variance weighted | 13 | -0.18945 | 0.141131 | 0.17947 | 0.994506 | -0.46607 | 0.087164 | 0.827412 | 0.627464 | 1.091076 |
| GCST007500-Waist-to-hip ratio adjusted for BMI \(additive genetic model\) | Inverse variance weighted | 14 | 0.302953 | 0.225693 | 0.179491 | 0.994506 | -0.1394 | 0.74531 | 1.353851 | 0.869876 | 2.107096 |
| GCST007228-Pulmonary arterial hypertension | Inverse variance weighted | 2 | -0.0552 | 0.041187 | 0.180173 | 0.994506 | -0.13592 | 0.025527 | 0.946297 | 0.872908 | 1.025855 |
| GCST007923-Medication use \(drugs used in diabetes\) | Inverse variance weighted | 39 | 0.06051 | 0.045282 | 0.181449 | 0.99703 | -0.02824 | 0.149263 | 1.062379 | 0.972153 | 1.160978 |
| GCST002329-Acne \(severe\) | Inverse variance weighted | 2 | 0.076413 | 0.057349 | 0.182723 | 0.99703 | -0.03599 | 0.188818 | 1.079409 | 0.964648 | 1.207821 |
| GCST006655-Breast size | Inverse variance weighted | 2 | -0.10815 | 0.081364 | 0.183768 | 0.99703 | -0.26763 | 0.051321 | 0.897491 | 0.765194 | 1.052661 |
| GCST001699-Serum albumin level | Inverse variance weighted | 6 | 0.756664 | 0.569444 | 0.183922 | 0.99703 | -0.35945 | 1.872773 | 2.131154 | 0.698063 | 6.506317 |
| GCST003220-Glioblastoma | Inverse variance weighted | 3 | -0.07667 | 0.05781 | 0.184764 | 0.99703 | -0.18998 | 0.036638 | 0.926196 | 0.826978 | 1.037318 |
| GCST008306-Dentures | Inverse variance weighted | 16 | 0.17481 | 0.132233 | 0.186174 | 0.99703 | -0.08437 | 0.433987 | 1.19102 | 0.919094 | 1.543398 |
| GCST001574-Activated partial thromboplastin time | Inverse variance weighted | 6 | 0.010099 | 0.007644 | 0.186411 | 0.99703 | -0.00488 | 0.025081 | 1.01015 | 0.99513 | 1.025398 |
| GCST001840-Stearic acid \(18:0\) levels | Inverse variance weighted | 3 | 0.109678 | 0.083083 | 0.186798 | 0.99703 | -0.05316 | 0.272521 | 1.115919 | 0.948225 | 1.313271 |
| GCST006491-Circulating fibroblast growth factor 23 levels | Inverse variance weighted | 4 | -0.45785 | 0.347279 | 0.187375 | 0.99703 | -1.13851 | 0.222819 | 0.632644 | 0.320295 | 1.249594 |
| GCST005520-Heart rate response to beta blockers \(atenolol add-on therapy\) | Inverse variance weighted | 5 | -0.00339 | 0.002579 | 0.188164 | 0.99703 | -0.00845 | 0.001661 | 0.996611 | 0.991586 | 1.001662 |
| GCST007020-Male-pattern baldness | Inverse variance weighted | 400 | -0.03862 | 0.029427 | 0.189387 | 0.998584 | -0.0963 | 0.019057 | 0.962116 | 0.908194 | 1.01924 |
| GCST003855-Gut microbiota \(bacterial taxa\) | Inverse variance weighted | 6 | -0.00179 | 0.001368 | 0.190404 | 0.998684 | -0.00447 | 0.00089 | 0.99821 | 0.995537 | 1.000891 |
| GCST001957-Obesity \(early onset extreme\) | Inverse variance weighted | 6 | -0.0345 | 0.026515 | 0.193156 | 0.998684 | -0.08647 | 0.017465 | 0.966085 | 0.91716 | 1.017619 |
| GCST005782-Serum 25-Hydroxyvitamin D levels | Inverse variance weighted | 6 | -0.00111 | 0.000854 | 0.193451 | 0.998684 | -0.00279 | 0.000563 | 0.99889 | 0.997219 | 1.000564 |
| GCST002545-Ossification of the posterior longitudinal ligament of the spine | Inverse variance weighted | 4 | -0.04363 | 0.033677 | 0.195161 | 0.998684 | -0.10963 | 0.022379 | 0.957311 | 0.896163 | 1.022632 |
| GCST006402-Energy intake | Inverse variance weighted | 2 | 0.000317 | 0.000246 | 0.198215 | 0.998684 | -0.00017 | 0.000799 | 1.000317 | 0.999834 | 1.0008 |
| GCST006291-Spherical equivalent or myopia \(age of diagnosis\) | Inverse variance weighted | 72 | 0.000456 | 0.000355 | 0.198704 | 0.998684 | -0.00024 | 0.001153 | 1.000457 | 0.99976 | 1.001153 |
| GCST005839-Depression | Inverse variance weighted | 27 | -0.16219 | 0.126482 | 0.199722 | 0.998684 | -0.4101 | 0.085711 | 0.850276 | 0.663585 | 1.089492 |
| GCST004606-Eosinophil counts | Inverse variance weighted | 99 | -0.06558 | 0.051207 | 0.200289 | 0.998684 | -0.16595 | 0.034784 | 0.936522 | 0.84709 | 1.035396 |
| GCST006023-Hypertension | Inverse variance weighted | 3 | -0.00293 | 0.00229 | 0.20092 | 0.998684 | -0.00742 | 0.00156 | 0.997076 | 0.99261 | 1.001561 |
| GCST003435-Body fat percentage | Inverse variance weighted | 7 | -4.56454 | 3.602783 | 0.205173 | 0.998684 | -11.626 | 2.49691 | 0.010415 | 8.93E-06 | 12.14491 |
| GCST004147-Chronic obstructive pulmonary disease | Inverse variance weighted | 15 | -0.05094 | 0.040267 | 0.205856 | 0.998684 | -0.12986 | 0.027984 | 0.950336 | 0.878216 | 1.028379 |
| GCST007512-Benign prostatic hyperplasia and lower urinary tract symptoms \(prostate cancer excluded\) | Inverse variance weighted | 9 | -0.10103 | 0.080104 | 0.207241 | 0.998684 | -0.25803 | 0.055977 | 0.90391 | 0.772573 | 1.057574 |
| GCST000708-Freckling | Inverse variance weighted | 3 | -0.01857 | 0.014734 | 0.207498 | 0.998684 | -0.04745 | 0.010307 | 0.981599 | 0.953656 | 1.01036 |
| GCST007236-Breast cancer | Inverse variance weighted | 32 | -0.04054 | 0.032248 | 0.208655 | 0.998684 | -0.10375 | 0.022661 | 0.960267 | 0.901451 | 1.02292 |
| GCST003273-Diastolic blood pressure | Inverse variance weighted | 5 | -0.02123 | 0.01689 | 0.208827 | 0.998684 | -0.05433 | 0.011877 | 0.978996 | 0.947118 | 1.011948 |
| GCST000612-Celiac disease | Inverse variance weighted | 13 | -0.03578 | 0.028561 | 0.21028 | 0.998684 | -0.09176 | 0.020198 | 0.964851 | 0.912324 | 1.020404 |
| GCST005849-Heart rate response to recovery post exercise \(40 sec\) | Inverse variance weighted | 10 | -0.13806 | 0.110842 | 0.212917 | 0.998684 | -0.35531 | 0.079187 | 0.871043 | 0.700953 | 1.082407 |
| GCST006368-Body mass index | Inverse variance weighted | 146 | -0.3447 | 0.277036 | 0.213405 | 0.998684 | -0.88769 | 0.198287 | 0.70843 | 0.411604 | 1.219312 |
| GCST001238-Hypertension | Inverse variance weighted | 3 | -0.20884 | 0.167928 | 0.213646 | 0.998684 | -0.53797 | 0.120303 | 0.811529 | 0.58393 | 1.127839 |
| GCST000292-Metabolic traits | Inverse variance weighted | 3 | 0.048919 | 0.039364 | 0.213969 | 0.998684 | -0.02824 | 0.126073 | 1.050135 | 0.97216 | 1.134365 |
| GCST001679-Complement C3 and C4 levels | Inverse variance weighted | 3 | 0.170572 | 0.137343 | 0.214258 | 0.998684 | -0.09862 | 0.439764 | 1.185983 | 0.906087 | 1.55234 |
| GCST006923-Loneliness | Inverse variance weighted | 7 | 1.519867 | 1.224047 | 0.214357 | 0.998684 | -0.87926 | 3.918999 | 4.571618 | 0.415088 | 50.35 |
| GCST005076-Breast cancer \(estrogen-receptor negative\) | Inverse variance weighted | 19 | -0.05102 | 0.041166 | 0.215194 | 0.998684 | -0.13171 | 0.029664 | 0.950258 | 0.876599 | 1.030108 |
| GCST007217-RR interval \(heart rate\) | Inverse variance weighted | 8 | -0.00101 | 0.000812 | 0.215559 | 0.998684 | -0.0026 | 0.000586 | 0.998994 | 0.997405 | 1.000586 |
| GCST001853-Circulating vasoactive peptide levels | Inverse variance weighted | 4 | 0.004428 | 0.003584 | 0.2166 | 0.998684 | -0.0026 | 0.011452 | 1.004438 | 0.997408 | 1.011517 |
| GCST000758-Triglycerides | Inverse variance weighted | 21 | 0.004448 | 0.003601 | 0.216785 | 0.998684 | -0.00261 | 0.011506 | 1.004458 | 0.997393 | 1.011572 |
| GCST001005-HDL Cholesterol - Triglycerides \(HDLC-TG\) | Inverse variance weighted | 6 | 0.307193 | 0.249144 | 0.217577 | 0.998684 | -0.18113 | 0.795515 | 1.359604 | 0.834328 | 2.215581 |
| GCST000403-Menarche and menopause \(age at onset\) | Inverse variance weighted | 4 | -0.02435 | 0.019818 | 0.219205 | 0.998684 | -0.06319 | 0.014494 | 0.975944 | 0.938762 | 1.0146 |
| GCST006022-Pulse pressure | Inverse variance weighted | 4 | -0.08942 | 0.072895 | 0.219946 | 0.998684 | -0.23229 | 0.053456 | 0.914463 | 0.792715 | 1.05491 |
| GCST006462-Uterine fibroids | Inverse variance weighted | 21 | -0.05694 | 0.046422 | 0.219972 | 0.998684 | -0.14793 | 0.034046 | 0.944649 | 0.862493 | 1.034632 |
| GCST000392-Type 1 diabetes | Inverse variance weighted | 11 | 0.070951 | 0.057856 | 0.220075 | 0.998684 | -0.04245 | 0.184349 | 1.073529 | 0.958441 | 1.202436 |
| GCST001915-Alzheimer's disease \(cognitive decline\) | Inverse variance weighted | 12 | 0.056534 | 0.046144 | 0.220513 | 0.998684 | -0.03391 | 0.146977 | 1.058163 | 0.96666 | 1.158328 |
| GCST003454-Morning vs. evening chronotype | Inverse variance weighted | 2 | -0.13408 | 0.109712 | 0.221649 | 0.998684 | -0.34912 | 0.08095 | 0.874516 | 0.705309 | 1.084317 |
| GCST008165-Thyroid stimulating hormone levels | Inverse variance weighted | 6 | -0.08843 | 0.07242 | 0.222046 | 0.998684 | -0.23037 | 0.05351 | 0.915365 | 0.794236 | 1.054968 |
| GCST004235-Total cholesterol levels | Inverse variance weighted | 49 | 0.067722 | 0.055496 | 0.222348 | 0.998684 | -0.04105 | 0.176494 | 1.070068 | 0.959781 | 1.193027 |
| GCST002525-Local histogram emphysema pattern | Inverse variance weighted | 6 | 0.640969 | 0.525255 | 0.222351 | 0.998684 | -0.38853 | 1.670468 | 1.898319 | 0.678052 | 5.314657 |
| GCST005325-Subjective well-being \(MTAG\) | Inverse variance weighted | 36 | -0.28681 | 0.235166 | 0.22261 | 0.998684 | -0.74774 | 0.174112 | 0.750653 | 0.473437 | 1.190189 |
| GCST000478-Type 2 diabetes | Inverse variance weighted | 3 | 0.089035 | 0.073112 | 0.223305 | 0.998684 | -0.05426 | 0.232334 | 1.093118 | 0.947182 | 1.26154 |
| GCST000438-Cutaneous nevi | Inverse variance weighted | 2 | -0.08727 | 0.071858 | 0.224579 | 0.998684 | -0.22811 | 0.053575 | 0.916432 | 0.796037 | 1.055036 |
| GCST000803-Glycated hemoglobin levels | Inverse variance weighted | 8 | 0.190332 | 0.156735 | 0.224612 | 0.998684 | -0.11687 | 0.497533 | 1.209651 | 0.889702 | 1.644659 |
| GCST000285-Cholesterol, total | Inverse variance weighted | 8 | 1.267259 | 1.045831 | 0.225618 | 0.998684 | -0.78257 | 3.317087 | 3.551106 | 0.45723 | 27.5799 |
| GCST001725-Inflammatory bowel disease | Inverse variance weighted | 81 | -0.02888 | 0.023862 | 0.226226 | 0.998684 | -0.07564 | 0.017893 | 0.971537 | 0.927146 | 1.018054 |
| GCST003075-Cognitive decline rate in late mild cognitive impairment | Inverse variance weighted | 8 | -0.06512 | 0.053837 | 0.226412 | 0.998684 | -0.17064 | 0.040397 | 0.936951 | 0.843121 | 1.041224 |
| GCST001221-Permanent tooth development | Inverse variance weighted | 2 | -0.14142 | 0.116912 | 0.226422 | 0.998684 | -0.37057 | 0.087727 | 0.868125 | 0.690343 | 1.09169 |
| GCST007705-Pulse pressure | Inverse variance weighted | 33 | -0.01126 | 0.009319 | 0.227002 | 0.998684 | -0.02952 | 0.007007 | 0.988804 | 0.970907 | 1.007032 |
| GCST005367-Vitamin D levels | Inverse variance weighted | 2 | -0.73519 | 0.609391 | 0.227648 | 0.998684 | -1.9296 | 0.459213 | 0.479412 | 0.145206 | 1.582828 |
| GCST004737-Neovascular age-related macular degeneration | Inverse variance weighted | 3 | -0.02017 | 0.016723 | 0.227836 | 0.998684 | -0.05295 | 0.01261 | 0.980035 | 0.948432 | 1.01269 |
| GCST000408-Primary biliary cholangitis | Inverse variance weighted | 2 | -0.03452 | 0.028661 | 0.228365 | 0.998684 | -0.0907 | 0.021651 | 0.966065 | 0.913292 | 1.021887 |
| GCST000224-Chronic lymphocytic leukemia | Inverse variance weighted | 4 | -0.04734 | 0.039431 | 0.229931 | 0.998684 | -0.12462 | 0.029946 | 0.953765 | 0.88283 | 1.030399 |
| GCST004887-Alcohol consumption in current drinkers | Inverse variance weighted | 4 | 0.594399 | 0.495418 | 0.23022 | 0.998684 | -0.37662 | 1.565418 | 1.811941 | 0.686177 | 4.784673 |
| GCST004946-Schizophrenia | Inverse variance weighted | 72 | -0.04641 | 0.038712 | 0.230544 | 0.998684 | -0.12229 | 0.029461 | 0.954647 | 0.884893 | 1.029899 |
| GCST007324-Adventurousness | Inverse variance weighted | 106 | -0.15085 | 0.125968 | 0.231097 | 0.998684 | -0.39775 | 0.096046 | 0.859975 | 0.67183 | 1.10081 |
| GCST006719-BRCA1/2-negative high-risk breast cancer | Inverse variance weighted | 2 | -0.06478 | 0.054101 | 0.231176 | 0.998684 | -0.17081 | 0.041261 | 0.937277 | 0.842978 | 1.042124 |
| GCST007062-Hodgkin's lymphoma | Inverse variance weighted | 3 | 0.076721 | 0.06418 | 0.231935 | 0.998684 | -0.04907 | 0.202514 | 1.07974 | 0.952112 | 1.224478 |
| GCST001708-Systemic lupus erythematosus | Inverse variance weighted | 3 | -0.03807 | 0.0319 | 0.232766 | 0.998684 | -0.10059 | 0.024459 | 0.96265 | 0.904304 | 1.02476 |
| GCST005795-Femoral neck bone mineral density | Inverse variance weighted | 15 | 0.13471 | 0.113253 | 0.23426 | 0.998684 | -0.08727 | 0.356687 | 1.144205 | 0.916433 | 1.428588 |
| GCST003335-Waist circumference | Inverse variance weighted | 2 | -0.39652 | 0.333598 | 0.234587 | 0.998684 | -1.05037 | 0.257329 | 0.672655 | 0.349807 | 1.29347 |
| GCST002626-Vertical cup-disc ratio | Inverse variance weighted | 9 | -0.85118 | 0.717088 | 0.235232 | 0.998684 | -2.25667 | 0.554317 | 0.426913 | 0.104699 | 1.740751 |
| GCST004006-Mean corpuscular hemoglobin | Inverse variance weighted | 7 | -2.17748 | 1.834837 | 0.235329 | 0.998684 | -5.77376 | 1.418799 | 0.113327 | 0.003108 | 4.132153 |
| GCST003094-Mitral valve prolapse | Inverse variance weighted | 2 | -0.07147 | 0.060623 | 0.238425 | 0.998684 | -0.19029 | 0.047351 | 0.931024 | 0.826718 | 1.04849 |
| GCST004462-Epithelial ovarian cancer | Inverse variance weighted | 7 | -0.07408 | 0.062877 | 0.238752 | 0.998684 | -0.19732 | 0.049163 | 0.928601 | 0.820931 | 1.050392 |
| GCST004441-Interleukin-18 levels | Inverse variance weighted | 5 | 0.041467 | 0.035211 | 0.238926 | 0.998684 | -0.02755 | 0.110481 | 1.042339 | 0.972829 | 1.116815 |
| GCST006702-Parental longevity \(combined parental age at death\) | Inverse variance weighted | 3 | -13.1268 | 11.15606 | 0.239333 | 0.998684 | -34.9927 | 8.739026 | 1.99E-06 | 6.35E-16 | 6241.811 |
| GCST002906-Skin colour saturation | Inverse variance weighted | 3 | 1.694678 | 1.441325 | 0.239684 | 0.998684 | -1.13032 | 4.519676 | 5.444895 | 0.32293 | 91.80584 |
| GCST006586-Urinary albumin excretion | Inverse variance weighted | 23 | 0.393966 | 0.335592 | 0.240418 | 0.998684 | -0.26379 | 1.051725 | 1.48285 | 0.768132 | 2.862586 |
| GCST004139-Bipolar disorder | Inverse variance weighted | 4 | 0.077791 | 0.066493 | 0.242035 | 0.998684 | -0.05253 | 0.208117 | 1.080897 | 0.948821 | 1.231357 |
| GCST005913-Fasting blood glucose | Inverse variance weighted | 3 | 0.123373 | 0.105674 | 0.243014 | 0.998684 | -0.08375 | 0.330493 | 1.131306 | 0.919663 | 1.391654 |
| GCST000809-Triglycerides | Inverse variance weighted | 5 | -0.1805 | 0.155215 | 0.244862 | 0.998684 | -0.48472 | 0.123719 | 0.83485 | 0.615867 | 1.131698 |
| GCST001650-C-reactive protein | Inverse variance weighted | 4 | -0.90562 | 0.780174 | 0.245728 | 0.998684 | -2.43476 | 0.623525 | 0.404293 | 0.087619 | 1.865492 |
| GCST006926-Osteoarthritis \(hip\) | Inverse variance weighted | 11 | 0.058965 | 0.050895 | 0.246632 | 0.998684 | -0.04079 | 0.158719 | 1.060738 | 0.960032 | 1.172009 |
| GCST000623-Ulcerative colitis | Inverse variance weighted | 2 | 0.177153 | 0.153115 | 0.247276 | 0.998684 | -0.12295 | 0.477258 | 1.193813 | 0.884305 | 1.611649 |
| GCST000142-Systemic lupus erythematosus | Inverse variance weighted | 4 | 0.044138 | 0.03815 | 0.247285 | 0.998684 | -0.03064 | 0.118912 | 1.045127 | 0.969829 | 1.126271 |
| GCST006091-Freckles | Inverse variance weighted | 6 | 0.047066 | 0.040817 | 0.248869 | 0.998684 | -0.03294 | 0.127068 | 1.048191 | 0.967601 | 1.135494 |
| GCST004337-Gondoic acid \(20:1n-9\) levels | Inverse variance weighted | 2 | -2.57185 | 2.236868 | 0.250246 | 0.998684 | -6.95611 | 1.812415 | 0.076394 | 0.000953 | 6.125225 |
| GCST005847-Heart rate response to recovery post exercise \(20 sec\) | Inverse variance weighted | 10 | -0.13835 | 0.120418 | 0.250595 | 0.998684 | -0.37437 | 0.09767 | 0.870795 | 0.687725 | 1.102599 |
| GCST004142-Melanoma | Inverse variance weighted | 3 | -0.07265 | 0.063266 | 0.250815 | 0.998684 | -0.19665 | 0.051348 | 0.929924 | 0.821475 | 1.052689 |
| GCST001237-HDL cholesterol | Inverse variance weighted | 4 | 0.523867 | 0.457915 | 0.252612 | 0.998684 | -0.37365 | 1.421381 | 1.688545 | 0.688221 | 4.142836 |
| GCST003218-Non-cardia gastric cancer | Inverse variance weighted | 2 | -0.09265 | 0.081013 | 0.25278 | 0.998684 | -0.25143 | 0.066137 | 0.911514 | 0.777686 | 1.068373 |
| GCST007485-Anthropometric traits | Inverse variance weighted | 5 | -0.26338 | 0.231835 | 0.255933 | 0.998684 | -0.71778 | 0.19102 | 0.768451 | 0.487836 | 1.210483 |
| GCST000970-Optic disc area | Inverse variance weighted | 4 | -0.19087 | 0.168237 | 0.256565 | 0.998684 | -0.52062 | 0.138871 | 0.826238 | 0.594154 | 1.148976 |
| GCST002326-Pulmonary emphysema | Inverse variance weighted | 2 | -0.07708 | 0.068004 | 0.257025 | 0.998684 | -0.21037 | 0.056209 | 0.925817 | 0.810287 | 1.057818 |
| GCST000298-Body mass index | Inverse variance weighted | 4 | -0.13416 | 0.118427 | 0.257275 | 0.998684 | -0.36628 | 0.097956 | 0.874449 | 0.69331 | 1.102914 |
| GCST002560-Type 2 diabetes | Inverse variance weighted | 2 | -0.13064 | 0.115769 | 0.259131 | 0.998684 | -0.35755 | 0.096268 | 0.877534 | 0.699389 | 1.101054 |
| GCST003391-Low high density lipoprotein cholesterol levels | Inverse variance weighted | 5 | 0.035371 | 0.031373 | 0.259566 | 0.998684 | -0.02612 | 0.096863 | 1.036004 | 0.974217 | 1.101709 |
| GCST002669-Percent mammographic density | Inverse variance weighted | 2 | 0.128355 | 0.113917 | 0.259851 | 0.998684 | -0.09492 | 0.351632 | 1.136957 | 0.909444 | 1.421385 |
| GCST004438-Monocyte chemoattractant protein-1 levels | Inverse variance weighted | 6 | 0.062475 | 0.055545 | 0.260688 | 0.998684 | -0.04639 | 0.171342 | 1.064468 | 0.954667 | 1.186897 |
| GCST001178-Plasma omega-3 polyunsaturated fatty acid level \(eicosapentaenoic acid\) | Inverse variance weighted | 8 | 0.112165 | 0.099733 | 0.260734 | 0.998684 | -0.08331 | 0.307641 | 1.118697 | 0.920065 | 1.360212 |
| GCST006980-Fractures | Inverse variance weighted | 8 | -0.15582 | 0.138767 | 0.261473 | 0.998684 | -0.42781 | 0.116159 | 0.85571 | 0.651938 | 1.123175 |
| GCST002759-Motion sickness | Inverse variance weighted | 24 | -0.09621 | 0.085765 | 0.261953 | 0.998684 | -0.26431 | 0.07189 | 0.908273 | 0.767735 | 1.074537 |
| GCST000759-LDL cholesterol | Inverse variance weighted | 24 | 0.002466 | 0.0022 | 0.262433 | 0.998684 | -0.00185 | 0.006778 | 1.002469 | 0.998155 | 1.006801 |
| GCST000180-Bone mineral density \(spine\) | Inverse variance weighted | 5 | -0.06953 | 0.062167 | 0.263384 | 0.998684 | -0.19138 | 0.052318 | 0.932833 | 0.825821 | 1.053711 |
| GCST006874-Hippocampal subfield CA1 volume \(corrected for total hippocampal volume\) | Inverse variance weighted | 2 | -0.00879 | 0.007866 | 0.264067 | 0.998684 | -0.0242 | 0.006633 | 0.991253 | 0.976087 | 1.006655 |
| GCST002731-Endothelial growth factor levels | Inverse variance weighted | 3 | 0.1153 | 0.1033 | 0.264351 | 0.998684 | -0.08717 | 0.317767 | 1.12221 | 0.916523 | 1.374056 |
| GCST007097-Pulse pressure | Inverse variance weighted | 32 | 0.013212 | 0.011855 | 0.265083 | 0.998684 | -0.01002 | 0.036448 | 1.0133 | 0.990026 | 1.03712 |
| GCST004433-Macrophage inflammatory protein 1b levels | Inverse variance weighted | 25 | 0.024272 | 0.021791 | 0.265355 | 0.998684 | -0.01844 | 0.066983 | 1.024569 | 0.98173 | 1.069277 |
| GCST002443-Blood metabolite levels | Inverse variance weighted | 120 | -0.03722 | 0.033476 | 0.266195 | 0.998684 | -0.10284 | 0.028392 | 0.963463 | 0.902276 | 1.028799 |
| GCST008057-Varicose veins | Inverse variance weighted | 6 | 2.118687 | 1.910744 | 0.267504 | 0.998684 | -1.62637 | 5.863746 | 8.320208 | 0.196642 | 352.0403 |
| GCST007924-Medication use \(antithrombotic agents\) | Inverse variance weighted | 7 | 0.488193 | 0.440911 | 0.268191 | 0.998684 | -0.37599 | 1.352378 | 1.629369 | 0.686608 | 3.86661 |
| GCST006705-Infantile hypertrophic pyloric stenosis | Inverse variance weighted | 2 | -0.07333 | 0.066264 | 0.268463 | 0.998684 | -0.20321 | 0.056549 | 0.929296 | 0.81611 | 1.058179 |
| GCST004127-White blood cell count \(basophil\) | Inverse variance weighted | 3 | -0.37936 | 0.343048 | 0.268788 | 0.998684 | -1.05174 | 0.293012 | 0.684297 | 0.34933 | 1.340459 |
| GCST000380-Height | Inverse variance weighted | 3 | -0.03356 | 0.030426 | 0.27008 | 0.998684 | -0.09319 | 0.026079 | 0.967 | 0.911019 | 1.026422 |
| GCST001233-Metabolite levels | Inverse variance weighted | 7 | 0.253442 | 0.229969 | 0.270431 | 0.998684 | -0.1973 | 0.704181 | 1.288453 | 0.820947 | 2.02219 |
| GCST003845-Breast cancer | Inverse variance weighted | 10 | -0.08059 | 0.073185 | 0.270797 | 0.998684 | -0.22404 | 0.062849 | 0.922569 | 0.799286 | 1.064866 |
| GCST003799-Colorectal cancer | Inverse variance weighted | 19 | 0.039017 | 0.035443 | 0.270967 | 0.998684 | -0.03045 | 0.108486 | 1.039788 | 0.970008 | 1.114589 |
| GCST007001-Cerebrospinal AB1-42 levels in normal cognition | Inverse variance weighted | 3 | -0.59301 | 0.53873 | 0.271003 | 0.998684 | -1.64892 | 0.462901 | 0.552661 | 0.192257 | 1.588676 |
| GCST004339-Palmitoleic acid \(16:1n-7\) levels | Inverse variance weighted | 4 | 0.465398 | 0.423278 | 0.271545 | 0.998684 | -0.36423 | 1.295022 | 1.592648 | 0.694734 | 3.651077 |
| GCST006062-White matter hyperintensity volume | Inverse variance weighted | 2 | -0.13872 | 0.126573 | 0.273086 | 0.998684 | -0.38681 | 0.109361 | 0.87047 | 0.679223 | 1.115565 |
| GCST007305-White matter hyperintensity volume | Inverse variance weighted | 2 | -0.14539 | 0.132716 | 0.273313 | 0.998684 | -0.40551 | 0.114737 | 0.864689 | 0.666638 | 1.121579 |
| GCST000452-QT interval | Inverse variance weighted | 2 | -0.0696 | 0.063759 | 0.274969 | 0.998684 | -0.19457 | 0.055362 | 0.932763 | 0.823187 | 1.056923 |
| GCST000879-Crohn's disease | Inverse variance weighted | 52 | -0.01928 | 0.017662 | 0.27503 | 0.998684 | -0.0539 | 0.015338 | 0.980906 | 0.94753 | 1.015457 |
| GCST004483-Multiple myeloma | Inverse variance weighted | 5 | -0.08341 | 0.076594 | 0.276156 | 0.998684 | -0.23353 | 0.066714 | 0.919973 | 0.79173 | 1.068989 |
| GCST004626-Myeloid white cell count | Inverse variance weighted | 69 | -0.08252 | 0.075798 | 0.276313 | 0.998684 | -0.23108 | 0.066047 | 0.920796 | 0.793675 | 1.068277 |
| GCST007536-Serum urea levels | Inverse variance weighted | 3 | -0.13877 | 0.12753 | 0.276524 | 0.998684 | -0.38873 | 0.111186 | 0.870425 | 0.677915 | 1.117603 |
| GCST001951-Alzheimer's disease biomarkers | Inverse variance weighted | 3 | 5.357175 | 4.933267 | 0.277511 | 0.998684 | -4.31203 | 15.02638 | 212.1249 | 0.013406 | 3356395 |
| GCST001089-Esophageal cancer | Inverse variance weighted | 3 | 0.04086 | 0.037645 | 0.277743 | 0.998684 | -0.03292 | 0.114645 | 1.041707 | 0.967612 | 1.121476 |
| GCST005046-N-glycan levels | Inverse variance weighted | 11 | 0.024093 | 0.022216 | 0.278155 | 0.998684 | -0.01945 | 0.067637 | 1.024386 | 0.980737 | 1.069977 |
| GCST000282-LDL cholesterol | Inverse variance weighted | 7 | 0.538684 | 0.496835 | 0.278262 | 0.998684 | -0.43511 | 1.51248 | 1.71375 | 0.647192 | 4.537972 |
| GCST006941-Irritable mood | Inverse variance weighted | 45 | 0.000568 | 0.000524 | 0.278517 | 0.998684 | -0.00046 | 0.001595 | 1.000568 | 0.999541 | 1.001596 |
| GCST007798-Asthma | Inverse variance weighted | 60 | -0.0476 | 0.044006 | 0.279448 | 0.998684 | -0.13385 | 0.038657 | 0.95352 | 0.874723 | 1.039414 |
| GCST007325-General risk tolerance \(MTAG\) | Inverse variance weighted | 185 | -0.17883 | 0.165537 | 0.280016 | 0.998684 | -0.50328 | 0.145625 | 0.836251 | 0.604546 | 1.156762 |
| GCST007937-Medication use \(salicylic acid and derivatives\) | Inverse variance weighted | 5 | 0.652764 | 0.605034 | 0.280638 | 0.998684 | -0.5331 | 1.838631 | 1.920842 | 0.586781 | 6.287925 |
| GCST006465-Endometrial cancer \(endometrioid histology\) | Inverse variance weighted | 8 | 0.058053 | 0.053909 | 0.281545 | 0.998684 | -0.04761 | 0.163715 | 1.059771 | 0.953506 | 1.177878 |
| GCST007993-Asthma \(adult onset\) | Inverse variance weighted | 9 | -0.07842 | 0.07293 | 0.282265 | 0.998684 | -0.22136 | 0.064525 | 0.924579 | 0.801428 | 1.066652 |
| GCST002562-Vogt-Koyanagi-Harada syndrome | Inverse variance weighted | 2 | 0.045918 | 0.042944 | 0.284953 | 0.998684 | -0.03825 | 0.130089 | 1.046989 | 0.96247 | 1.138929 |
| GCST002873-Thyroid cancer | Inverse variance weighted | 2 | 0.027792 | 0.026039 | 0.285822 | 0.998684 | -0.02324 | 0.078827 | 1.028182 | 0.977024 | 1.082018 |
| GCST002082-Cervical cancer | Inverse variance weighted | 2 | 0.061692 | 0.057921 | 0.286831 | 0.998684 | -0.05183 | 0.175218 | 1.063635 | 0.949487 | 1.191505 |
| GCST004617-Eosinophil percentage of granulocytes | Inverse variance weighted | 94 | -0.05935 | 0.05573 | 0.286897 | 0.998684 | -0.16858 | 0.049881 | 0.942377 | 0.844863 | 1.051146 |
| GCST001841-Palmitoleic acid \(16:1n-7\) levels | Inverse variance weighted | 5 | 0.425596 | 0.400457 | 0.287883 | 0.998684 | -0.3593 | 1.210492 | 1.530503 | 0.698166 | 3.355134 |
| GCST000168-Colorectal cancer | Inverse variance weighted | 2 | 0.085036 | 0.080206 | 0.289044 | 0.998684 | -0.07217 | 0.24224 | 1.088757 | 0.930375 | 1.2741 |
| GCST007091-Osteoarthritis \(hip\) | Inverse variance weighted | 15 | 0.071437 | 0.067611 | 0.290704 | 0.998684 | -0.06108 | 0.203955 | 1.07405 | 0.940746 | 1.226243 |
| GCST003372-Glomerular filtration rate \(creatinine\) | Inverse variance weighted | 25 | 0.459816 | 0.436026 | 0.291626 | 0.998684 | -0.3948 | 1.314428 | 1.583783 | 0.673818 | 3.722622 |
| GCST007095-Systolic blood pressure | Inverse variance weighted | 26 | -0.01039 | 0.009857 | 0.291876 | 0.998684 | -0.02971 | 0.008931 | 0.989664 | 0.970727 | 1.008971 |
| GCST007329-Automobile speeding propensity | Inverse variance weighted | 20 | -0.27238 | 0.258468 | 0.291955 | 0.998684 | -0.77898 | 0.234213 | 0.761561 | 0.458873 | 1.263913 |
| GCST001335-Mean platelet volume | Inverse variance weighted | 17 | 0.377203 | 0.358412 | 0.292603 | 0.998684 | -0.32529 | 1.079691 | 1.4582 | 0.722321 | 2.943771 |
| GCST004041-Response to paliperidone in schizophrenia \(negative Marder score\) | Inverse variance weighted | 2 | 0.013351 | 0.012693 | 0.292874 | 0.998684 | -0.01153 | 0.038228 | 1.01344 | 0.988539 | 1.038969 |
| GCST001292-Leprosy | Inverse variance weighted | 3 | -0.04369 | 0.041581 | 0.293378 | 0.998684 | -0.12519 | 0.037808 | 0.95725 | 0.882331 | 1.038531 |
| GCST000305-Mean platelet volume | Inverse variance weighted | 2 | 0.630609 | 0.603058 | 0.295706 | 0.998684 | -0.55139 | 1.812603 | 1.878754 | 0.576151 | 6.126372 |
| GCST000699-Optic disc parameters | Inverse variance weighted | 2 | -0.39898 | 0.381755 | 0.295972 | 0.998684 | -1.14721 | 0.349264 | 0.671007 | 0.31752 | 1.418023 |
| GCST006629-Pulse pressure | Inverse variance weighted | 71 | 0.02543 | 0.02437 | 0.296728 | 0.998684 | -0.02234 | 0.073196 | 1.025756 | 0.977912 | 1.075941 |
| GCST004460-Eotaxin levels | Inverse variance weighted | 7 | 0.05598 | 0.053749 | 0.297644 | 0.998684 | -0.04937 | 0.161328 | 1.057576 | 0.95183 | 1.175071 |
| GCST004621-Red cell distribution width | Inverse variance weighted | 98 | -0.23001 | 0.221108 | 0.298219 | 0.998684 | -0.66338 | 0.203362 | 0.794526 | 0.515106 | 1.225516 |
| GCST004633-Neutrophil percentage of white cells | Inverse variance weighted | 61 | 0.094332 | 0.090748 | 0.298573 | 0.998684 | -0.08353 | 0.272199 | 1.098925 | 0.91986 | 1.312848 |
| GCST000324-Carotenoid and tocopherol levels | Inverse variance weighted | 2 | 0.107465 | 0.103448 | 0.298881 | 0.998684 | -0.09529 | 0.310222 | 1.113452 | 0.909107 | 1.363728 |
| GCST006585-Blood protein levels | Inverse variance weighted | 536 | -0.00228 | 0.002203 | 0.300695 | 0.998684 | -0.0066 | 0.002038 | 0.997723 | 0.993424 | 1.00204 |
| GCST004628-Immature fraction of reticulocytes | Inverse variance weighted | 68 | 0.088705 | 0.085949 | 0.302044 | 0.998684 | -0.07976 | 0.257166 | 1.092758 | 0.923342 | 1.29326 |
| GCST000996-Systemic lupus erythematosus | Inverse variance weighted | 3 | 0.033726 | 0.032715 | 0.302583 | 0.998684 | -0.03039 | 0.097846 | 1.034301 | 0.970062 | 1.102793 |
| GCST004202-Systemic sclerosis | Inverse variance weighted | 3 | 0.060751 | 0.058936 | 0.302638 | 0.998684 | -0.05476 | 0.176265 | 1.062634 | 0.946709 | 1.192754 |
| GCST001941-Ovarian cancer | Inverse variance weighted | 5 | -0.06995 | 0.067888 | 0.302813 | 0.998684 | -0.20301 | 0.063108 | 0.932437 | 0.816267 | 1.065141 |
| GCST002252-Blood pressure measurement \(high sodium and potassium intervention\) | Inverse variance weighted | 3 | 0.004135 | 0.004016 | 0.303218 | 0.998684 | -0.00374 | 0.012006 | 1.004143 | 0.99627 | 1.012079 |
| GCST005326-Neuroticism \(MTAG\) | Inverse variance weighted | 27 | 0.247643 | 0.240615 | 0.303382 | 0.998684 | -0.22396 | 0.719249 | 1.281003 | 0.799345 | 2.052891 |
| GCST002875-Diisocyanate-induced asthma | Inverse variance weighted | 5 | -0.01005 | 0.009768 | 0.303659 | 0.998684 | -0.02919 | 0.009097 | 0.990003 | 0.97123 | 1.009139 |
| GCST002299-Chronic lymphocytic leukemia | Inverse variance weighted | 2 | -0.05594 | 0.054403 | 0.303873 | 0.998684 | -0.16257 | 0.050695 | 0.9456 | 0.84996 | 1.052002 |
| GCST006041-Major depressive disorder | Inverse variance weighted | 10 | -0.18077 | 0.176262 | 0.305102 | 0.998684 | -0.52624 | 0.164708 | 0.83463 | 0.590822 | 1.179049 |
| GCST000913-Iron status biomarkers | Inverse variance weighted | 2 | -0.32958 | 0.32155 | 0.305383 | 0.998684 | -0.95981 | 0.300663 | 0.719229 | 0.382964 | 1.350754 |
| GCST001134-White blood cell types | Inverse variance weighted | 6 | -0.20574 | 0.200742 | 0.305416 | 0.998684 | -0.59919 | 0.187716 | 0.814046 | 0.549255 | 1.206491 |
| GCST005324-Depressive symptoms | Inverse variance weighted | 25 | -0.25846 | 0.252208 | 0.305457 | 0.998684 | -0.75279 | 0.235865 | 0.772237 | 0.471049 | 1.266003 |
| GCST008167-Mean platelet volume | Inverse variance weighted | 2 | 0.082056 | 0.080082 | 0.305526 | 0.998684 | -0.0749 | 0.239016 | 1.085517 | 0.927833 | 1.269999 |
| GCST003559-Bone mineral density \(hip\) | Inverse variance weighted | 2 | -0.11647 | 0.113785 | 0.306015 | 0.998684 | -0.33949 | 0.106546 | 0.890055 | 0.712133 | 1.112429 |
| GCST000138-Triglycerides | Inverse variance weighted | 6 | -0.07454 | 0.073015 | 0.307284 | 0.998684 | -0.21765 | 0.068565 | 0.928167 | 0.804405 | 1.070971 |
| GCST003227-Non-glioblastoma glioma | Inverse variance weighted | 4 | -0.05237 | 0.051314 | 0.307476 | 0.998684 | -0.15294 | 0.048208 | 0.94898 | 0.858179 | 1.049389 |
| GCST005414-Type 2 diabetes | Inverse variance weighted | 3 | -0.18966 | 0.186114 | 0.308184 | 0.998684 | -0.55444 | 0.175126 | 0.827242 | 0.574393 | 1.191396 |
| GCST002500-QT interval | Inverse variance weighted | 42 | -0.00317 | 0.003114 | 0.309294 | 0.998684 | -0.00927 | 0.002938 | 0.996839 | 0.990773 | 1.002942 |
| GCST001804-Behcet's disease | Inverse variance weighted | 3 | -0.0421 | 0.04152 | 0.310584 | 0.998684 | -0.12348 | 0.039278 | 0.958773 | 0.883839 | 1.04006 |
| GCST006950-Feeling worry | Inverse variance weighted | 44 | 0.000624 | 0.000615 | 0.310984 | 0.998684 | -0.00058 | 0.00183 | 1.000624 | 0.999417 | 1.001832 |
| GCST000843-Colorectal cancer | Inverse variance weighted | 5 | -0.11644 | 0.114928 | 0.310994 | 0.998684 | -0.3417 | 0.108821 | 0.890085 | 0.710564 | 1.114963 |
| GCST005345-Total body bone mineral density \(age 0-15\) | Inverse variance weighted | 6 | -0.08445 | 0.083427 | 0.311401 | 0.998684 | -0.24797 | 0.079065 | 0.919016 | 0.780384 | 1.082274 |
| GCST004612-High light scatter reticulocyte percentage of red cells | Inverse variance weighted | 85 | 0.067494 | 0.066678 | 0.311426 | 0.998684 | -0.06319 | 0.198182 | 1.069823 | 0.93876 | 1.219185 |
| GCST001728-Ulcerative colitis | Inverse variance weighted | 18 | 0.042979 | 0.04247 | 0.311541 | 0.998684 | -0.04026 | 0.126221 | 1.043916 | 0.960538 | 1.134533 |
| GCST000371-Tanning | Inverse variance weighted | 5 | -0.05146 | 0.050894 | 0.311915 | 0.998684 | -0.15122 | 0.048288 | 0.949837 | 0.85966 | 1.049473 |
| GCST004424-TRAIL levels | Inverse variance weighted | 6 | 0.05529 | 0.054824 | 0.313216 | 0.998684 | -0.05217 | 0.162745 | 1.056847 | 0.949172 | 1.176737 |
| GCST008062-Blood urea nitrogen levels | Inverse variance weighted | 70 | -0.37931 | 0.376491 | 0.313701 | 0.998684 | -1.11723 | 0.358612 | 0.684334 | 0.327184 | 1.431342 |
| GCST008085-HDL cholesterol levels in current drinkers | Inverse variance weighted | 34 | -0.30808 | 0.306356 | 0.314595 | 0.998684 | -0.90854 | 0.292378 | 0.734856 | 0.403113 | 1.339609 |
| GCST005863-Menopause \(age at onset\) | Inverse variance weighted | 10 | -0.04547 | 0.045245 | 0.314912 | 0.998684 | -0.13415 | 0.04321 | 0.955549 | 0.87446 | 1.044157 |
| GCST004858-Dupuytren's disease | Inverse variance weighted | 20 | 0.01961 | 0.019516 | 0.31499 | 0.998684 | -0.01864 | 0.05786 | 1.019803 | 0.981531 | 1.059567 |
| GCST007142-Triglycerides | Inverse variance weighted | 139 | 0.195768 | 0.194962 | 0.315315 | 0.998684 | -0.18636 | 0.577893 | 1.216244 | 0.829976 | 1.78228 |
| GCST000585-Mean corpuscular volume | Inverse variance weighted | 11 | 0.098294 | 0.097944 | 0.315582 | 0.998684 | -0.09368 | 0.290265 | 1.103288 | 0.910578 | 1.336782 |
| GCST003879-Serum parathyroid hormone levels | Inverse variance weighted | 4 | 0.005672 | 0.005658 | 0.316099 | 0.998684 | -0.00542 | 0.016763 | 1.005689 | 0.994597 | 1.016904 |
| GCST004600-Eosinophil percentage of white cells | Inverse variance weighted | 87 | -0.05261 | 0.052794 | 0.318965 | 0.998684 | -0.15609 | 0.050862 | 0.948746 | 0.855482 | 1.052178 |
| GCST005790-Rosacea symptom severity | Inverse variance weighted | 6 | -0.05601 | 0.056248 | 0.319376 | 0.998684 | -0.16626 | 0.054238 | 0.945531 | 0.84683 | 1.055736 |
| GCST001912-Acute lymphoblastic leukemia \(childhood\) | Inverse variance weighted | 3 | -0.02394 | 0.024103 | 0.320601 | 0.998684 | -0.07118 | 0.023302 | 0.976345 | 0.931293 | 1.023576 |
| GCST003635-middle facial morphology traits \(quantitative measurement\) | Inverse variance weighted | 4 | -0.19231 | 0.193897 | 0.321284 | 0.998684 | -0.57235 | 0.187727 | 0.82505 | 0.564198 | 1.206504 |
| GCST000692-Vitiligo | Inverse variance weighted | 2 | -0.05898 | 0.059992 | 0.325506 | 0.998684 | -0.17657 | 0.058599 | 0.942722 | 0.838142 | 1.06035 |
| GCST002147-Fibrinogen | Inverse variance weighted | 12 | 0.487797 | 0.497855 | 0.327186 | 0.998684 | -0.488 | 1.463592 | 1.628724 | 0.613854 | 4.321455 |
| GCST004007-Mean corpuscular hemoglobin concentration | Inverse variance weighted | 3 | -5.09695 | 5.211364 | 0.328052 | 0.998684 | -15.3112 | 5.117325 | 0.006115 | 2.24E-07 | 166.8883 |
| GCST006436-Triglyceride levels | Inverse variance weighted | 9 | -0.00171 | 0.001748 | 0.329336 | 0.998684 | -0.00513 | 0.001721 | 0.998296 | 0.994881 | 1.001723 |
| GCST004560-Body mass index in physically inactive individuals | Inverse variance weighted | 10 | -0.08651 | 0.088889 | 0.330445 | 0.998684 | -0.26073 | 0.087714 | 0.917128 | 0.770489 | 1.091676 |
| GCST000842-Bladder cancer | Inverse variance weighted | 4 | 0.092451 | 0.095001 | 0.330478 | 0.998684 | -0.09375 | 0.278653 | 1.096859 | 0.910509 | 1.321349 |
| GCST005075-Breast Cancer in BRCA1 mutation carriers | Inverse variance weighted | 2 | -0.09348 | 0.096518 | 0.332791 | 0.998684 | -0.28265 | 0.095697 | 0.910758 | 0.753782 | 1.100425 |
| GCST002582-Glaucoma \(primary open-angle\) | Inverse variance weighted | 2 | -0.05082 | 0.052484 | 0.33294 | 0.998684 | -0.15368 | 0.052053 | 0.950454 | 0.857543 | 1.053432 |
| GCST006481-Lung function \(FEV1\) | Inverse variance weighted | 10 | 0.000296 | 0.000306 | 0.332999 | 0.998684 | -0.0003 | 0.000895 | 1.000296 | 0.999697 | 1.000895 |
| GCST000440-Glioma \(high-grade\) | Inverse variance weighted | 2 | -0.06647 | 0.068717 | 0.333392 | 0.998684 | -0.20116 | 0.068215 | 0.935691 | 0.817785 | 1.070595 |
| GCST006949-Suffering from nerves | Inverse variance weighted | 7 | 0.002444 | 0.002529 | 0.333827 | 0.998684 | -0.00251 | 0.007401 | 1.002447 | 0.997491 | 1.007428 |
| GCST001856-Thyroid hormone levels | Inverse variance weighted | 16 | -0.05336 | 0.055272 | 0.334311 | 0.998684 | -0.1617 | 0.05497 | 0.948035 | 0.850698 | 1.056509 |
| GCST001482-Lumbar spine bone mineral density | Inverse variance weighted | 16 | 0.077251 | 0.080249 | 0.335731 | 0.998684 | -0.08004 | 0.23454 | 1.080313 | 0.923081 | 1.264327 |
| GCST001587-Coronary heart disease | Inverse variance weighted | 3 | 0.041909 | 0.043611 | 0.336562 | 0.998684 | -0.04357 | 0.127387 | 1.0428 | 0.957367 | 1.135856 |
| GCST001179-Plasma omega-3 polyunsaturated fatty acid levels \(docosapentaenoic acid\) | Inverse variance weighted | 11 | 0.099558 | 0.103716 | 0.3371 | 0.998684 | -0.10373 | 0.302841 | 1.104682 | 0.901473 | 1.353699 |
| GCST004011-RR interval \(tricyclic/tetracyclic antidepressant use interaction\) | Inverse variance weighted | 2 | -0.00041 | 0.000433 | 0.338107 | 0.998684 | -0.00126 | 0.000434 | 0.999585 | 0.998738 | 1.000434 |
| GCST002115-Axial length | Inverse variance weighted | 4 | -0.11522 | 0.120871 | 0.340463 | 0.998684 | -0.35213 | 0.121687 | 0.89117 | 0.70319 | 1.129401 |
| GCST004775-Pulse pressure | Inverse variance weighted | 15 | -0.01322 | 0.013895 | 0.341476 | 0.998684 | -0.04045 | 0.014017 | 0.986869 | 0.960355 | 1.014115 |
| GCST001086-Paget's disease | Inverse variance weighted | 6 | 0.016192 | 0.017038 | 0.341942 | 0.998684 | -0.0172 | 0.049587 | 1.016324 | 0.982944 | 1.050837 |
| GCST004498-BMI in smokers | Inverse variance weighted | 9 | -0.1244 | 0.131049 | 0.34247 | 0.998684 | -0.38126 | 0.132452 | 0.883023 | 0.683 | 1.141624 |
| GCST001812-Epstein-Barr virus immune response \(EBNA-1\) | Inverse variance weighted | 2 | -0.13664 | 0.144045 | 0.342832 | 0.998684 | -0.41897 | 0.145689 | 0.872286 | 0.657727 | 1.156836 |
| GCST005346-Total body bone mineral density \(age 30-45\) | Inverse variance weighted | 6 | 0.056935 | 0.060091 | 0.343395 | 0.998684 | -0.06084 | 0.174715 | 1.058587 | 0.94097 | 1.190906 |
| GCST006464-Endometrial cancer | Inverse variance weighted | 10 | 0.046069 | 0.049032 | 0.347434 | 0.998684 | -0.05003 | 0.142171 | 1.047147 | 0.951198 | 1.152774 |
| GCST001438-Crohn's disease | Inverse variance weighted | 10 | -0.01816 | 0.019335 | 0.347591 | 0.998684 | -0.05606 | 0.019736 | 0.982003 | 0.945484 | 1.019932 |
| GCST005196-Coronary artery disease | Inverse variance weighted | 97 | -0.04567 | 0.048688 | 0.348266 | 0.998684 | -0.1411 | 0.049762 | 0.955359 | 0.868405 | 1.05102 |
| GCST000998-Coronary heart disease | Inverse variance weighted | 14 | -0.04943 | 0.052723 | 0.34846 | 0.998684 | -0.15277 | 0.053905 | 0.95177 | 0.858329 | 1.055384 |
| GCST006021-Systolic blood pressure | Inverse variance weighted | 14 | -0.02194 | 0.02347 | 0.349782 | 0.998684 | -0.06795 | 0.024057 | 0.978294 | 0.93431 | 1.024348 |
| GCST000258-Type 1 diabetes | Inverse variance weighted | 3 | -0.07826 | 0.083815 | 0.350429 | 0.998684 | -0.24254 | 0.086015 | 0.924721 | 0.784632 | 1.089822 |
| GCST001351-Type 2 diabetes | Inverse variance weighted | 5 | 0.080917 | 0.086735 | 0.35086 | 0.998684 | -0.08908 | 0.250919 | 1.084281 | 0.914769 | 1.285206 |
| GCST003116-Coronary artery disease | Inverse variance weighted | 24 | -0.03961 | 0.042533 | 0.351748 | 0.998684 | -0.12297 | 0.043758 | 0.961167 | 0.884289 | 1.044729 |
| GCST001218-Lp \(a\) levels | Inverse variance weighted | 2 | -0.02498 | 0.026841 | 0.352112 | 0.998684 | -0.07758 | 0.027633 | 0.975334 | 0.925349 | 1.028018 |
| GCST001727-Lipoprotein-associated phospholipase A2 activity and mass | Inverse variance weighted | 5 | -0.78307 | 0.843081 | 0.352983 | 0.998684 | -2.43551 | 0.869369 | 0.457001 | 0.087553 | 2.385405 |
| GCST001729-Crohn's disease | Inverse variance weighted | 23 | -0.03441 | 0.037056 | 0.353136 | 0.998684 | -0.10704 | 0.038222 | 0.966178 | 0.898494 | 1.038962 |
| GCST005789-Resting heart rate | Inverse variance weighted | 10 | 0.008758 | 0.009455 | 0.354306 | 0.998684 | -0.00977 | 0.027289 | 1.008796 | 0.990274 | 1.027665 |
| GCST001003-Metabolic syndrome | Inverse variance weighted | 4 | 0.055015 | 0.059444 | 0.354711 | 0.998684 | -0.0615 | 0.171525 | 1.056556 | 0.940357 | 1.187114 |
| GCST002700-Cervical artery dissection | Inverse variance weighted | 2 | 0.045008 | 0.048656 | 0.354951 | 0.998684 | -0.05036 | 0.140374 | 1.046036 | 0.950889 | 1.150704 |
| GCST008279-Trochanter size | Inverse variance weighted | 2 | -0.15579 | 0.169526 | 0.358103 | 0.998684 | -0.48806 | 0.176479 | 0.855738 | 0.613815 | 1.193009 |
| GCST002128-Type 2 diabetes | Inverse variance weighted | 5 | 0.046445 | 0.050562 | 0.358323 | 0.998684 | -0.05266 | 0.145547 | 1.04754 | 0.948705 | 1.156673 |
| GCST002174-Lipid traits | Inverse variance weighted | 3 | 0.880982 | 0.961652 | 0.359608 | 0.998684 | -1.00386 | 2.765821 | 2.413269 | 0.366463 | 15.89208 |
| GCST001615-Sclerosing cholangitis and ulcerative colitis \(combined\) | Inverse variance weighted | 2 | -0.04202 | 0.045978 | 0.36073 | 0.998684 | -0.13214 | 0.048094 | 0.958848 | 0.87622 | 1.049269 |
| GCST005749-Digit length ratio \(left hand\) | Inverse variance weighted | 6 | 0.023293 | 0.025583 | 0.362551 | 0.998684 | -0.02685 | 0.073436 | 1.023567 | 0.973508 | 1.076199 |
| GCST006097-Moderate to vigorous physical activity levels | Inverse variance weighted | 5 | 10.75603 | 11.81416 | 0.362593 | 0.998684 | -12.3997 | 33.91178 | 46912.03 | 4.12E-06 | 5.34E+14 |
| GCST001585-Breast size | Inverse variance weighted | 3 | -0.13 | 0.143547 | 0.365146 | 0.998684 | -0.41135 | 0.151356 | 0.878098 | 0.662756 | 1.16341 |
| GCST004398-Lipoprotein \(a\) levels | Inverse variance weighted | 18 | -0.00148 | 0.001639 | 0.365646 | 0.998684 | -0.0047 | 0.00173 | 0.998518 | 0.995316 | 1.001731 |
| GCST004003-Hematocrit | Inverse variance weighted | 3 | -0.06493 | 0.071828 | 0.366006 | 0.998684 | -0.20571 | 0.075852 | 0.937132 | 0.814066 | 1.078802 |
| GCST007436-Carotid intima media thickness | Inverse variance weighted | 4 | 8.098445 | 9.019369 | 0.369242 | 0.998684 | -9.57952 | 25.77641 | 3289.348 | 6.91E-05 | 1.57E+11 |
| GCST003877-Abdominal aortic aneurysm | Inverse variance weighted | 7 | -0.03733 | 0.041684 | 0.370469 | 0.998684 | -0.11903 | 0.044368 | 0.963356 | 0.887779 | 1.045367 |
| GCST006921-Regular attendance at a pub or social club | Inverse variance weighted | 7 | 1.154771 | 1.290342 | 0.370822 | 0.998684 | -1.3743 | 3.68384 | 3.173296 | 0.253017 | 39.79895 |
| GCST000287-LDL cholesterol | Inverse variance weighted | 8 | -0.04242 | 0.047672 | 0.373509 | 0.998684 | -0.13586 | 0.051013 | 0.958463 | 0.872963 | 1.052337 |
| GCST002446-Plasma omega-6 polyunsaturated fatty acid levels \(linoleic acid\) | Inverse variance weighted | 3 | -0.00916 | 0.010304 | 0.373909 | 0.998684 | -0.02936 | 0.011033 | 0.99088 | 0.97107 | 1.011095 |
| GCST000503-Mean corpuscular volume | Inverse variance weighted | 3 | -0.99207 | 1.11767 | 0.374745 | 0.998684 | -3.1827 | 1.198567 | 0.370809 | 0.041473 | 3.315361 |
| GCST004365-Blood protein levels | Inverse variance weighted | 298 | -0.00199 | 0.00224 | 0.375324 | 0.998684 | -0.00638 | 0.002405 | 0.998016 | 0.993643 | 1.002408 |
| GCST000731-Resting heart rate | Inverse variance weighted | 5 | -0.00096 | 0.001084 | 0.377131 | 0.998684 | -0.00308 | 0.001167 | 0.999043 | 0.996923 | 1.001168 |
| GCST007933-Medication use \(immunosuppressants\) | Inverse variance weighted | 2 | -0.1239 | 0.140321 | 0.377244 | 0.998684 | -0.39893 | 0.151128 | 0.883467 | 0.671037 | 1.163145 |
| GCST003598-QRS duration | Inverse variance weighted | 15 | -0.00723 | 0.008187 | 0.377453 | 0.998684 | -0.02327 | 0.008821 | 0.9928 | 0.976995 | 1.00886 |
| GCST007432-FEV1 | Inverse variance weighted | 109 | 0.076144 | 0.086351 | 0.37789 | 0.998684 | -0.0931 | 0.245392 | 1.079118 | 0.911098 | 1.278123 |
| GCST005951-Body mass index | Inverse variance weighted | 123 | -0.26049 | 0.295896 | 0.378674 | 0.998684 | -0.84045 | 0.319467 | 0.770674 | 0.431518 | 1.376393 |
| GCST004504-Waist circumference adjusted for BMI in non-smokers | Inverse variance weighted | 25 | -0.1262 | 0.143467 | 0.37906 | 0.998684 | -0.40739 | 0.154997 | 0.881441 | 0.665383 | 1.167655 |
| GCST003643-Nose morphology | Inverse variance weighted | 2 | 0.041981 | 0.047761 | 0.379408 | 0.998684 | -0.05163 | 0.135593 | 1.042875 | 0.94968 | 1.145215 |
| GCST006110-Nose morphology | Inverse variance weighted | 4 | 0.848561 | 0.965457 | 0.379444 | 0.998684 | -1.04374 | 2.740858 | 2.336283 | 0.352137 | 15.50028 |
| GCST001363-Atopic dermatitis | Inverse variance weighted | 2 | 0.081507 | 0.092785 | 0.379699 | 0.998684 | -0.10035 | 0.263365 | 1.08492 | 0.90452 | 1.301301 |
| GCST002546-Osteoprotegerin levels | Inverse variance weighted | 2 | -0.34075 | 0.388414 | 0.380329 | 0.998684 | -1.10204 | 0.420539 | 0.711235 | 0.332192 | 1.522783 |
| GCST008086-LDL cholesterol levels in current drinkers | Inverse variance weighted | 24 | 0.003289 | 0.003751 | 0.380535 | 0.998684 | -0.00406 | 0.010641 | 1.003295 | 0.995946 | 1.010698 |
| GCST007985-Snoring | Inverse variance weighted | 21 | 0.107539 | 0.12267 | 0.380674 | 0.998684 | -0.13289 | 0.347971 | 1.113534 | 0.875558 | 1.416192 |
| GCST003123-Severe influenza A \(H1N1\) infection | Inverse variance weighted | 3 | -0.00872 | 0.009952 | 0.38094 | 0.998684 | -0.02822 | 0.010786 | 0.991319 | 0.97217 | 1.010844 |
| GCST003524-Endometrial cancer | Inverse variance weighted | 4 | 0.051038 | 0.058319 | 0.381492 | 0.998684 | -0.06327 | 0.165344 | 1.052363 | 0.938692 | 1.179799 |
| GCST004137-Optic cup area | Inverse variance weighted | 13 | -0.37638 | 0.431611 | 0.383195 | 0.998684 | -1.22233 | 0.469582 | 0.686344 | 0.294542 | 1.599326 |
| GCST004480-High-grade serous ovarian cancer | Inverse variance weighted | 5 | -0.04854 | 0.055783 | 0.384222 | 0.998684 | -0.15787 | 0.060796 | 0.95262 | 0.853957 | 1.062682 |
| GCST001614-Central corneal thickness | Inverse variance weighted | 2 | 0.066827 | 0.07681 | 0.384287 | 0.998684 | -0.08372 | 0.217374 | 1.06911 | 0.919688 | 1.242809 |
| GCST001148-Prostate cancer | Inverse variance weighted | 4 | 0.190933 | 0.21973 | 0.384876 | 0.998684 | -0.23974 | 0.621604 | 1.210379 | 0.786835 | 1.861911 |
| GCST004478-Serous invasive ovarian cancer | Inverse variance weighted | 5 | -0.04901 | 0.056425 | 0.385109 | 0.998684 | -0.1596 | 0.061587 | 0.952175 | 0.852484 | 1.063523 |
| GCST007323-Risk-taking tendency \(4-domain principal component model\) | Inverse variance weighted | 52 | -0.17048 | 0.196318 | 0.385188 | 0.998684 | -0.55526 | 0.214305 | 0.843262 | 0.573923 | 1.239 |
| GCST001779-Hematology traits | Inverse variance weighted | 3 | -0.21521 | 0.248103 | 0.385712 | 0.998684 | -0.70149 | 0.271073 | 0.806372 | 0.495845 | 1.311371 |
| GCST003043-Inflammatory bowel disease | Inverse variance weighted | 35 | -0.02786 | 0.032125 | 0.385766 | 0.998684 | -0.09083 | 0.035103 | 0.972522 | 0.913175 | 1.035726 |
| GCST002702-Height | Inverse variance weighted | 60 | -0.04488 | 0.051804 | 0.386307 | 0.998684 | -0.14642 | 0.056657 | 0.956112 | 0.863798 | 1.058293 |
| GCST003875-Gut microbiota \(bacterial taxa\) | Inverse variance weighted | 28 | -0.00579 | 0.006691 | 0.386795 | 0.998684 | -0.0189 | 0.007323 | 0.994226 | 0.981274 | 1.00735 |
| GCST005656-IgG glycosylation patterns | Inverse variance weighted | 31 | 0.008964 | 0.010369 | 0.387331 | 0.998684 | -0.01136 | 0.029288 | 1.009004 | 0.988704 | 1.029721 |
| GCST004180-Pediatric bone mineral content \(hip\) | Inverse variance weighted | 2 | -0.07959 | 0.092962 | 0.391925 | 0.998684 | -0.26179 | 0.102618 | 0.923497 | 0.769669 | 1.108068 |
| GCST002783-Body mass index | Inverse variance weighted | 74 | -0.36166 | 0.422877 | 0.392425 | 0.998684 | -1.1905 | 0.467183 | 0.696522 | 0.304071 | 1.595494 |
| GCST002925-Sex hormone levels | Inverse variance weighted | 4 | -0.06634 | 0.077862 | 0.394235 | 0.998684 | -0.21894 | 0.086274 | 0.935817 | 0.803366 | 1.090105 |
| GCST004616-Platelet distribution width | Inverse variance weighted | 89 | -0.04037 | 0.047426 | 0.394601 | 0.998684 | -0.13333 | 0.052581 | 0.96043 | 0.875176 | 1.053988 |
| GCST004863-Mosquito bite size | Inverse variance weighted | 14 | -0.14636 | 0.172201 | 0.39535 | 0.998684 | -0.48388 | 0.191151 | 0.863844 | 0.616389 | 1.210642 |
| GCST001047-Soluble ICAM-1 | Inverse variance weighted | 2 | 0.00067 | 0.00079 | 0.396158 | 0.998684 | -0.00088 | 0.002219 | 1.000671 | 0.999122 | 1.002221 |
| GCST007994-Asthma \(age of onset\) | Inverse variance weighted | 8 | 0.004143 | 0.004884 | 0.396362 | 0.998684 | -0.00543 | 0.013716 | 1.004151 | 0.994584 | 1.01381 |
| GCST004206-Fasting plasma glucose | Inverse variance weighted | 5 | 0.066306 | 0.078243 | 0.396747 | 0.998684 | -0.08705 | 0.219662 | 1.068554 | 0.916632 | 1.245655 |
| GCST001942-Prostate cancer | Inverse variance weighted | 14 | -0.04537 | 0.053565 | 0.396953 | 0.998684 | -0.15036 | 0.059614 | 0.95564 | 0.860397 | 1.061426 |
| GCST000439-Glioma | Inverse variance weighted | 3 | -0.07225 | 0.085338 | 0.397186 | 0.998684 | -0.23951 | 0.09501 | 0.930296 | 0.78701 | 1.09967 |
| GCST001862-Sickle cell anemia \(haemolysis\) | Inverse variance weighted | 2 | -0.02426 | 0.028676 | 0.397585 | 0.998684 | -0.08046 | 0.031947 | 0.976034 | 0.922689 | 1.032462 |
| GCST000805-HDL cholesterol | Inverse variance weighted | 3 | 0.26289 | 0.31087 | 0.397744 | 0.998684 | -0.34642 | 0.872196 | 1.300683 | 0.707218 | 2.392158 |
| GCST001666-Type 2 diabetes | Inverse variance weighted | 6 | 0.043617 | 0.051594 | 0.397896 | 0.998684 | -0.05751 | 0.144741 | 1.044582 | 0.944115 | 1.15574 |
| GCST000494-Bone mineral density \(spine\) | Inverse variance weighted | 7 | -0.05998 | 0.071015 | 0.398357 | 0.998684 | -0.19916 | 0.079213 | 0.941787 | 0.819415 | 1.082434 |
| GCST006020-Diastolic blood pressure | Inverse variance weighted | 16 | -0.02594 | 0.03074 | 0.398716 | 0.998684 | -0.08619 | 0.034308 | 0.974392 | 0.917418 | 1.034903 |
| GCST004176-Pediatric areal bone mineral density \(radius\) | Inverse variance weighted | 2 | -0.0361 | 0.042798 | 0.398967 | 0.998684 | -0.11998 | 0.047785 | 0.964545 | 0.886936 | 1.048945 |
| GCST008302-Number of decayed, missing and filled tooth surfaces | Inverse variance weighted | 2 | 0.271982 | 0.323161 | 0.399995 | 0.998684 | -0.36141 | 0.905377 | 1.312563 | 0.696691 | 2.472864 |
| GCST007429-Lung function \(FVC\) | Inverse variance weighted | 85 | 0.093817 | 0.111606 | 0.400564 | 0.998684 | -0.12493 | 0.312565 | 1.098359 | 0.882559 | 1.366927 |
| GCST003766-Subjective well-being | Inverse variance weighted | 4 | 0.420123 | 0.500178 | 0.400938 | 0.998684 | -0.56023 | 1.400472 | 1.522149 | 0.57108 | 4.057116 |
| GCST004352-Early onset atrial fibrillation | Inverse variance weighted | 3 | -0.02111 | 0.025171 | 0.401593 | 0.998684 | -0.07045 | 0.028222 | 0.979109 | 0.931977 | 1.028624 |
| GCST001550-Type 2 diabetes | Inverse variance weighted | 5 | 0.041508 | 0.049492 | 0.401647 | 0.998684 | -0.0555 | 0.138511 | 1.042381 | 0.946016 | 1.148563 |
| GCST007877-Creatinine levels | Inverse variance weighted | 13 | -0.08868 | 0.105759 | 0.401739 | 0.998684 | -0.29597 | 0.118607 | 0.915137 | 0.74381 | 1.125927 |
| GCST005850-Heart rate response to recovery post exercise \(30 sec\) | Inverse variance weighted | 9 | -0.10099 | 0.120563 | 0.402234 | 0.998684 | -0.33729 | 0.135316 | 0.903944 | 0.7137 | 1.144898 |
| GCST002352-Type 2 diabetes | Inverse variance weighted | 21 | 0.043932 | 0.052615 | 0.403732 | 0.998684 | -0.05919 | 0.147057 | 1.044911 | 0.942525 | 1.15842 |
| GCST000649-Chronic kidney disease | Inverse variance weighted | 14 | -0.01278 | 0.01532 | 0.404065 | 0.998684 | -0.04281 | 0.017244 | 0.987299 | 0.958095 | 1.017393 |
| GCST002897-Triglycerides | Inverse variance weighted | 23 | -0.0516 | 0.061939 | 0.404774 | 0.998684 | -0.173 | 0.069798 | 0.949706 | 0.841134 | 1.072291 |
| GCST007431-Lung function \(FEV1/FVC\) | Inverse variance weighted | 96 | 0.054918 | 0.06614 | 0.406359 | 0.998684 | -0.07472 | 0.184553 | 1.056453 | 0.928006 | 1.20268 |
| GCST001228-Diastolic blood pressure | Inverse variance weighted | 6 | -0.01899 | 0.02289 | 0.406718 | 0.998684 | -0.06386 | 0.025873 | 0.981188 | 0.93814 | 1.026211 |
| GCST005848-Heart rate response to recovery post exercise \(50 sec\) | Inverse variance weighted | 13 | -0.08635 | 0.1044 | 0.408173 | 0.998684 | -0.29098 | 0.118274 | 0.917272 | 0.747534 | 1.125552 |
| GCST004519-Body mass index \(adult\) | Inverse variance weighted | 6 | -0.14594 | 0.176545 | 0.408433 | 0.998684 | -0.49197 | 0.200086 | 0.864208 | 0.611421 | 1.221508 |
| GCST007464-Smoking cessation \(MTAG\) | Inverse variance weighted | 46 | -0.17738 | 0.21501 | 0.409392 | 0.998684 | -0.59879 | 0.244044 | 0.837466 | 0.549474 | 1.2764 |
| GCST004064-Waist-hip ratio | Inverse variance weighted | 28 | -0.89006 | 1.079717 | 0.409743 | 0.998684 | -3.0063 | 1.226185 | 0.410631 | 0.049474 | 3.408203 |
| GCST003360-Crohn's disease | Inverse variance weighted | 3 | 0.017972 | 0.021815 | 0.410043 | 0.998684 | -0.02479 | 0.06073 | 1.018134 | 0.975518 | 1.062612 |
| GCST001526-Fasting blood insulin \(BMI interaction\) | Inverse variance weighted | 7 | -3.50422 | 4.261746 | 0.410935 | 0.998684 | -11.8572 | 4.848806 | 0.03007 | 7.09E-06 | 127.5879 |
| GCST004276-Plasma thyroid-stimulating hormone levels | Inverse variance weighted | 2 | 0.048963 | 0.059563 | 0.411058 | 0.998684 | -0.06778 | 0.165706 | 1.050181 | 0.934466 | 1.180226 |
| GCST004864-Perceived unattractiveness to mosquitoes | Inverse variance weighted | 4 | -0.03848 | 0.046814 | 0.411131 | 0.998684 | -0.13023 | 0.053278 | 0.962254 | 0.877892 | 1.054723 |
| GCST004651-Aortic root size | Inverse variance weighted | 5 | 0.393232 | 0.479324 | 0.411994 | 0.998684 | -0.54624 | 1.332707 | 1.481763 | 0.579122 | 3.791293 |
| GCST004620-Sum basophil neutrophil counts | Inverse variance weighted | 64 | -0.07059 | 0.086069 | 0.412143 | 0.998684 | -0.23928 | 0.098107 | 0.931846 | 0.787192 | 1.103081 |
| GCST004279-Systolic blood pressure | Inverse variance weighted | 18 | 0.013295 | 0.016221 | 0.412412 | 0.998684 | -0.0185 | 0.045088 | 1.013384 | 0.981673 | 1.04612 |
| GCST001887-Monocyte count | Inverse variance weighted | 3 | -0.08625 | 0.105257 | 0.412522 | 0.998684 | -0.29256 | 0.120049 | 0.917361 | 0.746353 | 1.127552 |
| GCST004865-Itch intensity from mosquito bite adjusted by bite size | Inverse variance weighted | 12 | 0.146883 | 0.179495 | 0.413181 | 0.998684 | -0.20493 | 0.498693 | 1.158218 | 0.814706 | 1.646568 |
| GCST005905-Global electrical heterogeneity phenotypes | Inverse variance weighted | 7 | -0.0581 | 0.071029 | 0.413351 | 0.998684 | -0.19732 | 0.081115 | 0.943553 | 0.820927 | 1.084496 |
| GCST007468-Smoking initiation \(ever regular vs never regular\) \(MTAG\) | Inverse variance weighted | 391 | -0.09687 | 0.118452 | 0.413473 | 0.998684 | -0.32903 | 0.135296 | 0.907675 | 0.719618 | 1.144876 |
| GCST002636-Diffuse large B cell lymphoma | Inverse variance weighted | 3 | -0.04426 | 0.054301 | 0.415064 | 0.998684 | -0.15069 | 0.062174 | 0.956709 | 0.860118 | 1.064147 |
| GCST004748-Lung cancer | Inverse variance weighted | 21 | -0.03454 | 0.042385 | 0.415094 | 0.998684 | -0.11762 | 0.048533 | 0.966047 | 0.889036 | 1.04973 |
| GCST001884-Age-related macular degeneration | Inverse variance weighted | 9 | 0.011071 | 0.013641 | 0.417002 | 0.998684 | -0.01566 | 0.037808 | 1.011133 | 0.984457 | 1.038532 |
| GCST006228-Systolic blood pressure | Inverse variance weighted | 6 | -0.01733 | 0.021357 | 0.417065 | 0.998684 | -0.05919 | 0.024528 | 0.982818 | 0.942527 | 1.024831 |
| GCST001500-Wilms tumor | Inverse variance weighted | 5 | 0.027938 | 0.034503 | 0.418088 | 0.998684 | -0.03969 | 0.095564 | 1.028332 | 0.96109 | 1.100279 |
| GCST001740-Lung cancer | Inverse variance weighted | 4 | -0.07381 | 0.091583 | 0.42031 | 0.998684 | -0.25331 | 0.105698 | 0.928853 | 0.776228 | 1.111486 |
| GCST004895-Colorectal cancer | Inverse variance weighted | 2 | 0.060257 | 0.074849 | 0.420794 | 0.998684 | -0.08645 | 0.20696 | 1.062109 | 0.917184 | 1.229934 |
| GCST001236-Blood pressure | Inverse variance weighted | 13 | -0.01204 | 0.01496 | 0.421045 | 0.998684 | -0.04136 | 0.017285 | 0.988035 | 0.959484 | 1.017435 |
| GCST004184-Lung function \(FVC\) | Inverse variance weighted | 8 | -0.20912 | 0.260224 | 0.421626 | 0.998684 | -0.71915 | 0.300922 | 0.811301 | 0.487164 | 1.351103 |
| GCST005337-Headache | Inverse variance weighted | 18 | -0.29644 | 0.369035 | 0.421816 | 0.998684 | -1.01975 | 0.426872 | 0.743463 | 0.360687 | 1.532457 |
| GCST006290-Myopia \(age of diagnosis\) | Inverse variance weighted | 42 | 0.034991 | 0.043626 | 0.422512 | 0.998684 | -0.05052 | 0.120498 | 1.035611 | 0.950739 | 1.128059 |
| GCST000569-Two-hour glucose challenge | Inverse variance weighted | 2 | 0.122793 | 0.153266 | 0.423031 | 0.998684 | -0.17761 | 0.423194 | 1.13065 | 0.83727 | 1.52683 |
| GCST004904-Body mass index | Inverse variance weighted | 164 | -0.03625 | 0.045317 | 0.423807 | 0.998684 | -0.12507 | 0.052575 | 0.964403 | 0.882438 | 1.053981 |
| GCST004749-Lung cancer in ever smokers | Inverse variance weighted | 11 | -0.03753 | 0.046966 | 0.424294 | 0.998684 | -0.12958 | 0.054528 | 0.96317 | 0.878466 | 1.056042 |
| GCST004415-Invasive epithelial ovarian cancer | Inverse variance weighted | 3 | -0.0744 | 0.093148 | 0.424438 | 0.998684 | -0.25697 | 0.108168 | 0.928299 | 0.773391 | 1.114235 |
| GCST007441-Total cholesterol levels | Inverse variance weighted | 4 | -0.00206 | 0.002577 | 0.424762 | 0.998684 | -0.00711 | 0.002994 | 0.997945 | 0.992917 | 1.002999 |
| GCST002201-Calcium levels | Inverse variance weighted | 6 | -0.22551 | 0.282572 | 0.424845 | 0.998684 | -0.77935 | 0.328336 | 0.798113 | 0.458705 | 1.388656 |
| GCST007400-Systemic lupus erythematosus | Inverse variance weighted | 15 | 0.019707 | 0.024746 | 0.425805 | 0.998684 | -0.02879 | 0.068209 | 1.019903 | 0.971616 | 1.070589 |
| GCST004510-Sporadic neuroblastoma | Inverse variance weighted | 6 | -0.02338 | 0.029412 | 0.426563 | 0.998684 | -0.08103 | 0.034262 | 0.976886 | 0.922164 | 1.034856 |
| GCST001706-Stroke \(ischemic\) | Inverse variance weighted | 2 | -0.04201 | 0.052884 | 0.427013 | 0.998684 | -0.14566 | 0.061646 | 0.958864 | 0.864453 | 1.063586 |
| GCST002544-Parkinson's disease | Inverse variance weighted | 18 | -0.03929 | 0.04963 | 0.428518 | 0.998684 | -0.13657 | 0.057981 | 0.961469 | 0.872347 | 1.059695 |
| GCST007437-Triglyceride levels | Inverse variance weighted | 3 | 2.953403 | 3.731085 | 0.428613 | 0.998684 | -4.35952 | 10.26633 | 19.17107 | 0.012784 | 28748.16 |
| GCST000646-Intracranial aneurysm | Inverse variance weighted | 4 | -0.03545 | 0.044792 | 0.428711 | 0.998684 | -0.12324 | 0.052344 | 0.965172 | 0.88405 | 1.053739 |
| GCST007614-C-reactive protein levels | Inverse variance weighted | 31 | -0.08288 | 0.104834 | 0.429168 | 0.998684 | -0.28836 | 0.122592 | 0.920458 | 0.749492 | 1.130423 |
| GCST005145-Glycated hemoglobin levels | Inverse variance weighted | 3 | -0.23701 | 0.300415 | 0.430139 | 0.998684 | -0.82583 | 0.3518 | 0.78898 | 0.437873 | 1.421624 |
| GCST002899-HDL cholesterol | Inverse variance weighted | 17 | -0.67917 | 0.860956 | 0.430194 | 0.998684 | -2.36665 | 1.008301 | 0.507036 | 0.093795 | 2.740941 |
| GCST005185-Fasting blood insulin | Inverse variance weighted | 3 | 0.403554 | 0.511651 | 0.430271 | 0.998684 | -0.59928 | 1.406389 | 1.497135 | 0.549206 | 4.081193 |
| GCST005288-Extrinsic epigenetic age acceleration | Inverse variance weighted | 2 | 0.02548 | 0.03233 | 0.430623 | 0.998684 | -0.03789 | 0.088848 | 1.025808 | 0.962822 | 1.092914 |
| GCST007354-Intracranial aneurysm | Inverse variance weighted | 11 | -0.00851 | 0.010799 | 0.430706 | 0.998684 | -0.02968 | 0.012657 | 0.991526 | 0.970759 | 1.012738 |
| GCST000935-Iron status biomarkers | Inverse variance weighted | 2 | -0.00051 | 0.000645 | 0.432103 | 0.998684 | -0.00177 | 0.000757 | 0.999494 | 0.998231 | 1.000757 |
| GCST001746-QT interval | Inverse variance weighted | 2 | -0.00409 | 0.005217 | 0.432939 | 0.998684 | -0.01432 | 0.006134 | 0.995917 | 0.985786 | 1.006153 |
| GCST002346-Breast cancer \(early onset\) | Inverse variance weighted | 10 | -0.0256 | 0.032678 | 0.433465 | 0.998684 | -0.08964 | 0.038453 | 0.974729 | 0.914257 | 1.039202 |
| GCST008059-Estimated glomerular filtration rate | Inverse variance weighted | 150 | -0.4128 | 0.528191 | 0.434483 | 0.998684 | -1.44806 | 0.62245 | 0.661792 | 0.235027 | 1.863488 |
| GCST002559-Vitamin B levels in ischemic stroke | Inverse variance weighted | 2 | 0.05356 | 0.06867 | 0.435418 | 0.998684 | -0.08103 | 0.188153 | 1.05502 | 0.922162 | 1.207019 |
| GCST002318-Rheumatoid arthritis | Inverse variance weighted | 47 | 0.020781 | 0.026646 | 0.435456 | 0.998684 | -0.03144 | 0.073006 | 1.020998 | 0.969044 | 1.075737 |
| GCST001273-Lipoprotein-associated phospholipase A2 activity and mass | Inverse variance weighted | 4 | 0.24298 | 0.311797 | 0.43581 | 0.998684 | -0.36814 | 0.854102 | 1.275043 | 0.692018 | 2.349264 |
| GCST007389-Suicidality | Inverse variance weighted | 2 | 0.180107 | 0.231415 | 0.436402 | 0.998684 | -0.27347 | 0.63368 | 1.197345 | 0.760737 | 1.884534 |
| GCST000925-N-glycan levels | Inverse variance weighted | 4 | 0.040302 | 0.05181 | 0.43664 | 0.998684 | -0.06125 | 0.141849 | 1.041125 | 0.940593 | 1.152402 |
| GCST002961-Acylcarnitine levels | Inverse variance weighted | 8 | -0.05137 | 0.066086 | 0.437011 | 0.998684 | -0.18089 | 0.078163 | 0.949932 | 0.834525 | 1.081299 |
| GCST001474-Hypothyroidism | Inverse variance weighted | 3 | 0.0443 | 0.057011 | 0.437135 | 0.998684 | -0.06744 | 0.156041 | 1.045296 | 0.934782 | 1.168874 |
| GCST004295-Atrial fibrillation | Inverse variance weighted | 2 | 0.086293 | 0.111075 | 0.437222 | 0.998684 | -0.13141 | 0.303999 | 1.090126 | 0.876855 | 1.355268 |
| GCST001790-Gout | Inverse variance weighted | 2 | 0.023334 | 0.030053 | 0.437487 | 0.998684 | -0.03557 | 0.082238 | 1.023609 | 0.965056 | 1.085714 |
| GCST000154-Prostate cancer | Inverse variance weighted | 4 | -0.04716 | 0.060749 | 0.437537 | 0.998684 | -0.16623 | 0.071905 | 0.953932 | 0.846851 | 1.074553 |
| GCST005750-Digit length ratio | Inverse variance weighted | 7 | 0.018277 | 0.023593 | 0.438545 | 0.998684 | -0.02797 | 0.06452 | 1.018445 | 0.972421 | 1.066647 |
| GCST003214-Cholesterol, total | Inverse variance weighted | 5 | -0.00281 | 0.003627 | 0.438564 | 0.998684 | -0.00992 | 0.004299 | 0.997195 | 0.990131 | 1.004308 |
| GCST002481-Acne \(severe\) | Inverse variance weighted | 3 | 0.070344 | 0.090867 | 0.438845 | 0.998684 | -0.10775 | 0.248443 | 1.072877 | 0.897848 | 1.282028 |
| GCST008258-Alcohol use disorder \(consumption score\) | Inverse variance weighted | 14 | -0.00098 | 0.001267 | 0.438851 | 0.998684 | -0.00346 | 0.001502 | 0.99902 | 0.996543 | 1.001503 |
| GCST000999-Coronary heart disease | Inverse variance weighted | 5 | -0.07076 | 0.091553 | 0.439608 | 0.998684 | -0.2502 | 0.108687 | 0.931688 | 0.778644 | 1.114813 |
| GCST003298-NT-proBNP levels in acute coronary syndrome | Inverse variance weighted | 2 | 0.056274 | 0.072845 | 0.439812 | 0.998684 | -0.0865 | 0.19905 | 1.057887 | 0.917133 | 1.220243 |
| GCST006919-Ability to confide in someone | Inverse variance weighted | 2 | 1.394197 | 1.805798 | 0.440075 | 0.998684 | -2.14517 | 4.933562 | 4.031736 | 0.117048 | 138.8732 |
| GCST004602-Mean corpuscular volume | Inverse variance weighted | 134 | 0.026476 | 0.034301 | 0.440189 | 0.998684 | -0.04075 | 0.093705 | 1.026829 | 0.960066 | 1.098236 |
| GCST001814-Age-related macular degeneration | Inverse variance weighted | 2 | 0.02557 | 0.033168 | 0.440759 | 0.998684 | -0.03944 | 0.09058 | 1.0259 | 0.961327 | 1.094809 |
| GCST000214-Restless legs syndrome | Inverse variance weighted | 2 | 0.036789 | 0.047917 | 0.442619 | 0.998684 | -0.05713 | 0.130707 | 1.037475 | 0.944474 | 1.139633 |
| GCST005748-Digit length ratio \(right hand\) | Inverse variance weighted | 6 | 0.020337 | 0.026528 | 0.443304 | 0.998684 | -0.03166 | 0.072332 | 1.020545 | 0.968838 | 1.075013 |
| GCST006395-Glaucoma | Inverse variance weighted | 15 | -0.02577 | 0.03369 | 0.444323 | 0.998684 | -0.0918 | 0.040263 | 0.974559 | 0.912284 | 1.041085 |
| GCST001454-Rheumatoid arthritis | Inverse variance weighted | 8 | 0.045248 | 0.059213 | 0.44477 | 0.998684 | -0.07081 | 0.161305 | 1.046287 | 0.93164 | 1.175043 |
| GCST007944-Medication use \(antiglaucoma preparations and miotics\) | Inverse variance weighted | 11 | 0.026187 | 0.034288 | 0.445022 | 0.998684 | -0.04102 | 0.093392 | 1.026533 | 0.959812 | 1.097892 |
| GCST000952-Breast cancer | Inverse variance weighted | 5 | 0.038349 | 0.050271 | 0.445557 | 0.998684 | -0.06018 | 0.13688 | 1.039094 | 0.941593 | 1.146691 |
| GCST000580-Platelet count | Inverse variance weighted | 4 | 0.002881 | 0.003787 | 0.44668 | 0.998684 | -0.00454 | 0.010303 | 1.002886 | 0.99547 | 1.010356 |
| GCST003180-Atopic march | Inverse variance weighted | 5 | 0.023191 | 0.030644 | 0.449188 | 0.998684 | -0.03687 | 0.083254 | 1.023462 | 0.963799 | 1.086818 |
| GCST000420-Rheumatoid arthritis | Inverse variance weighted | 3 | -0.06491 | 0.085854 | 0.449648 | 0.998684 | -0.23318 | 0.103368 | 0.937155 | 0.792011 | 1.1089 |
| GCST007704-Diastolic blood pressure | Inverse variance weighted | 49 | -0.00611 | 0.008089 | 0.449749 | 0.998684 | -0.02197 | 0.00974 | 0.993905 | 0.978272 | 1.009788 |
| GCST004457-Growth-regulated protein alpha levels | Inverse variance weighted | 5 | 0.019181 | 0.025406 | 0.450252 | 0.998684 | -0.03061 | 0.068977 | 1.019366 | 0.96985 | 1.071411 |
| GCST000038-Type 1 diabetes | Inverse variance weighted | 7 | 0.017255 | 0.022867 | 0.450507 | 0.998684 | -0.02756 | 0.062074 | 1.017404 | 0.972812 | 1.064041 |
| GCST002250-Blood pressure measurement \(low sodium intervention\) | Inverse variance weighted | 3 | 0.002114 | 0.002802 | 0.450662 | 0.998684 | -0.00338 | 0.007606 | 1.002116 | 0.996627 | 1.007635 |
| GCST002964-Sphingolipid levels | Inverse variance weighted | 3 | 0.17535 | 0.232541 | 0.450812 | 0.998684 | -0.28043 | 0.631131 | 1.191664 | 0.755459 | 1.879735 |
| GCST001247-Cardiovascular disease risk factors | Inverse variance weighted | 15 | 0.235322 | 0.312697 | 0.451717 | 0.998684 | -0.37756 | 0.848208 | 1.265316 | 0.685529 | 2.335459 |
| GCST007295-Body fat distribution \(leg fat ratio\) | Inverse variance weighted | 39 | -0.09473 | 0.126041 | 0.452291 | 0.998684 | -0.34177 | 0.152308 | 0.909616 | 0.710509 | 1.164519 |
| GCST004066-Hip circumference | Inverse variance weighted | 47 | -0.07922 | 0.105458 | 0.452547 | 0.998684 | -0.28591 | 0.12748 | 0.923839 | 0.751327 | 1.135962 |
| GCST003228-Glioma | Inverse variance weighted | 2 | -0.06386 | 0.085042 | 0.452715 | 0.998684 | -0.23054 | 0.102824 | 0.938139 | 0.794105 | 1.108297 |
| GCST006952-Feeling tense | Inverse variance weighted | 14 | 0.000693 | 0.000923 | 0.452784 | 0.998684 | -0.00112 | 0.002501 | 1.000693 | 0.998885 | 1.002504 |
| GCST004065-Waist circumference | Inverse variance weighted | 35 | -0.64863 | 0.864599 | 0.453132 | 0.998684 | -2.34324 | 1.045989 | 0.522764 | 0.096016 | 2.846212 |
| GCST008158-Body mass index | Inverse variance weighted | 8 | -0.22876 | 0.305071 | 0.453331 | 0.998684 | -0.8267 | 0.369175 | 0.795516 | 0.437489 | 1.44654 |
| GCST000152-Prostate cancer | Inverse variance weighted | 5 | -0.03895 | 0.052037 | 0.454102 | 0.998684 | -0.14095 | 0.063038 | 0.961795 | 0.868536 | 1.065067 |
| GCST003017-Colorectal cancer | Inverse variance weighted | 5 | -0.05367 | 0.071775 | 0.454625 | 0.998684 | -0.19435 | 0.087011 | 0.947746 | 0.823371 | 1.090909 |
| GCST002940-Sporadic pituitary adenoma | Inverse variance weighted | 3 | 0.026197 | 0.035054 | 0.454868 | 0.998684 | -0.04251 | 0.094902 | 1.026543 | 0.958382 | 1.099551 |
| GCST006670-Primary sclerosing cholangitis | Inverse variance weighted | 10 | -0.01932 | 0.025916 | 0.455937 | 0.998684 | -0.07012 | 0.031473 | 0.980864 | 0.932286 | 1.031974 |
| GCST001481-Brain structure | Inverse variance weighted | 2 | \#\#\#\#\#\#\#\# | 3.70E-06 | 0.456625 | 0.998684 | \#\#\#\#\#\#\#\# | 4.50E-06 | 0.999997 | 0.99999 | 1.000004 |
| GCST003304-HDL cholesterol | Inverse variance weighted | 5 | -0.12391 | 0.16658 | 0.456968 | 0.998684 | -0.45041 | 0.202586 | 0.883459 | 0.637369 | 1.224566 |
| GCST004412-Craniofacial microsomia | Inverse variance weighted | 6 | -0.0099 | 0.013324 | 0.457453 | 0.998684 | -0.03602 | 0.016215 | 0.990148 | 0.964625 | 1.016347 |
| GCST002449-Plasma omega-6 polyunsaturated fatty acid levels \(arachidonic acid\) | Inverse variance weighted | 3 | 0.005365 | 0.007223 | 0.45763 | 0.998684 | -0.00879 | 0.019523 | 1.00538 | 0.991246 | 1.019715 |
| GCST006959-Rheumatoid arthritis | Inverse variance weighted | 35 | -0.01597 | 0.021523 | 0.457959 | 0.998684 | -0.05816 | 0.02621 | 0.984153 | 0.9435 | 1.026556 |
| GCST002186-Platelet count | Inverse variance weighted | 3 | 0.001117 | 0.001506 | 0.458214 | 0.998684 | -0.00183 | 0.00407 | 1.001118 | 0.998167 | 1.004078 |
| GCST007990-Coronary artery disease | Inverse variance weighted | 11 | -0.04246 | 0.057398 | 0.459445 | 0.998684 | -0.15496 | 0.07004 | 0.958428 | 0.856448 | 1.072551 |
| GCST004145-Primary biliary cholangitis | Inverse variance weighted | 4 | 0.018578 | 0.025159 | 0.460259 | 0.998684 | -0.03073 | 0.06789 | 1.018752 | 0.969734 | 1.070247 |
| GCST001142-Vitamin E levels | Inverse variance weighted | 2 | -0.42374 | 0.573972 | 0.460359 | 0.998684 | -1.54872 | 0.701247 | 0.654595 | 0.212519 | 2.016266 |
| GCST003453-Chronotype | Inverse variance weighted | 4 | -0.21893 | 0.297537 | 0.461854 | 0.998684 | -0.8021 | 0.364246 | 0.80338 | 0.448386 | 1.439428 |
| GCST007133-Triglycerides | Inverse variance weighted | 10 | 0.215351 | 0.293475 | 0.463072 | 0.998684 | -0.35986 | 0.790561 | 1.240297 | 0.697774 | 2.204633 |
| GCST005215-Corrected insulin response | Inverse variance weighted | 4 | 0.070775 | 0.096499 | 0.463298 | 0.998684 | -0.11836 | 0.259912 | 1.07334 | 0.888374 | 1.296817 |
| GCST000914-Polycystic ovary syndrome | Inverse variance weighted | 5 | 0.021067 | 0.028797 | 0.464431 | 0.998684 | -0.03537 | 0.077508 | 1.02129 | 0.965244 | 1.080591 |
| GCST004161-Vitamin B12 levels | Inverse variance weighted | 3 | -0.0901 | 0.123421 | 0.46539 | 0.998684 | -0.332 | 0.151808 | 0.913842 | 0.717485 | 1.163937 |
| GCST000584-Triglycerides | Inverse variance weighted | 3 | -0.05836 | 0.08012 | 0.466342 | 0.998684 | -0.2154 | 0.098673 | 0.943307 | 0.806219 | 1.103705 |
| GCST004297-Atrial fibrillation | Inverse variance weighted | 11 | 0.038192 | 0.052431 | 0.466355 | 0.998684 | -0.06457 | 0.140957 | 1.038931 | 0.937468 | 1.151375 |
| GCST000050-Prostate cancer | Inverse variance weighted | 2 | 0.084747 | 0.116587 | 0.467288 | 0.998684 | -0.14376 | 0.313257 | 1.088442 | 0.866092 | 1.367874 |
| GCST002494-Bone mineral density \(paediatric, total body less head\) | Inverse variance weighted | 5 | 0.054054 | 0.074482 | 0.468002 | 0.998684 | -0.09193 | 0.200039 | 1.055542 | 0.912168 | 1.221451 |
| GCST006983-Attention deficit hyperactivity disorder or cannabis use | Inverse variance weighted | 11 | -0.05237 | 0.072191 | 0.46819 | 0.998684 | -0.19386 | 0.089125 | 0.948978 | 0.82377 | 1.093217 |
| GCST001762-Obesity-related traits | Inverse variance weighted | 6 | 0.090305 | 0.124583 | 0.468537 | 0.998684 | -0.15388 | 0.334487 | 1.094508 | 0.857378 | 1.397224 |
| GCST001496-Non-albumin protein levels | Inverse variance weighted | 3 | -0.08347 | 0.115325 | 0.469201 | 0.998684 | -0.30951 | 0.142567 | 0.919919 | 0.733808 | 1.153231 |
| GCST006186-Systolic blood pressure x smoking status \(current vs non-current\) interaction \(1df test\) | Inverse variance weighted | 2 | 0.003908 | 0.005404 | 0.469622 | 0.998684 | -0.00668 | 0.0145 | 1.003915 | 0.993338 | 1.014606 |
| GCST001159-Restless legs syndrome | Inverse variance weighted | 6 | 0.014949 | 0.020793 | 0.472182 | 0.998684 | -0.02581 | 0.055703 | 1.015061 | 0.974525 | 1.057283 |
| GCST002081-Migraine | Inverse variance weighted | 5 | 0.084581 | 0.117651 | 0.472197 | 0.998684 | -0.14602 | 0.315177 | 1.088261 | 0.864144 | 1.370502 |
| GCST000174-Height | Inverse variance weighted | 12 | -0.05412 | 0.075286 | 0.472204 | 0.998684 | -0.20168 | 0.093438 | 0.947316 | 0.817353 | 1.097942 |
| GCST000169-Colorectal cancer | Inverse variance weighted | 2 | -0.12394 | 0.173093 | 0.473965 | 0.998684 | -0.4632 | 0.21532 | 0.883431 | 0.629264 | 1.240259 |
| GCST005651-Urinary metabolite concentrations in chronic kidney disease | Inverse variance weighted | 4 | -0.02315 | 0.032401 | 0.474899 | 0.998684 | -0.08666 | 0.040355 | 0.977114 | 0.916991 | 1.04118 |
| GCST003258-Ischemic stroke | Inverse variance weighted | 2 | 0.137003 | 0.192404 | 0.47643 | 0.998684 | -0.24011 | 0.514116 | 1.146831 | 0.786542 | 1.672159 |
| GCST004576-Waist-to-hip ratio adjusted for body mass index | Inverse variance weighted | 40 | 0.055746 | 0.078497 | 0.477602 | 0.998684 | -0.09811 | 0.209601 | 1.057329 | 0.90655 | 1.233186 |
| GCST002217-Sj?gren's syndrome | Inverse variance weighted | 2 | 0.053032 | 0.074736 | 0.47796 | 0.998684 | -0.09345 | 0.199516 | 1.054464 | 0.910782 | 1.220811 |
| GCST000442-Aortic root size | Inverse variance weighted | 3 | -0.23605 | 0.332818 | 0.478163 | 0.998684 | -0.88838 | 0.416269 | 0.789737 | 0.411322 | 1.516294 |
| GCST002461-Body mass index | Inverse variance weighted | 10 | 0.107611 | 0.151753 | 0.47825 | 0.998684 | -0.18983 | 0.405048 | 1.113615 | 0.827104 | 1.499374 |
| GCST002012-Venous thromboembolism | Inverse variance weighted | 2 | -0.03761 | 0.053085 | 0.478626 | 0.998684 | -0.14166 | 0.066435 | 0.963087 | 0.867918 | 1.068692 |
| GCST000428-Adiposity | Inverse variance weighted | 2 | -0.3966 | 0.56218 | 0.480524 | 0.998684 | -1.49847 | 0.705277 | 0.672606 | 0.223472 | 2.024407 |
| GCST007134-Total cholesterol levels | Inverse variance weighted | 8 | 0.331014 | 0.470513 | 0.481733 | 0.998684 | -0.59119 | 1.25322 | 1.39238 | 0.553667 | 3.5016 |
| GCST001267-Melanoma | Inverse variance weighted | 4 | 0.044682 | 0.063581 | 0.482205 | 0.998684 | -0.07994 | 0.1693 | 1.045695 | 0.923175 | 1.184476 |
| GCST007293-Body fat distribution \(arm fat ratio\) | Inverse variance weighted | 21 | 0.135671 | 0.193752 | 0.483782 | 0.998684 | -0.24408 | 0.515425 | 1.145305 | 0.783423 | 1.67435 |
| GCST007098-Diastolic blood pressure | Inverse variance weighted | 12 | 0.020585 | 0.029436 | 0.484371 | 0.998684 | -0.03711 | 0.07828 | 1.020798 | 0.963569 | 1.081425 |
| GCST000157-Celiac disease | Inverse variance weighted | 4 | 0.023615 | 0.03379 | 0.484626 | 0.998684 | -0.04261 | 0.089844 | 1.023896 | 0.958282 | 1.094004 |
| GCST004607-Plateletcrit | Inverse variance weighted | 128 | -0.02613 | 0.037432 | 0.485219 | 0.998684 | -0.09949 | 0.047242 | 0.974213 | 0.905297 | 1.048375 |
| GCST006700-Parental longevity \(father's age at death\) | Inverse variance weighted | 2 | -17.9067 | 25.7031 | 0.486007 | 0.998684 | -68.2848 | 32.47139 | 1.67E-08 | 2.21E-30 | 1.27E+14 |
| GCST003666-Metabolite levels \(small molecules and protein measures\) | Inverse variance weighted | 22 | -0.02356 | 0.033837 | 0.486201 | 0.998684 | -0.08988 | 0.042757 | 0.976713 | 0.914038 | 1.043685 |
| GCST007707-Hypertension | Inverse variance weighted | 40 | 0.025039 | 0.036029 | 0.487077 | 0.998684 | -0.04558 | 0.095656 | 1.025355 | 0.955445 | 1.10038 |
| GCST005896-Non-melanoma skin cancer | Inverse variance weighted | 23 | 0.021328 | 0.03069 | 0.487091 | 0.998684 | -0.03882 | 0.08148 | 1.021557 | 0.961919 | 1.084892 |
| GCST000810-Lung adenocarcinoma | Inverse variance weighted | 2 | -0.0808 | 0.116689 | 0.488654 | 0.998684 | -0.30951 | 0.147909 | 0.922377 | 0.733806 | 1.159407 |
| GCST007340-Depressive symptoms | Inverse variance weighted | 154 | -0.16058 | 0.232087 | 0.489001 | 0.998684 | -0.61547 | 0.294309 | 0.851649 | 0.540387 | 1.342199 |
| GCST005273-Polycystic ovary syndrome | Inverse variance weighted | 2 | -0.02712 | 0.039209 | 0.489115 | 0.998684 | -0.10397 | 0.049728 | 0.973243 | 0.901252 | 1.050985 |
| GCST004329-Mean corpuscular hemoglobin concentration | Inverse variance weighted | 2 | 0.13997 | 0.202477 | 0.489385 | 0.998684 | -0.25688 | 0.536824 | 1.150239 | 0.773457 | 1.710566 |
| GCST000499-Hemoglobin | Inverse variance weighted | 5 | -0.08332 | 0.120674 | 0.48989 | 0.998684 | -0.31984 | 0.153198 | 0.920053 | 0.726262 | 1.165555 |
| GCST000358-Folate pathway vitamin levels | Inverse variance weighted | 2 | -0.00047 | 0.000677 | 0.489994 | 0.998684 | -0.00179 | 0.00086 | 0.999533 | 0.998207 | 1.00086 |
| GCST004623-Neutrophil percentage of granulocytes | Inverse variance weighted | 92 | 0.039342 | 0.056995 | 0.49002 | 0.998684 | -0.07237 | 0.151052 | 1.040126 | 0.930189 | 1.163057 |
| GCST004171-Macular telangiectasia type 2 | Inverse variance weighted | 2 | 0.014837 | 0.021497 | 0.490076 | 0.998684 | -0.0273 | 0.056972 | 1.014948 | 0.973072 | 1.058626 |
| GCST007350-Focal epilepsy \(with hippocampal sclerosis\) | Inverse variance weighted | 2 | -0.00259 | 0.00376 | 0.49058 | 0.998684 | -0.00996 | 0.004777 | 0.997411 | 0.990089 | 1.004789 |
| GCST001810-Menopause \(age at onset\) | Inverse variance weighted | 2 | 0.030122 | 0.043917 | 0.492778 | 0.998684 | -0.05595 | 0.116199 | 1.030581 | 0.945582 | 1.123219 |
| GCST001276-Liver enzyme levels \(alkaline phosphatase\) | Inverse variance weighted | 9 | 0.001466 | 0.002137 | 0.492798 | 0.998684 | -0.00272 | 0.005655 | 1.001467 | 0.99728 | 1.005671 |
| GCST003177-Childhood body mass index | Inverse variance weighted | 13 | -0.05774 | 0.084488 | 0.494381 | 0.998684 | -0.22333 | 0.107861 | 0.943899 | 0.799849 | 1.113893 |
| GCST004207-HDL cholesterol | Inverse variance weighted | 10 | -0.10856 | 0.159052 | 0.494906 | 0.998684 | -0.4203 | 0.203184 | 0.897128 | 0.656851 | 1.225298 |
| GCST000679-Rheumatoid arthritis | Inverse variance weighted | 3 | 0.024789 | 0.036367 | 0.495467 | 0.998684 | -0.04649 | 0.09607 | 1.025099 | 0.954573 | 1.100836 |
| GCST001702-Prostate cancer | Inverse variance weighted | 2 | -0.03466 | 0.05098 | 0.496613 | 0.998684 | -0.13458 | 0.065263 | 0.965936 | 0.874084 | 1.06744 |
| GCST004696-Chronotype | Inverse variance weighted | 3 | -0.22967 | 0.340595 | 0.500108 | 0.998684 | -0.89724 | 0.437897 | 0.794796 | 0.407695 | 1.549445 |
| GCST000290-HDL cholesterol | Inverse variance weighted | 11 | -0.04416 | 0.065566 | 0.500593 | 0.998684 | -0.17267 | 0.084347 | 0.956798 | 0.841413 | 1.088007 |
| GCST005891-Glomerular filtration rate in diabetes | Inverse variance weighted | 2 | -0.01254 | 0.018633 | 0.500926 | 0.998684 | -0.04906 | 0.02398 | 0.987538 | 0.952123 | 1.02427 |
| GCST002477-Alcohol dependence \(age at onset\) | Inverse variance weighted | 3 | 0.028535 | 0.042468 | 0.501643 | 0.998684 | -0.0547 | 0.111773 | 1.028946 | 0.946766 | 1.118259 |
| GCST007463-Cigarettes smoked per day \(MTAG\) | Inverse variance weighted | 52 | -0.09789 | 0.145794 | 0.501944 | 0.998684 | -0.38365 | 0.187866 | 0.906747 | 0.681371 | 1.206671 |
| GCST004278-Pulse pressure | Inverse variance weighted | 35 | -0.01676 | 0.025009 | 0.502645 | 0.998684 | -0.06578 | 0.032253 | 0.983376 | 0.936336 | 1.032779 |
| GCST002861-Breast cancer \(survival\) | Inverse variance weighted | 2 | 0.034058 | 0.050867 | 0.503145 | 0.998684 | -0.06564 | 0.133757 | 1.034645 | 0.936467 | 1.143116 |
| GCST004234-HDL cholesterol levels | Inverse variance weighted | 8 | -0.06102 | 0.091165 | 0.503266 | 0.998684 | -0.2397 | 0.117661 | 0.940803 | 0.78686 | 1.124862 |
| GCST000289-Triglycerides | Inverse variance weighted | 7 | 0.326676 | 0.488286 | 0.503478 | 0.998684 | -0.63036 | 1.283717 | 1.386353 | 0.532398 | 3.610032 |
| GCST000488-Prostate cancer | Inverse variance weighted | 2 | -0.07013 | 0.104902 | 0.503798 | 0.998684 | -0.27574 | 0.135478 | 0.932273 | 0.759012 | 1.145084 |
| GCST006424-Severe diabetic retinopathy in type 2 diabetes | Inverse variance weighted | 2 | 0.019197 | 0.028759 | 0.504441 | 0.998684 | -0.03717 | 0.075566 | 1.019383 | 0.963512 | 1.078494 |
| GCST002797-Pulmonary artery enlargement in chronic obstructive pulmonary disease | Inverse variance weighted | 2 | -0.07684 | 0.115122 | 0.504462 | 0.998684 | -0.30248 | 0.148797 | 0.926036 | 0.738981 | 1.160438 |
| GCST004422-Vascular endothelial growth factor levels | Inverse variance weighted | 3 | 0.052779 | 0.079104 | 0.504638 | 0.998684 | -0.10227 | 0.207824 | 1.054197 | 0.90279 | 1.230996 |
| GCST004508-Waist-to-hip ratio adjusted for BMI in non-smokers | Inverse variance weighted | 10 | -0.17115 | 0.256546 | 0.50469 | 0.998684 | -0.67398 | 0.33168 | 0.842696 | 0.509677 | 1.393307 |
| GCST002233-Adiponectin levels | Inverse variance weighted | 3 | -0.07336 | 0.109997 | 0.504811 | 0.998684 | -0.28896 | 0.142233 | 0.929265 | 0.749046 | 1.152845 |
| GCST000297-Bone mineral density \(hip\) | Inverse variance weighted | 3 | -0.06438 | 0.09669 | 0.505546 | 0.998684 | -0.25389 | 0.125138 | 0.937653 | 0.775779 | 1.133304 |
| GCST008171-Platelet aggregation | Inverse variance weighted | 3 | -0.05741 | 0.086457 | 0.506654 | 0.998684 | -0.22687 | 0.112044 | 0.944204 | 0.797025 | 1.118562 |
| GCST001140-Lung cancer | Inverse variance weighted | 4 | -0.04484 | 0.067549 | 0.506854 | 0.998684 | -0.17723 | 0.087561 | 0.956155 | 0.837586 | 1.091508 |
| GCST003853-Hip minimal joint space width | Inverse variance weighted | 4 | -0.07402 | 0.111668 | 0.507428 | 0.998684 | -0.29289 | 0.14485 | 0.928654 | 0.746107 | 1.155866 |
| GCST007099-Systolic blood pressure | Inverse variance weighted | 104 | -0.00439 | 0.006652 | 0.509096 | 0.998684 | -0.01743 | 0.008646 | 0.995618 | 0.982721 | 1.008684 |
| GCST002223-HDL cholesterol | Inverse variance weighted | 39 | -0.06281 | 0.095139 | 0.509122 | 0.998684 | -0.24928 | 0.123661 | 0.939121 | 0.779359 | 1.131633 |
| GCST004619-Reticulocyte fraction of red cells | Inverse variance weighted | 99 | 0.038947 | 0.059151 | 0.510261 | 0.998684 | -0.07699 | 0.154883 | 1.039715 | 0.9259 | 1.167521 |
| GCST001506-Intraocular pressure | Inverse variance weighted | 2 | -0.05703 | 0.086726 | 0.510813 | 0.998684 | -0.22701 | 0.112954 | 0.944567 | 0.796912 | 1.11958 |
| GCST000589-White blood cell count | Inverse variance weighted | 4 | -0.07549 | 0.115028 | 0.511665 | 0.998684 | -0.30094 | 0.149968 | 0.927292 | 0.740121 | 1.161797 |
| GCST001826-Lymphoma | Inverse variance weighted | 2 | 0.114694 | 0.175188 | 0.512669 | 0.998684 | -0.22868 | 0.458063 | 1.12153 | 0.795587 | 1.581008 |
| GCST007939-Medication use \(antimigraine preparations\) | Inverse variance weighted | 10 | 0.029238 | 0.04469 | 0.512962 | 0.998684 | -0.05835 | 0.11683 | 1.029669 | 0.943315 | 1.123928 |
| GCST007701-High density lipoprotein cholesterol levels | Inverse variance weighted | 7 | 0.001963 | 0.003001 | 0.513096 | 0.998684 | -0.00392 | 0.007844 | 1.001965 | 0.996089 | 1.007875 |
| GCST004332-Red blood cell count | Inverse variance weighted | 3 | -0.17404 | 0.266723 | 0.514071 | 0.998684 | -0.69682 | 0.348737 | 0.840263 | 0.498169 | 1.417276 |
| GCST007438-High density lipoprotein cholesterol levels | Inverse variance weighted | 6 | -2.34696 | 3.607184 | 0.515283 | 0.998684 | -9.41704 | 4.723125 | 0.09566 | 8.13E-05 | 112.5193 |
| GCST002239-Symmetrical dimethylarginine levels | Inverse variance weighted | 3 | 0.044987 | 0.069164 | 0.51541 | 0.998684 | -0.09057 | 0.180548 | 1.046014 | 0.913406 | 1.197874 |
| GCST003720-Migraine | Inverse variance weighted | 19 | -0.04606 | 0.070973 | 0.516337 | 0.998684 | -0.18517 | 0.093045 | 0.954983 | 0.830965 | 1.097511 |
| GCST004713-Testicular germ cell tumor | Inverse variance weighted | 21 | 0.011436 | 0.017623 | 0.516387 | 0.998684 | -0.0231 | 0.045976 | 1.011501 | 0.97716 | 1.047049 |
| GCST001688-Type 1 diabetes nephropathy | Inverse variance weighted | 2 | 0.040063 | 0.061797 | 0.516785 | 0.998684 | -0.08106 | 0.161184 | 1.040877 | 0.92214 | 1.174902 |
| GCST002047-Educational attainment | Inverse variance weighted | 2 | 0.095817 | 0.147987 | 0.517328 | 0.998684 | -0.19424 | 0.385872 | 1.100558 | 0.823462 | 1.470896 |
| GCST001011-Oral cavity and pharyngeal cancer | Inverse variance weighted | 3 | 0.076991 | 0.119019 | 0.517713 | 0.998684 | -0.15629 | 0.310269 | 1.080032 | 0.855313 | 1.363792 |
| GCST000139-Triglycerides | Inverse variance weighted | 6 | -0.00054 | 0.000828 | 0.518095 | 0.998684 | -0.00216 | 0.001088 | 0.999465 | 0.997843 | 1.001089 |
| GCST006867-Type 2 diabetes | Inverse variance weighted | 92 | 0.021816 | 0.033851 | 0.51927 | 0.998684 | -0.04453 | 0.088165 | 1.022056 | 0.956445 | 1.092168 |
| GCST004605-Mean corpuscular hemoglobin concentration | Inverse variance weighted | 34 | -0.05308 | 0.08244 | 0.519628 | 0.998684 | -0.21467 | 0.108498 | 0.9483 | 0.80681 | 1.114602 |
| GCST004074-Intraocular pressure | Inverse variance weighted | 8 | -0.02239 | 0.034785 | 0.51974 | 0.998684 | -0.09057 | 0.045786 | 0.977856 | 0.913409 | 1.04685 |
| GCST002073-Chronic lymphocytic leukemia | Inverse variance weighted | 5 | -0.02052 | 0.031897 | 0.519962 | 0.998684 | -0.08304 | 0.041995 | 0.979687 | 0.920314 | 1.04289 |
| GCST000945-Coronary artery disease | Inverse variance weighted | 2 | 0.035892 | 0.055853 | 0.520474 | 0.998684 | -0.07358 | 0.145363 | 1.036544 | 0.929062 | 1.15646 |
| GCST006947-Feeling fed-up | Inverse variance weighted | 30 | 0.000348 | 0.000541 | 0.520617 | 0.998684 | -0.00071 | 0.001409 | 1.000348 | 0.999287 | 1.00141 |
| GCST002748-Epithelial ovarian cancer | Inverse variance weighted | 6 | -0.03546 | 0.055291 | 0.521314 | 0.998684 | -0.14383 | 0.072911 | 0.965162 | 0.866035 | 1.075635 |
| GCST003128-Adolescent idiopathic scoliosis | Inverse variance weighted | 2 | -0.0249 | 0.038855 | 0.521652 | 0.998684 | -0.10105 | 0.051258 | 0.975409 | 0.903883 | 1.052594 |
| GCST006925-Knee osteoarthritis | Inverse variance weighted | 4 | 0.140116 | 0.218792 | 0.521907 | 0.998684 | -0.28872 | 0.568948 | 1.150407 | 0.749225 | 1.766408 |
| GCST006045-Age at first birth | Inverse variance weighted | 5 | -0.06868 | 0.107359 | 0.52234 | 0.998684 | -0.27911 | 0.141742 | 0.933623 | 0.75646 | 1.152279 |
| GCST002553-Pancreatic cancer | Inverse variance weighted | 5 | 0.033421 | 0.052298 | 0.522785 | 0.998684 | -0.06908 | 0.135924 | 1.033986 | 0.93325 | 1.145595 |
| GCST003238-Plasma omega-6 polyunsaturated fatty acid levels \(gamma-linolenic acid\) | Inverse variance weighted | 3 | 0.013362 | 0.02094 | 0.523401 | 0.998684 | -0.02768 | 0.054404 | 1.013452 | 0.972699 | 1.055911 |
| GCST007998-Intraocular pressure | Inverse variance weighted | 8 | 0.000761 | 0.001193 | 0.523413 | 0.998684 | -0.00158 | 0.003099 | 1.000761 | 0.998424 | 1.003104 |
| GCST000796-Type 2 diabetes | Inverse variance weighted | 2 | 0.057787 | 0.090727 | 0.524168 | 0.998684 | -0.12004 | 0.235613 | 1.05949 | 0.886887 | 1.265684 |
| GCST004629-Neutrophil count | Inverse variance weighted | 65 | -0.05299 | 0.083246 | 0.524402 | 0.998684 | -0.21616 | 0.11017 | 0.948387 | 0.80561 | 1.116468 |
| GCST002030-Primary tooth development \(time to first tooth eruption\) | Inverse variance weighted | 5 | 0.022886 | 0.036009 | 0.525067 | 0.998684 | -0.04769 | 0.093463 | 1.023149 | 0.953428 | 1.09797 |
| GCST007094-Diastolic blood pressure | Inverse variance weighted | 104 | -0.00748 | 0.011782 | 0.5256 | 0.998684 | -0.03057 | 0.015614 | 0.992549 | 0.969892 | 1.015737 |
| GCST003274-Pulse pressure | Inverse variance weighted | 3 | -0.01455 | 0.023022 | 0.52727 | 0.998684 | -0.05968 | 0.03057 | 0.985551 | 0.942068 | 1.031042 |
| GCST004292-Glomerular filtration rate \(creatinine\) | Inverse variance weighted | 35 | 0.226967 | 0.359029 | 0.527277 | 0.998684 | -0.47673 | 0.930664 | 1.254788 | 0.620809 | 2.536194 |
| GCST002568-Esophageal squamous cell carcinoma | Inverse variance weighted | 4 | 0.023844 | 0.037755 | 0.527689 | 0.998684 | -0.05016 | 0.097844 | 1.02413 | 0.951081 | 1.102791 |
| GCST000599-Soluble levels of adhesion molecules | Inverse variance weighted | 3 | 0.000566 | 0.000899 | 0.528817 | 0.998684 | -0.0012 | 0.002327 | 1.000566 | 0.998806 | 1.00233 |
| GCST002390-Glycated hemoglobin levels | Inverse variance weighted | 8 | -0.05446 | 0.086473 | 0.528826 | 0.998684 | -0.22395 | 0.115026 | 0.946996 | 0.799358 | 1.121903 |
| GCST005327-Neuroticism | Inverse variance weighted | 2 | -0.33769 | 0.536485 | 0.529052 | 0.998684 | -1.3892 | 0.713818 | 0.713415 | 0.249274 | 2.041772 |
| GCST007337-Life satisfaction | Inverse variance weighted | 92 | 0.151137 | 0.24082 | 0.530269 | 0.998684 | -0.32087 | 0.623145 | 1.163156 | 0.725518 | 1.864783 |
| GCST000673-Cleft lip | Inverse variance weighted | 2 | -0.01942 | 0.031002 | 0.530982 | 0.998684 | -0.08019 | 0.041341 | 0.980764 | 0.922943 | 1.042208 |
| GCST001787-Colorectal cancer | Inverse variance weighted | 2 | 0.149981 | 0.240054 | 0.532115 | 0.998684 | -0.32052 | 0.620487 | 1.161812 | 0.725768 | 1.859833 |
| GCST003301-Triglycerides | Inverse variance weighted | 2 | 0.084797 | 0.13577 | 0.532257 | 0.998684 | -0.18131 | 0.350906 | 1.088496 | 0.834175 | 1.420353 |
| GCST000025-Type 2 diabetes | Inverse variance weighted | 5 | 0.023961 | 0.038431 | 0.532965 | 0.998684 | -0.05136 | 0.099287 | 1.024251 | 0.949933 | 1.104383 |
| GCST002843-Sitting height ratio | Inverse variance weighted | 5 | -0.06285 | 0.101257 | 0.534775 | 0.998684 | -0.26132 | 0.13561 | 0.939081 | 0.770036 | 1.145235 |
| GCST007388-Insomnia symptoms \(never/rarely vs. usually\) | Inverse variance weighted | 27 | 0.073453 | 0.118716 | 0.536093 | 0.998684 | -0.15923 | 0.306136 | 1.076218 | 0.8528 | 1.358167 |
| GCST004231-Total cholesterol levels | Inverse variance weighted | 11 | 0.089514 | 0.144787 | 0.536413 | 0.998684 | -0.19427 | 0.373296 | 1.093642 | 0.823437 | 1.452514 |
| GCST004559-Body mass index in physically active individuals | Inverse variance weighted | 37 | -0.06894 | 0.111594 | 0.536712 | 0.998684 | -0.28767 | 0.149783 | 0.933381 | 0.750011 | 1.161582 |
| GCST007934-Medication use \(anti-inflammatory and antirheumatic products, non-steroids\) | Inverse variance weighted | 3 | 0.124134 | 0.201128 | 0.537112 | 0.998684 | -0.27008 | 0.518345 | 1.132167 | 0.76332 | 1.679246 |
| GCST002378-Thyroid peroxidase antibody positivity | Inverse variance weighted | 3 | -0.04123 | 0.066953 | 0.538068 | 0.998684 | -0.17245 | 0.090003 | 0.959613 | 0.841597 | 1.094177 |
| GCST007856-Colorectal cancer or advanced adenoma | Inverse variance weighted | 65 | 0.018641 | 0.030353 | 0.539116 | 0.998684 | -0.04085 | 0.078133 | 1.018816 | 0.959973 | 1.081267 |
| GCST000024-Type 2 diabetes | Inverse variance weighted | 4 | 0.036099 | 0.058865 | 0.539706 | 0.998684 | -0.07928 | 0.151475 | 1.036759 | 0.923785 | 1.163549 |
| GCST004413-Spontaneous dizygotic twinning | Inverse variance weighted | 2 | -0.06475 | 0.105603 | 0.53976 | 0.998684 | -0.27174 | 0.142229 | 0.937299 | 0.762056 | 1.15284 |
| GCST004549-Endometriosis | Inverse variance weighted | 7 | -0.04316 | 0.070477 | 0.540256 | 0.998684 | -0.1813 | 0.094972 | 0.957757 | 0.834189 | 1.099628 |
| GCST000035-Breast cancer | Inverse variance weighted | 5 | -0.03014 | 0.049288 | 0.540898 | 0.998684 | -0.12674 | 0.066467 | 0.970312 | 0.880961 | 1.068726 |
| GCST001069-Thyroid volume | Inverse variance weighted | 5 | 0.017017 | 0.02785 | 0.541197 | 0.998684 | -0.03757 | 0.071603 | 1.017162 | 0.963127 | 1.074229 |
| GCST006896-Free thyroxine concentration | Inverse variance weighted | 9 | -0.09796 | 0.160403 | 0.541405 | 0.998684 | -0.41235 | 0.216434 | 0.906688 | 0.662095 | 1.241641 |
| GCST003790-Glomerular filtration rate | Inverse variance weighted | 11 | 0.003126 | 0.005119 | 0.541429 | 0.998684 | -0.00691 | 0.013158 | 1.003131 | 0.993117 | 1.013245 |
| GCST002444-Plasma omega-6 polyunsaturated fatty acid levels \(dihomo-gamma-linolenic acid\) | Inverse variance weighted | 3 | -0.02201 | 0.036126 | 0.542322 | 0.998684 | -0.09282 | 0.048795 | 0.978229 | 0.911359 | 1.050005 |
| GCST007710-Anxiety/tension \(special factor of neuroticism\) | Inverse variance weighted | 13 | -0.30612 | 0.5036 | 0.543284 | 0.998684 | -1.29317 | 0.68094 | 0.736301 | 0.274399 | 1.975735 |
| GCST004631-Basophil percentage of white cells | Inverse variance weighted | 26 | -0.06268 | 0.10319 | 0.543573 | 0.998684 | -0.26493 | 0.139573 | 0.939244 | 0.767258 | 1.149783 |
| GCST005287-Intrinsic epigenetic age acceleration | Inverse variance weighted | 5 | -0.01213 | 0.019987 | 0.543803 | 0.998684 | -0.05131 | 0.027041 | 0.98794 | 0.949986 | 1.02741 |
| GCST003842-Breast cancer \(estrogen-receptor negative\) | Inverse variance weighted | 7 | -0.03518 | 0.057982 | 0.544078 | 0.998684 | -0.14882 | 0.07847 | 0.965436 | 0.861724 | 1.081631 |
| GCST001436-Metabolic syndrome | Inverse variance weighted | 12 | 0.321715 | 0.530817 | 0.544466 | 0.998684 | -0.71869 | 1.362117 | 1.379491 | 0.487391 | 3.90445 |
| GCST003619-Type 2 diabetes | Inverse variance weighted | 8 | -0.49103 | 0.81246 | 0.545596 | 0.998684 | -2.08345 | 1.101392 | 0.611996 | 0.1245 | 3.008351 |
| GCST004867-Systemic lupus erythematosus | Inverse variance weighted | 10 | 0.022827 | 0.037804 | 0.545954 | 0.998684 | -0.05127 | 0.096923 | 1.02309 | 0.950023 | 1.101776 |
| GCST000175-Height | Inverse variance weighted | 17 | -0.00041 | 0.000688 | 0.547318 | 0.998684 | -0.00176 | 0.000935 | 0.999586 | 0.998238 | 1.000935 |
| GCST007513-Prostate-specific antigen levels | Inverse variance weighted | 4 | -0.14708 | 0.244597 | 0.547621 | 0.998684 | -0.62649 | 0.332326 | 0.863222 | 0.534463 | 1.394208 |
| GCST002087-Homocysteine levels | Inverse variance weighted | 11 | 0.040031 | 0.06662 | 0.547922 | 0.998684 | -0.09055 | 0.170606 | 1.040843 | 0.913433 | 1.186024 |
| GCST003520-Breast cancer | Inverse variance weighted | 4 | -0.02991 | 0.04991 | 0.548945 | 0.998684 | -0.12774 | 0.06791 | 0.97053 | 0.880085 | 1.070269 |
| GCST005187-Matrix metalloproteinase-8 levels | Inverse variance weighted | 2 | 0.047788 | 0.079808 | 0.549309 | 0.998684 | -0.10863 | 0.204212 | 1.048949 | 0.897058 | 1.226558 |
| GCST007442-Low density lipoprotein cholesterol levels | Inverse variance weighted | 3 | -0.23945 | 0.401156 | 0.550579 | 0.998684 | -1.02571 | 0.546819 | 0.787063 | 0.358541 | 1.727748 |
| GCST002965-Glycerophospholipid levels | Inverse variance weighted | 15 | 0.034269 | 0.057494 | 0.551142 | 0.998684 | -0.07842 | 0.146957 | 1.034863 | 0.924577 | 1.158304 |
| GCST001235-Blood pressure | Inverse variance weighted | 7 | -0.0118 | 0.019795 | 0.551152 | 0.998684 | -0.0506 | 0.026999 | 0.988271 | 0.950663 | 1.027367 |
| GCST008154-Trunk fat mass | Inverse variance weighted | 2 | 0.075326 | 0.126888 | 0.552753 | 0.998684 | -0.17338 | 0.324027 | 1.078236 | 0.840822 | 1.382685 |
| GCST000190-Black vs. blond hair color | Inverse variance weighted | 4 | -0.02076 | 0.035056 | 0.553802 | 0.998684 | -0.08947 | 0.047954 | 0.979458 | 0.91442 | 1.049122 |
| GCST006627-Diastolic blood pressure | Inverse variance weighted | 69 | 0.01136 | 0.019226 | 0.554607 | 0.998684 | -0.02632 | 0.049044 | 1.011425 | 0.97402 | 1.050266 |
| GCST002756-Subcortical brain region volumes | Inverse variance weighted | 3 | 0.000359 | 0.000609 | 0.555118 | 0.998684 | -0.00083 | 0.001552 | 1.000359 | 0.999166 | 1.001553 |
| GCST007128-Blood protein levels | Inverse variance weighted | 7 | 0.044417 | 0.075338 | 0.55548 | 0.998684 | -0.10325 | 0.192079 | 1.045418 | 0.901906 | 1.211766 |
| GCST002227-Body mass index | Inverse variance weighted | 2 | -0.14267 | 0.242147 | 0.55573 | 0.998684 | -0.61728 | 0.331936 | 0.867038 | 0.53941 | 1.393664 |
| GCST000178-C-reactive protein | Inverse variance weighted | 3 | -0.03798 | 0.064546 | 0.55629 | 0.998684 | -0.16449 | 0.088534 | 0.962735 | 0.848328 | 1.092572 |
| GCST005308-Nonalcoholic fatty liver disease | Inverse variance weighted | 5 | -0.01235 | 0.021042 | 0.557191 | 0.998684 | -0.05359 | 0.02889 | 0.987724 | 0.947817 | 1.029312 |
| GCST006096-Age spots | Inverse variance weighted | 2 | 0.057265 | 0.097621 | 0.557468 | 0.998684 | -0.13407 | 0.248602 | 1.058936 | 0.874527 | 1.282232 |
| GCST001709-Atopic dermatitis | Inverse variance weighted | 7 | 0.018408 | 0.031409 | 0.557823 | 0.998684 | -0.04315 | 0.079969 | 1.018578 | 0.957765 | 1.083253 |
| GCST005796-Lumbar spine bone mineral density | Inverse variance weighted | 17 | 0.049195 | 0.084009 | 0.558147 | 0.998684 | -0.11546 | 0.213853 | 1.050425 | 0.890954 | 1.23844 |
| GCST002145-Infantile hypertrophic pyloric stenosis | Inverse variance weighted | 3 | -0.02335 | 0.040126 | 0.560697 | 0.998684 | -0.10199 | 0.055301 | 0.976925 | 0.903037 | 1.056859 |
| GCST001027-Uterine fibroids | Inverse variance weighted | 3 | -0.03891 | 0.066941 | 0.561076 | 0.998684 | -0.17011 | 0.092296 | 0.961838 | 0.843568 | 1.096689 |
| GCST004440-Interferon gamma-induced protein 10 levels | Inverse variance weighted | 2 | -0.07544 | 0.129793 | 0.561077 | 0.998684 | -0.32983 | 0.178952 | 0.927334 | 0.719043 | 1.195964 |
| GCST006897-Hyperthyroidism | Inverse variance weighted | 6 | 0.023523 | 0.040514 | 0.561498 | 0.998684 | -0.05588 | 0.102931 | 1.023802 | 0.945648 | 1.108415 |
| GCST006412-Intraocular pressure | Inverse variance weighted | 78 | 0.011534 | 0.019915 | 0.562485 | 0.998684 | -0.0275 | 0.050567 | 1.011601 | 0.972875 | 1.051868 |
| GCST000232-Rheumatoid arthritis | Inverse variance weighted | 2 | 0.03217 | 0.055799 | 0.564254 | 0.998684 | -0.0772 | 0.141535 | 1.032693 | 0.925709 | 1.152041 |
| GCST005195-Coronary artery disease | Inverse variance weighted | 93 | -0.0317 | 0.055008 | 0.564433 | 0.998684 | -0.13952 | 0.076117 | 0.968798 | 0.869779 | 1.079089 |
| GCST005666-Fractional excretion of metabolites in chronic kidney disease | Inverse variance weighted | 2 | -0.03029 | 0.052808 | 0.566222 | 0.998684 | -0.1338 | 0.073212 | 0.970162 | 0.874768 | 1.075959 |
| GCST000965-C-reactive protein levels | Inverse variance weighted | 14 | 0.041588 | 0.072715 | 0.567371 | 0.998684 | -0.10093 | 0.184108 | 1.042464 | 0.903993 | 1.202146 |
| GCST001230-Triglycerides | Inverse variance weighted | 4 | 0.108196 | 0.189183 | 0.56738 | 0.998684 | -0.2626 | 0.478995 | 1.114267 | 0.769048 | 1.614452 |
| GCST001745-Sagittal craniosynostosis | Inverse variance weighted | 2 | 0.005241 | 0.009178 | 0.567997 | 0.998684 | -0.01275 | 0.023229 | 1.005254 | 0.987333 | 1.023501 |
| GCST000662-Vitiligo | Inverse variance weighted | 5 | 0.01953 | 0.034281 | 0.568877 | 0.998684 | -0.04766 | 0.08672 | 1.019722 | 0.953458 | 1.090591 |
| GCST003144-Polycystic ovary syndrome | Inverse variance weighted | 3 | -0.04746 | 0.083368 | 0.56919 | 0.998684 | -0.21086 | 0.115945 | 0.953651 | 0.809888 | 1.122934 |
| GCST000539-Type 1 diabetes | Inverse variance weighted | 2 | 0.083081 | 0.145997 | 0.569317 | 0.998684 | -0.20307 | 0.369236 | 1.08663 | 0.816218 | 1.446628 |
| GCST008163-Height | Inverse variance weighted | 73 | -0.02883 | 0.050989 | 0.571743 | 0.998684 | -0.12877 | 0.071105 | 0.971578 | 0.879174 | 1.073694 |
| GCST001735-PR interval | Inverse variance weighted | 5 | 0.001326 | 0.002346 | 0.571841 | 0.998684 | -0.00327 | 0.005924 | 1.001327 | 0.996734 | 1.005942 |
| GCST005208-B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio | Inverse variance weighted | 2 | -0.04274 | 0.075961 | 0.573663 | 0.998684 | -0.19162 | 0.106143 | 0.95816 | 0.825617 | 1.111981 |
| GCST002680-Iron status biomarkers \(transferrin saturation\) | Inverse variance weighted | 3 | -0.0378 | 0.067191 | 0.57376 | 0.998684 | -0.16949 | 0.093897 | 0.962909 | 0.844095 | 1.098447 |
| GCST002782-Waist-to-hip ratio adjusted for body mass index | Inverse variance weighted | 45 | 0.056825 | 0.10115 | 0.574259 | 0.998684 | -0.14143 | 0.255079 | 1.058471 | 0.868117 | 1.290563 |
| GCST000504-Mean corpuscular hemoglobin | Inverse variance weighted | 3 | -0.57244 | 1.01903 | 0.574284 | 0.998684 | -2.56974 | 1.424855 | 0.564145 | 0.076555 | 4.157255 |
| GCST002996-Folding of antihelix | Inverse variance weighted | 2 | -0.17009 | 0.302963 | 0.574505 | 0.998684 | -0.7639 | 0.423714 | 0.843587 | 0.465847 | 1.527625 |
| GCST003155-Systemic lupus erythematosus | Inverse variance weighted | 33 | 0.011687 | 0.020829 | 0.574716 | 0.998684 | -0.02914 | 0.052512 | 1.011756 | 0.971284 | 1.053915 |
| GCST003854-Gut microbiota \(functional units\) | Inverse variance weighted | 17 | -0.00061 | 0.001094 | 0.576519 | 0.998684 | -0.00276 | 0.001533 | 0.999389 | 0.997248 | 1.001535 |
| GCST000971-PR interval | Inverse variance weighted | 5 | 0.001154 | 0.002072 | 0.577589 | 0.998684 | -0.00291 | 0.005215 | 1.001155 | 0.997097 | 1.005229 |
| GCST000363-QT interval | Inverse variance weighted | 10 | -0.00218 | 0.003908 | 0.577841 | 0.998684 | -0.00984 | 0.005485 | 0.997827 | 0.990212 | 1.0055 |
| GCST000587-Mean corpuscular hemoglobin | Inverse variance weighted | 9 | -0.04068 | 0.073194 | 0.578339 | 0.998684 | -0.18414 | 0.102778 | 0.960134 | 0.831817 | 1.108246 |
| GCST000919-Serum prostate-specific antigen levels | Inverse variance weighted | 6 | -0.00034 | 0.000622 | 0.579812 | 0.998684 | -0.00156 | 0.000875 | 0.999656 | 0.998437 | 1.000875 |
| GCST002221-Cholesterol, total | Inverse variance weighted | 48 | 0.015283 | 0.027699 | 0.581115 | 0.998684 | -0.03901 | 0.069573 | 1.0154 | 0.961744 | 1.07205 |
| GCST002555-Monocyte count | Inverse variance weighted | 3 | -0.00426 | 0.007727 | 0.581186 | 0.998684 | -0.01941 | 0.010882 | 0.995746 | 0.980779 | 1.010942 |
| GCST006048-Rheumatoid arthritis \(ACPA-positive\) | Inverse variance weighted | 34 | -0.01373 | 0.024918 | 0.581544 | 0.998684 | -0.06257 | 0.035106 | 0.986361 | 0.939345 | 1.03573 |
| GCST004030-Primary sclerosing cholangitis | Inverse variance weighted | 15 | -0.01719 | 0.031219 | 0.581812 | 0.998684 | -0.07838 | 0.043995 | 0.982954 | 0.924611 | 1.044977 |
| GCST007983-Morningness | Inverse variance weighted | 165 | 0.054368 | 0.099117 | 0.583335 | 0.998684 | -0.1399 | 0.248637 | 1.055873 | 0.869444 | 1.282277 |
| GCST002547-Epilepsy | Inverse variance weighted | 2 | -0.05546 | 0.101597 | 0.58515 | 0.998684 | -0.25459 | 0.14367 | 0.94605 | 0.775235 | 1.154503 |
| GCST002373-Thyroid peroxidase antibody levels | Inverse variance weighted | 2 | -0.34188 | 0.627055 | 0.5856 | 0.998684 | -1.57091 | 0.887143 | 0.71043 | 0.207856 | 2.428182 |
| GCST001968-Interstitial lung disease | Inverse variance weighted | 7 | -0.02509 | 0.046076 | 0.586023 | 0.998684 | -0.1154 | 0.065216 | 0.975219 | 0.891007 | 1.067389 |
| GCST003045-Ulcerative colitis | Inverse variance weighted | 30 | 0.019967 | 0.036701 | 0.586405 | 0.998684 | -0.05197 | 0.091901 | 1.020168 | 0.949361 | 1.096256 |
| GCST004948-Breast cancer | Inverse variance weighted | 2 | 0.076512 | 0.140851 | 0.586986 | 0.998684 | -0.19956 | 0.35258 | 1.079515 | 0.819094 | 1.422734 |
| GCST007443-Nasal polyps | Inverse variance weighted | 5 | -0.02163 | 0.039818 | 0.587011 | 0.998684 | -0.09967 | 0.056415 | 0.978604 | 0.905135 | 1.058037 |
| GCST008157-Body fat mass | Inverse variance weighted | 2 | -0.17483 | 0.322273 | 0.587483 | 0.998684 | -0.80648 | 0.456826 | 0.839601 | 0.446425 | 1.579054 |
| GCST004643-1,5-anhydroglucitol levels | Inverse variance weighted | 5 | -0.00043 | 0.000801 | 0.587944 | 0.998684 | -0.002 | 0.001136 | 0.999566 | 0.997998 | 1.001136 |
| GCST002677-Iron status biomarkers \(ferritin levels\) | Inverse variance weighted | 2 | -0.07341 | 0.136014 | 0.589409 | 0.998684 | -0.33999 | 0.193182 | 0.929223 | 0.711774 | 1.213104 |
| GCST006066-Glaucoma \(primary open-angle\) | Inverse variance weighted | 4 | 0.039589 | 0.07357 | 0.590497 | 0.998684 | -0.10461 | 0.183786 | 1.040383 | 0.900678 | 1.201759 |
| GCST004733-Heart rate variability traits \(RMSSD\) | Inverse variance weighted | 10 | 0.067925 | 0.126449 | 0.591148 | 0.998684 | -0.17991 | 0.315764 | 1.070285 | 0.835342 | 1.371307 |
| GCST007842-Glioma | Inverse variance weighted | 2 | -0.04688 | 0.087297 | 0.591266 | 0.998684 | -0.21798 | 0.124224 | 0.954203 | 0.804141 | 1.132269 |
| GCST002391-Plasma homocysteine levels \(post-methionine load test\) | Inverse variance weighted | 4 | -0.01542 | 0.028718 | 0.591334 | 0.998684 | -0.07171 | 0.040868 | 0.984699 | 0.930804 | 1.041715 |
| GCST000701-Testicular germ cell cancer | Inverse variance weighted | 2 | 0.060133 | 0.112072 | 0.591571 | 0.998684 | -0.15953 | 0.279794 | 1.061978 | 0.852547 | 1.322857 |
| GCST003119-Urinary metabolites | Inverse variance weighted | 8 | -0.00719 | 0.013414 | 0.591985 | 0.998684 | -0.03348 | 0.019102 | 0.992836 | 0.967074 | 1.019286 |
| GCST004697-Ease of getting up in the morning | Inverse variance weighted | 2 | 0.24603 | 0.460378 | 0.593059 | 0.998684 | -0.65631 | 1.14837 | 1.278937 | 0.518762 | 3.153049 |
| GCST001320-Acute lymphoblastic leukemia \(childhood\) | Inverse variance weighted | 5 | -0.01751 | 0.032785 | 0.593387 | 0.998684 | -0.08176 | 0.046754 | 0.982647 | 0.921489 | 1.047864 |
| GCST005650-Serum metabolite ratios in chronic kidney disease | Inverse variance weighted | 32 | -0.00407 | 0.007649 | 0.594585 | 0.998684 | -0.01906 | 0.010921 | 0.995937 | 0.981118 | 1.010981 |
| GCST000755-HDL cholesterol | Inverse variance weighted | 26 | -0.00242 | 0.004576 | 0.596538 | 0.998684 | -0.01139 | 0.006546 | 0.997581 | 0.988674 | 1.006568 |
| GCST001302-White blood cell count | Inverse variance weighted | 3 | -0.00659 | 0.012449 | 0.596547 | 0.998684 | -0.03099 | 0.01781 | 0.993432 | 0.969485 | 1.017969 |
| GCST007458-Age of smoking initiation | Inverse variance weighted | 5 | -0.25044 | 0.473381 | 0.596777 | 0.998684 | -1.17826 | 0.677389 | 0.77846 | 0.307813 | 1.968731 |
| GCST000531-Inflammatory bowel disease \(early onset\) | Inverse variance weighted | 2 | 0.041229 | 0.077942 | 0.596823 | 0.998684 | -0.11154 | 0.193995 | 1.042091 | 0.894459 | 1.21409 |
| GCST000248-Liver enzyme levels | Inverse variance weighted | 7 | -0.12176 | 0.230804 | 0.597811 | 0.998684 | -0.57414 | 0.330615 | 0.88536 | 0.563191 | 1.391824 |
| GCST000037-Breast cancer | Inverse variance weighted | 2 | -0.03152 | 0.059758 | 0.597894 | 0.998684 | -0.14864 | 0.085608 | 0.968973 | 0.861876 | 1.089379 |
| GCST005349-Total body bone mineral density \(age over 60\) | Inverse variance weighted | 8 | -0.04833 | 0.091643 | 0.597971 | 0.998684 | -0.22794 | 0.131295 | 0.952824 | 0.796168 | 1.140304 |
| GCST007552-Colorectal cancer | Inverse variance weighted | 20 | 0.024708 | 0.046858 | 0.597987 | 0.998684 | -0.06713 | 0.116549 | 1.025016 | 0.935071 | 1.123613 |
| GCST005586-Breast milk fatty acid composition \(maternal genotype effect\) | Inverse variance weighted | 4 | -0.00294 | 0.005569 | 0.598046 | 0.998684 | -0.01385 | 0.007979 | 0.997068 | 0.986245 | 1.008011 |
| GCST002894-Body mass index | Inverse variance weighted | 2 | 0.51353 | 0.976139 | 0.598831 | 0.998684 | -1.3997 | 2.426762 | 1.67118 | 0.24667 | 11.32216 |
| GCST003525-Endometrial endometrioid carcinoma | Inverse variance weighted | 3 | 0.035989 | 0.068609 | 0.599901 | 0.998684 | -0.09849 | 0.170463 | 1.036644 | 0.906209 | 1.185853 |
| GCST001904-HDL cholesterol | Inverse variance weighted | 3 | 0.029917 | 0.057118 | 0.600432 | 0.998684 | -0.08203 | 0.141868 | 1.030369 | 0.921241 | 1.152424 |
| GCST005580-Intraocular pressure | Inverse variance weighted | 189 | 0.00664 | 0.012679 | 0.60051 | 0.998684 | -0.01821 | 0.03149 | 1.006662 | 0.981954 | 1.031992 |
| GCST006247-Pediatric areal bone mineral density \(radius vs spine & hip discordant skeletal phenotype\) | Inverse variance weighted | 2 | -0.01951 | 0.037297 | 0.600869 | 0.998684 | -0.09261 | 0.05359 | 0.980677 | 0.911545 | 1.055052 |
| GCST002881-ADAMTS13 activity | Inverse variance weighted | 2 | 0.001591 | 0.003042 | 0.600915 | 0.998684 | -0.00437 | 0.007554 | 1.001592 | 0.995638 | 1.007582 |
| GCST002943-IgA nephropathy | Inverse variance weighted | 6 | -0.03 | 0.0581 | 0.605655 | 0.998684 | -0.14387 | 0.08388 | 0.970449 | 0.865998 | 1.087498 |
| GCST003216-LDL cholesterol | Inverse variance weighted | 2 | 0.002652 | 0.005137 | 0.605673 | 0.998684 | -0.00742 | 0.01272 | 1.002655 | 0.992611 | 1.012802 |
| GCST001606-Renal function-related traits \(sCR\) | Inverse variance weighted | 5 | -0.89588 | 1.735854 | 0.605781 | 0.998684 | -4.29816 | 2.50639 | 0.408246 | 0.013594 | 12.26058 |
| GCST000424-Multiple sclerosis | Inverse variance weighted | 3 | 0.034094 | 0.066093 | 0.605962 | 0.998684 | -0.09545 | 0.163637 | 1.034682 | 0.908965 | 1.177786 |
| GCST004710-Renal cell carcinoma | Inverse variance weighted | 5 | -0.04754 | 0.092239 | 0.606248 | 0.998684 | -0.22833 | 0.133245 | 0.953569 | 0.79586 | 1.14253 |
| GCST006227-Diastolic blood pressure | Inverse variance weighted | 6 | 0.017038 | 0.033146 | 0.607244 | 0.998684 | -0.04793 | 0.082004 | 1.017184 | 0.953201 | 1.08546 |
| GCST007988-Insomnia | Inverse variance weighted | 189 | -0.05456 | 0.106345 | 0.607911 | 0.998684 | -0.263 | 0.153875 | 0.946901 | 0.768745 | 1.166345 |
| GCST005003-Mumps | Inverse variance weighted | 2 | -0.13925 | 0.27147 | 0.607976 | 0.998684 | -0.67134 | 0.392826 | 0.870007 | 0.511026 | 1.481161 |
| GCST005581-Primary biliary cirrhosis | Inverse variance weighted | 17 | -0.00835 | 0.016284 | 0.608062 | 0.998684 | -0.04027 | 0.023566 | 0.991684 | 0.960532 | 1.023846 |
| GCST002468-Triglycerides | Inverse variance weighted | 2 | 0.037341 | 0.073025 | 0.609112 | 0.998684 | -0.10579 | 0.18047 | 1.038047 | 0.899615 | 1.19778 |
| GCST007941-Medication use \(adrenergics, inhalants\) | Inverse variance weighted | 38 | -0.0242 | 0.047543 | 0.610743 | 0.998684 | -0.11738 | 0.068984 | 0.976091 | 0.889244 | 1.071419 |
| GCST000601-Type 2 diabetes | Inverse variance weighted | 2 | 0.019974 | 0.03939 | 0.612097 | 0.998684 | -0.05723 | 0.097178 | 1.020175 | 0.944377 | 1.102057 |
| GCST001607-Renal function-related traits \(eGRFcrea\) | Inverse variance weighted | 5 | 0.79256 | 1.564685 | 0.612485 | 0.998684 | -2.27422 | 3.859342 | 2.209044 | 0.102877 | 47.43415 |
| GCST001852-Metabolite levels | Inverse variance weighted | 3 | -0.01289 | 0.025462 | 0.612718 | 0.998684 | -0.06279 | 0.037017 | 0.987194 | 0.939136 | 1.037711 |
| GCST002094-Crohn's disease | Inverse variance weighted | 3 | -0.02856 | 0.056477 | 0.613062 | 0.998684 | -0.13926 | 0.082134 | 0.971843 | 0.870006 | 1.085601 |
| GCST006946-Worry too long after an embarrassing experience | Inverse variance weighted | 20 | -0.00054 | 0.001067 | 0.613893 | 0.998684 | -0.00263 | 0.001553 | 0.999462 | 0.997374 | 1.001554 |
| GCST001415-Body mass index | Inverse variance weighted | 4 | 0.001219 | 0.002417 | 0.61406 | 0.998684 | -0.00352 | 0.005956 | 1.00122 | 0.996488 | 1.005974 |
| GCST005956-Waist-to-hip ratio adjusted for BMI | Inverse variance weighted | 43 | 0.049737 | 0.098754 | 0.614513 | 0.998684 | -0.14382 | 0.243295 | 1.050994 | 0.866043 | 1.275444 |
| GCST000340-Myocardial infarction \(early onset\) | Inverse variance weighted | 5 | -0.0396 | 0.078635 | 0.614585 | 0.998684 | -0.19372 | 0.114529 | 0.961178 | 0.823888 | 1.121345 |
| GCST004350-Bone ultrasound measurement \(velocity of sound\) | Inverse variance weighted | 5 | 0.034829 | 0.069172 | 0.614609 | 0.998684 | -0.10075 | 0.170406 | 1.035442 | 0.90416 | 1.185786 |
| GCST003117-Myocardial infarction | Inverse variance weighted | 16 | 0.262522 | 0.522156 | 0.615129 | 0.998684 | -0.7609 | 1.285948 | 1.300205 | 0.467244 | 3.618098 |
| GCST003215-HDL cholesterol | Inverse variance weighted | 4 | -0.00399 | 0.007939 | 0.615374 | 0.998684 | -0.01955 | 0.011572 | 0.996019 | 0.980641 | 1.011639 |
| GCST001399-Infantile hypertrophic pyloric stenosis | Inverse variance weighted | 2 | -0.02775 | 0.055315 | 0.615964 | 0.998684 | -0.13616 | 0.080673 | 0.972636 | 0.8727 | 1.084016 |
| GCST006194-Diastolic blood pressure x smoking status \(current vs non-current\) interaction \(1df test\) | Inverse variance weighted | 2 | 0.0017 | 0.00339 | 0.615983 | 0.998684 | -0.00494 | 0.008344 | 1.001702 | 0.995069 | 1.008379 |
| GCST006977-Predicted suicide risk | Inverse variance weighted | 2 | -0.12756 | 0.254393 | 0.61607 | 0.998684 | -0.62617 | 0.371051 | 0.880241 | 0.534635 | 1.449257 |
| GCST006403-Energy expenditure | Inverse variance weighted | 4 | -0.00013 | 0.000258 | 0.616786 | 0.998684 | -0.00063 | 0.000376 | 0.999871 | 0.999366 | 1.000376 |
| GCST006862-Asthma | Inverse variance weighted | 15 | -0.03119 | 0.06235 | 0.616949 | 0.998684 | -0.15339 | 0.091021 | 0.969295 | 0.857792 | 1.095291 |
| GCST000368-Fibrinogen | Inverse variance weighted | 2 | 0.000685 | 0.001371 | 0.617147 | 0.998684 | -0.002 | 0.003372 | 1.000686 | 0.998 | 1.003378 |
| GCST000339-Eosinophil counts | Inverse variance weighted | 4 | 0.000644 | 0.001289 | 0.617576 | 0.998684 | -0.00188 | 0.003171 | 1.000644 | 0.998118 | 1.003176 |
| GCST001007-Metabolic syndrome \(bivariate traits\) | Inverse variance weighted | 10 | 0.01241 | 0.024875 | 0.617865 | 0.998684 | -0.03635 | 0.061166 | 1.012487 | 0.964307 | 1.063075 |
| GCST004481-Low-grade serous and serous borderline ovarian cancer | Inverse variance weighted | 3 | -0.02791 | 0.055989 | 0.61814 | 0.998684 | -0.13765 | 0.081829 | 0.972476 | 0.871404 | 1.08527 |
| GCST007339-Neuroticism | Inverse variance weighted | 167 | 0.067775 | 0.136627 | 0.619851 | 0.998684 | -0.20001 | 0.335564 | 1.070125 | 0.81872 | 1.398729 |
| GCST005528-Juvenile idiopathic arthritis \(oligoarticular or rheumatoid factor-negative polyarticular\) | Inverse variance weighted | 9 | -0.01858 | 0.037477 | 0.620024 | 0.998684 | -0.09204 | 0.054873 | 0.98159 | 0.912072 | 1.056406 |
| GCST005038-Allergic disease \(asthma, hay fever or eczema\) | Inverse variance weighted | 80 | -0.02617 | 0.052876 | 0.620591 | 0.998684 | -0.12981 | 0.077463 | 0.974165 | 0.87826 | 1.080542 |
| GCST005001-Shingles | Inverse variance weighted | 2 | 0.086937 | 0.175829 | 0.620997 | 0.998684 | -0.25769 | 0.431562 | 1.090828 | 0.772836 | 1.539661 |
| GCST000564-Electrocardiographic traits | Inverse variance weighted | 2 | -0.00189 | 0.003821 | 0.62104 | 0.998684 | -0.00938 | 0.0056 | 0.998113 | 0.990666 | 1.005616 |
| GCST005315-Acute lymphoblastic leukemia \(childhood\) | Inverse variance weighted | 2 | -0.03466 | 0.070164 | 0.621292 | 0.998684 | -0.17218 | 0.102859 | 0.965931 | 0.841824 | 1.108335 |
| GCST007302-Breast cancer in BRCA2 mutation carriers | Inverse variance weighted | 3 | -0.02274 | 0.046243 | 0.622861 | 0.998684 | -0.11338 | 0.067894 | 0.977514 | 0.892813 | 1.070251 |
| GCST001557-Venous thromboembolism | Inverse variance weighted | 3 | 0.011515 | 0.023443 | 0.623302 | 0.998684 | -0.03443 | 0.057464 | 1.011581 | 0.966152 | 1.059147 |
| GCST004603-Platelet count | Inverse variance weighted | 128 | -0.08002 | 0.163287 | 0.624074 | 0.998684 | -0.40007 | 0.240018 | 0.923094 | 0.670276 | 1.271272 |
| GCST002036-Congenital heart malformation | Inverse variance weighted | 2 | 0.023037 | 0.047165 | 0.625239 | 0.998684 | -0.06941 | 0.115481 | 1.023305 | 0.932947 | 1.122413 |
| GCST004601-Red blood cell count | Inverse variance weighted | 101 | -0.02201 | 0.04509 | 0.625494 | 0.998684 | -0.11038 | 0.066368 | 0.978233 | 0.895491 | 1.06862 |
| GCST007327-Smoking status \(ever vs never smokers\) | Inverse variance weighted | 145 | -0.05459 | 0.111953 | 0.625844 | 0.998684 | -0.27401 | 0.164842 | 0.946876 | 0.760321 | 1.179206 |
| GCST007294-Body fat distribution \(trunk fat ratio\) | Inverse variance weighted | 45 | -0.05727 | 0.11778 | 0.62681 | 0.998684 | -0.28812 | 0.173581 | 0.944342 | 0.749675 | 1.189558 |
| GCST000414-Testicular germ cell tumor | Inverse variance weighted | 3 | 0.008362 | 0.017222 | 0.627276 | 0.998684 | -0.02539 | 0.042117 | 1.008397 | 0.974927 | 1.043016 |
| GCST005763-Blood glucose levels | Inverse variance weighted | 2 | 0.008023 | 0.01656 | 0.628046 | 0.998684 | -0.02444 | 0.040481 | 1.008055 | 0.975861 | 1.041312 |
| GCST007234-Acne \(severe\) | Inverse variance weighted | 9 | 0.020888 | 0.04312 | 0.628082 | 0.998684 | -0.06363 | 0.105403 | 1.021108 | 0.938356 | 1.111159 |
| GCST000719-Alopecia areata | Inverse variance weighted | 3 | -0.01211 | 0.025008 | 0.628166 | 0.998684 | -0.06113 | 0.036904 | 0.987961 | 0.940704 | 1.037593 |
| GCST006461-Self-reported risk-taking behaviour | Inverse variance weighted | 7 | -0.07569 | 0.157702 | 0.631238 | 0.998684 | -0.38479 | 0.233401 | 0.927099 | 0.680594 | 1.262887 |
| GCST004075-Vertical cup-disc ratio | Inverse variance weighted | 12 | -0.31739 | 0.66223 | 0.631738 | 0.998684 | -1.61537 | 0.980575 | 0.728043 | 0.198818 | 2.665989 |
| GCST002333-Bone properties \(heel\) | Inverse variance weighted | 5 | 0.039592 | 0.082726 | 0.632228 | 0.998684 | -0.12255 | 0.201736 | 1.040387 | 0.88466 | 1.223525 |
| GCST000563-Ankylosing spondylitis | Inverse variance weighted | 2 | -0.01887 | 0.039452 | 0.632379 | 0.998684 | -0.0962 | 0.058453 | 0.981304 | 0.908283 | 1.060195 |
| GCST005146-Birth weight | Inverse variance weighted | 39 | -0.05326 | 0.111344 | 0.632425 | 0.998684 | -0.27149 | 0.164977 | 0.948135 | 0.762241 | 1.179366 |
| GCST002173-Lipid traits | Inverse variance weighted | 2 | 0.00115 | 0.002404 | 0.632491 | 0.998684 | -0.00356 | 0.005862 | 1.00115 | 0.996444 | 1.005879 |
| GCST007104-QRS duration | Inverse variance weighted | 18 | 0.004517 | 0.009509 | 0.634767 | 0.998684 | -0.01412 | 0.023154 | 1.004527 | 0.985979 | 1.023424 |
| GCST001660-Neuroblastoma | Inverse variance weighted | 2 | 0.025285 | 0.053291 | 0.635165 | 0.998684 | -0.07917 | 0.129735 | 1.025607 | 0.923887 | 1.138526 |
| GCST006903-Hip shape \(DXA scan\) | Inverse variance weighted | 7 | -0.03256 | 0.069032 | 0.637137 | 0.998684 | -0.16787 | 0.10274 | 0.967962 | 0.845468 | 1.108203 |
| GCST007154-Paediatric migraine | Inverse variance weighted | 2 | 0.00786 | 0.016736 | 0.638594 | 0.998684 | -0.02494 | 0.040663 | 1.007891 | 0.975366 | 1.041501 |
| GCST007839-Mouth ulcers | Inverse variance weighted | 48 | -0.0214 | 0.045571 | 0.638686 | 0.998684 | -0.11072 | 0.067922 | 0.97883 | 0.895192 | 1.070282 |
| GCST004624-Sum eosinophil basophil counts | Inverse variance weighted | 100 | -0.02414 | 0.051519 | 0.639373 | 0.998684 | -0.12512 | 0.076837 | 0.976148 | 0.882392 | 1.079866 |
| GCST008276-Corneal resistance factor | Inverse variance weighted | 2 | -0.03342 | 0.071474 | 0.640048 | 0.998684 | -0.17351 | 0.106666 | 0.967129 | 0.840706 | 1.112563 |
| GCST006801-Type 2 diabetes | Inverse variance weighted | 4 | 0.026869 | 0.057621 | 0.640998 | 0.998684 | -0.08607 | 0.139805 | 1.027233 | 0.917532 | 1.15005 |
| GCST007692-Chronic obstructive pulmonary disease | Inverse variance weighted | 37 | -0.01908 | 0.041014 | 0.641841 | 0.998684 | -0.09946 | 0.061311 | 0.981104 | 0.905322 | 1.063229 |
| GCST004338-Oleic acid \(18:1n-9\) levels | Inverse variance weighted | 2 | 0.020167 | 0.04346 | 0.642613 | 0.998684 | -0.06501 | 0.105349 | 1.020372 | 0.937055 | 1.111098 |
| GCST008109-Fasting blood proinsulin levels | Inverse variance weighted | 4 | -0.16445 | 0.354652 | 0.64287 | 0.998684 | -0.85957 | 0.53067 | 0.848361 | 0.423345 | 1.700072 |
| GCST008280-Intertrochanteric region size | Inverse variance weighted | 5 | 0.057832 | 0.124973 | 0.643539 | 0.998684 | -0.18711 | 0.302779 | 1.059537 | 0.829348 | 1.353615 |
| GCST000395-Systolic blood pressure | Inverse variance weighted | 2 | -0.01593 | 0.034453 | 0.643823 | 0.998684 | -0.08346 | 0.051598 | 0.984196 | 0.91993 | 1.052953 |
| GCST006423-Fractures | Inverse variance weighted | 9 | -0.05836 | 0.126538 | 0.644674 | 0.998684 | -0.30637 | 0.189658 | 0.943314 | 0.736115 | 1.208836 |
| GCST007401-Factor VII activity | Inverse variance weighted | 13 | -0.11224 | 0.243587 | 0.644966 | 0.998684 | -0.58967 | 0.365194 | 0.893833 | 0.554512 | 1.440793 |
| GCST001967-Body mass index | Inverse variance weighted | 6 | 0.104857 | 0.227927 | 0.645485 | 0.998684 | -0.34188 | 0.551594 | 1.110551 | 0.710433 | 1.736019 |
| GCST007987-Daytime nap | Inverse variance weighted | 5 | 0.056055 | 0.12239 | 0.646952 | 0.998684 | -0.18383 | 0.29594 | 1.057656 | 0.832077 | 1.344389 |
| GCST002455-Parkinson's disease | Inverse variance weighted | 2 | -0.01735 | 0.037903 | 0.647128 | 0.998684 | -0.09164 | 0.05694 | 0.982799 | 0.912433 | 1.058592 |
| GCST003659-Modified Stumvoll Insulin Sensitivity Index \(BMI interaction\) | Inverse variance weighted | 5 | 0.388607 | 0.84899 | 0.647147 | 0.998684 | -1.27541 | 2.052627 | 1.474925 | 0.279316 | 7.788335 |
| GCST007799-Asthma \(adult onset\) | Inverse variance weighted | 4 | -0.16405 | 0.359492 | 0.648157 | 0.998684 | -0.86865 | 0.54056 | 0.848704 | 0.419517 | 1.716968 |
| GCST003127-Lipoprotein \(a\) levels | Inverse variance weighted | 4 | -0.02425 | 0.053351 | 0.649404 | 0.998684 | -0.12882 | 0.080315 | 0.976039 | 0.879132 | 1.083628 |
| GCST007995-Asthma \(childhood onset\) | Inverse variance weighted | 36 | -0.01324 | 0.029189 | 0.650071 | 0.998684 | -0.07045 | 0.043969 | 0.986845 | 0.931971 | 1.04495 |
| GCST007778-Urinary sodium to creatinine ratio | Inverse variance weighted | 2 | 0.19684 | 0.434115 | 0.65024 | 0.998684 | -0.65403 | 1.047706 | 1.217549 | 0.519948 | 2.851104 |
| GCST007797-Asthma onset \(childhood vs adult\) | Inverse variance weighted | 18 | -0.01901 | 0.042091 | 0.651607 | 0.998684 | -0.1015 | 0.063494 | 0.981174 | 0.903477 | 1.065553 |
| GCST001364-IgA nephropathy | Inverse variance weighted | 5 | -0.03853 | 0.085434 | 0.651993 | 0.998684 | -0.20598 | 0.128921 | 0.962202 | 0.813848 | 1.1376 |
| GCST004331-Hemoglobin | Inverse variance weighted | 2 | -0.1055 | 0.234157 | 0.652307 | 0.998684 | -0.56445 | 0.353445 | 0.899873 | 0.568674 | 1.423965 |
| GCST001021-Iron status biomarkers | Inverse variance weighted | 2 | 0.000239 | 0.000532 | 0.652345 | 0.998684 | -0.0008 | 0.001281 | 1.00024 | 0.999198 | 1.001282 |
| GCST001099-Sudden cardiac arrest | Inverse variance weighted | 8 | 0.011072 | 0.024609 | 0.652758 | 0.998684 | -0.03716 | 0.059306 | 1.011134 | 0.963521 | 1.061099 |
| GCST001628-Orofacial clefts | Inverse variance weighted | 9 | 0.007426 | 0.016516 | 0.652999 | 0.998684 | -0.02495 | 0.039798 | 1.007453 | 0.975362 | 1.0406 |
| GCST001791-Urate levels | Inverse variance weighted | 21 | 0.018371 | 0.040863 | 0.653012 | 0.998684 | -0.06172 | 0.098463 | 1.018541 | 0.940146 | 1.103474 |
| GCST002945-Emphysema imaging phenotypes | Inverse variance weighted | 2 | -0.04546 | 0.101227 | 0.653392 | 0.998684 | -0.24386 | 0.152948 | 0.955561 | 0.783597 | 1.165264 |
| GCST006621-Midgestational cytokine/chemokine levels \(maternal genetic effect\) | Inverse variance weighted | 3 | -0.00929 | 0.020708 | 0.653694 | 0.998684 | -0.04988 | 0.031297 | 0.990753 | 0.951346 | 1.031792 |
| GCST001350-Pancreatic cancer | Inverse variance weighted | 3 | -0.01817 | 0.040523 | 0.653882 | 0.998684 | -0.09759 | 0.061256 | 0.981995 | 0.907017 | 1.063171 |
| GCST002463-Systemic lupus erythematosus | Inverse variance weighted | 7 | 0.010879 | 0.024379 | 0.655436 | 0.998684 | -0.0369 | 0.058662 | 1.010938 | 0.963768 | 1.060417 |
| GCST000464-Acute lymphoblastic leukemia \(childhood\) | Inverse variance weighted | 2 | -0.01453 | 0.032588 | 0.655761 | 0.998684 | -0.0784 | 0.049345 | 0.985578 | 0.924596 | 1.050583 |
| GCST000657-Optic nerve measurement \(disc area\) | Inverse variance weighted | 2 | 0.019706 | 0.044254 | 0.656117 | 0.998684 | -0.06703 | 0.106444 | 1.019901 | 0.935164 | 1.112316 |
| GCST002140-Multiple myeloma | Inverse variance weighted | 3 | -0.02543 | 0.057358 | 0.657543 | 0.998684 | -0.13785 | 0.086994 | 0.974893 | 0.871231 | 1.09089 |
| GCST007561-Sleep duration | Inverse variance weighted | 34 | -0.00158 | 0.003582 | 0.659332 | 0.998684 | -0.0086 | 0.005442 | 0.998422 | 0.991437 | 1.005457 |
| GCST002149-Schizophrenia | Inverse variance weighted | 12 | 0.029127 | 0.066129 | 0.659606 | 0.998684 | -0.10049 | 0.158741 | 1.029556 | 0.904397 | 1.172034 |
| GCST001126-Parkinson's disease | Inverse variance weighted | 2 | -0.02851 | 0.06477 | 0.65981 | 0.998684 | -0.15546 | 0.098438 | 0.971893 | 0.856023 | 1.103446 |
| GCST003358-Betaine levels in individuals undergoing cardiac evaluation | Inverse variance weighted | 2 | -0.16473 | 0.374741 | 0.660233 | 0.998684 | -0.89923 | 0.569759 | 0.84812 | 0.406885 | 1.767842 |
| GCST000383-Type 2 diabetes | Inverse variance weighted | 4 | -0.01752 | 0.039956 | 0.661123 | 0.998684 | -0.09583 | 0.060799 | 0.982637 | 0.908619 | 1.062685 |
| GCST002535-PR interval | Inverse variance weighted | 2 | 0.002067 | 0.004724 | 0.661768 | 0.998684 | -0.00719 | 0.011326 | 1.002069 | 0.992833 | 1.011391 |
| GCST002842-Basal cell carcinoma | Inverse variance weighted | 2 | 0.025115 | 0.057427 | 0.661864 | 0.998684 | -0.08744 | 0.137672 | 1.025433 | 0.916272 | 1.147599 |
| GCST000730-Bilirubin levels | Inverse variance weighted | 2 | 0.041096 | 0.094096 | 0.662295 | 0.998684 | -0.14333 | 0.225524 | 1.041952 | 0.866466 | 1.252979 |
| GCST000561-Electrocardiographic traits | Inverse variance weighted | 8 | -0.00029 | 0.00066 | 0.663165 | 0.998684 | -0.00158 | 0.001006 | 0.999713 | 0.998421 | 1.001006 |
| GCST000295-Bone mineral density \(spine\) | Inverse variance weighted | 2 | 0.044928 | 0.103204 | 0.66332 | 0.998684 | -0.15735 | 0.247207 | 1.045953 | 0.854404 | 1.280445 |
| GCST001674-Esophageal cancer \(squamous cell\) | Inverse variance weighted | 6 | 0.016549 | 0.038121 | 0.664201 | 0.998684 | -0.05817 | 0.091266 | 1.016687 | 0.943492 | 1.09556 |
| GCST002763-Optic disc area | Inverse variance weighted | 8 | 0.086443 | 0.199467 | 0.664744 | 0.998684 | -0.30451 | 0.477399 | 1.09029 | 0.737483 | 1.611876 |
| GCST000707-Hair color | Inverse variance weighted | 4 | -0.00749 | 0.017289 | 0.664868 | 0.998684 | -0.04138 | 0.026397 | 0.992538 | 0.959468 | 1.026749 |
| GCST003664-Metabolite levels \(lipid measures\) | Inverse variance weighted | 3 | 0.018731 | 0.043397 | 0.666019 | 0.998684 | -0.06633 | 0.10379 | 1.018908 | 0.935824 | 1.109367 |
| GCST000651-Creatinine levels | Inverse variance weighted | 2 | -0.01206 | 0.028089 | 0.667637 | 0.998684 | -0.06712 | 0.042993 | 0.988011 | 0.935087 | 1.043931 |
| GCST007089-Polycystic ovary syndrome | Inverse variance weighted | 6 | -0.02595 | 0.060547 | 0.668258 | 0.998684 | -0.14462 | 0.092725 | 0.974387 | 0.865352 | 1.09716 |
| GCST007954-Glycated hemoglobin levels | Inverse variance weighted | 28 | -0.09275 | 0.216469 | 0.668324 | 0.998684 | -0.51703 | 0.331533 | 0.911425 | 0.596292 | 1.393102 |
| GCST002083-Self-reported allergy | Inverse variance weighted | 11 | -0.02616 | 0.061321 | 0.669702 | 0.998684 | -0.14635 | 0.094032 | 0.974182 | 0.863859 | 1.098595 |
| GCST007847-Type 2 diabetes | Inverse variance weighted | 51 | -0.01319 | 0.030954 | 0.669951 | 0.998684 | -0.07386 | 0.047477 | 0.986894 | 0.928799 | 1.048622 |
| GCST005013-Childhood ear infection | Inverse variance weighted | 6 | -0.04284 | 0.100816 | 0.670851 | 0.998684 | -0.24044 | 0.154754 | 0.95806 | 0.786279 | 1.167371 |
| GCST001010-Primary biliary cholangitis | Inverse variance weighted | 15 | -0.00774 | 0.01823 | 0.671347 | 0.998684 | -0.04347 | 0.027996 | 0.992295 | 0.957464 | 1.028392 |
| GCST004899-Gestational age at birth \(maternal effect\) | Inverse variance weighted | 2 | -0.006 | 0.014194 | 0.672257 | 0.998684 | -0.03382 | 0.021815 | 0.994013 | 0.966742 | 1.022054 |
| GCST007708-Worry/vulnerability \(special factor of neuroticism\) | Inverse variance weighted | 10 | 0.277211 | 0.65689 | 0.673021 | 0.998684 | -1.01029 | 1.564715 | 1.319445 | 0.364112 | 4.781313 |
| GCST000804-Asthma | Inverse variance weighted | 3 | -0.02794 | 0.06628 | 0.673341 | 0.998684 | -0.15785 | 0.101968 | 0.972445 | 0.853977 | 1.107348 |
| GCST002496-Bone mineral density \(paediatric, upper limb\) | Inverse variance weighted | 4 | 0.026621 | 0.063259 | 0.673886 | 0.998684 | -0.09737 | 0.150609 | 1.026978 | 0.907223 | 1.162542 |
| GCST004635-Testicular germ cell tumor | Inverse variance weighted | 24 | 0.007687 | 0.018364 | 0.675507 | 0.998684 | -0.02831 | 0.043681 | 1.007717 | 0.97209 | 1.044649 |
| GCST001038-Dehydroepiandrosterone sulphate levels | Inverse variance weighted | 6 | -0.07959 | 0.190288 | 0.675771 | 0.998684 | -0.45255 | 0.293378 | 0.923498 | 0.636004 | 1.34095 |
| GCST005077-Breast cancer | Inverse variance weighted | 4 | 0.061466 | 0.147062 | 0.675976 | 0.998684 | -0.22678 | 0.349708 | 1.063395 | 0.7971 | 1.418653 |
| GCST003429-Morning vs. evening chronotype | Inverse variance weighted | 5 | -0.06061 | 0.145039 | 0.676048 | 0.998684 | -0.34488 | 0.223671 | 0.941194 | 0.708303 | 1.250659 |
| GCST003586-Prostate cancer | Inverse variance weighted | 3 | 0.014022 | 0.033606 | 0.676501 | 0.998684 | -0.05185 | 0.079889 | 1.01412 | 0.949476 | 1.083167 |
| GCST001796-Prostate-specific antigen levels | Inverse variance weighted | 2 | -0.05313 | 0.12745 | 0.676767 | 0.998684 | -0.30293 | 0.196671 | 0.948256 | 0.738648 | 1.217344 |
| GCST000683-Central corneal thickness | Inverse variance weighted | 2 | 0.032323 | 0.078091 | 0.678935 | 0.998684 | -0.12073 | 0.185381 | 1.032851 | 0.886269 | 1.203677 |
| GCST001807-Tetralogy of Fallot | Inverse variance weighted | 2 | -0.01731 | 0.041885 | 0.679467 | 0.998684 | -0.0994 | 0.064787 | 0.982843 | 0.905381 | 1.066932 |
| GCST000498-Hematological parameters | Inverse variance weighted | 6 | 0.000855 | 0.002078 | 0.680747 | 0.998684 | -0.00322 | 0.004927 | 1.000855 | 0.996788 | 1.004939 |
| GCST007114-Cholesterol efflux capacity | Inverse variance weighted | 3 | 0.029107 | 0.071025 | 0.681939 | 0.998684 | -0.1101 | 0.168317 | 1.029535 | 0.895743 | 1.183311 |
| GCST000317-Obesity | Inverse variance weighted | 3 | -0.01965 | 0.048324 | 0.684281 | 0.998684 | -0.11436 | 0.075065 | 0.980542 | 0.891933 | 1.077954 |
| GCST001527-Fasting blood glucose \(BMI interaction\) | Inverse variance weighted | 18 | 2.816583 | 6.933952 | 0.684594 | 0.998684 | -10.774 | 16.40713 | 16.71962 | 2.09E-05 | 13351349 |
| GCST006414-Atrial fibrillation | Inverse variance weighted | 89 | 0.012384 | 0.030494 | 0.684653 | 0.998684 | -0.04738 | 0.072152 | 1.012461 | 0.953722 | 1.074818 |
| GCST004634-Basophil percentage of granulocytes | Inverse variance weighted | 25 | -0.03991 | 0.098713 | 0.685971 | 0.998684 | -0.23339 | 0.153565 | 0.960873 | 0.791844 | 1.165984 |
| GCST001234-Gamma glutamyl transpeptidase | Inverse variance weighted | 4 | 0.681962 | 1.68756 | 0.686131 | 0.998684 | -2.62565 | 3.989579 | 1.977755 | 0.072392 | 54.03216 |
| GCST002255-Inflammatory biomarkers | Inverse variance weighted | 3 | -0.05987 | 0.148384 | 0.686571 | 0.998684 | -0.35071 | 0.230958 | 0.941882 | 0.70419 | 1.259806 |
| GCST002450-Plasma omega-6 polyunsaturated fatty acid levels \(gamma-linolenic acid\) | Inverse variance weighted | 2 | 0.292189 | 0.727143 | 0.687808 | 0.998684 | -1.13301 | 1.717389 | 1.339357 | 0.322062 | 5.569965 |
| GCST003818-Resting heart rate | Inverse variance weighted | 49 | 0.00293 | 0.0073 | 0.688181 | 0.998684 | -0.01138 | 0.017238 | 1.002934 | 0.988686 | 1.017387 |
| GCST000775-Central corneal thickness | Inverse variance weighted | 3 | 0.029405 | 0.0736 | 0.689507 | 0.998684 | -0.11485 | 0.173662 | 1.029842 | 0.891498 | 1.189654 |
| GCST005434-Pancreatic cancer | Inverse variance weighted | 11 | 0.019489 | 0.049005 | 0.690861 | 0.998684 | -0.07656 | 0.115539 | 1.01968 | 0.926296 | 1.122478 |
| GCST000191-Black vs. red hair color | Inverse variance weighted | 3 | -0.01849 | 0.046587 | 0.691527 | 0.998684 | -0.1098 | 0.072826 | 0.981685 | 0.896017 | 1.075543 |
| GCST007462-Age of smoking initiation \(MTAG\) | Inverse variance weighted | 99 | -0.07376 | 0.185953 | 0.691599 | 0.998684 | -0.43823 | 0.290702 | 0.92889 | 0.645176 | 1.337367 |
| GCST003641-Cranial base width | Inverse variance weighted | 2 | -0.01032 | 0.02607 | 0.692219 | 0.998684 | -0.06142 | 0.040777 | 0.989734 | 0.940432 | 1.04162 |
| GCST002882-Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor | Inverse variance weighted | 2 | 0.069996 | 0.176954 | 0.69243 | 0.998684 | -0.27683 | 0.416825 | 1.072504 | 0.758181 | 1.517137 |
| GCST001416-Body mass index \(SNP x SNP interaction\) | Inverse variance weighted | 7 | 0.053536 | 0.13581 | 0.693434 | 0.998684 | -0.21265 | 0.319725 | 1.054995 | 0.808437 | 1.376749 |
| GCST004627-Lymphocyte counts | Inverse variance weighted | 86 | 0.024291 | 0.061749 | 0.694032 | 0.998684 | -0.09674 | 0.14532 | 1.024589 | 0.907795 | 1.156409 |
| GCST003170-Subcutaneous adipose tissue | Inverse variance weighted | 2 | 5.71E-05 | 0.000145 | 0.694059 | 0.998684 | -0.00023 | 0.000341 | 1.000057 | 0.999773 | 1.000342 |
| GCST000134-LDL cholesterol | Inverse variance weighted | 4 | 0.025294 | 0.064367 | 0.694342 | 0.998684 | -0.10086 | 0.151453 | 1.025617 | 0.904055 | 1.163524 |
| GCST004525-Subclinical trait of interstitial lung disease \(basilar peel-core ratio of high attentuation areas on CT scan\) | Inverse variance weighted | 2 | 0.164005 | 0.419991 | 0.696169 | 0.998684 | -0.65918 | 0.987187 | 1.178221 | 0.517277 | 2.683676 |
| GCST006479-Diverticular disease | Inverse variance weighted | 27 | 0.347449 | 0.89059 | 0.696438 | 0.998684 | -1.39811 | 2.093005 | 1.415451 | 0.247064 | 8.109247 |
| GCST004630-Mean corpuscular hemoglobin | Inverse variance weighted | 112 | 0.013575 | 0.034809 | 0.69655 | 0.998684 | -0.05465 | 0.081801 | 1.013668 | 0.946815 | 1.08524 |
| GCST002764-Optic cup area | Inverse variance weighted | 4 | 0.362863 | 0.93053 | 0.696571 | 0.998684 | -1.46098 | 2.186702 | 1.437439 | 0.23201 | 8.905794 |
| GCST004335-Mean corpuscular volume | Inverse variance weighted | 3 | -0.0085 | 0.021807 | 0.696833 | 0.998684 | -0.05124 | 0.034246 | 0.99154 | 0.950052 | 1.03484 |
| GCST001653-Androgen levels | Inverse variance weighted | 2 | 0.044711 | 0.11529 | 0.698156 | 0.998684 | -0.18126 | 0.27068 | 1.045725 | 0.83422 | 1.310855 |
| GCST004076-Optic disc area | Inverse variance weighted | 8 | -0.08748 | 0.225928 | 0.698602 | 0.998684 | -0.5303 | 0.355337 | 0.916236 | 0.588429 | 1.426662 |
| GCST001780-Mean corpuscular hemoglobin | Inverse variance weighted | 3 | -0.01946 | 0.050477 | 0.699784 | 0.998684 | -0.1184 | 0.07947 | 0.980724 | 0.888341 | 1.082713 |
| GCST006951-Feeling hurt | Inverse variance weighted | 20 | -0.00026 | 0.000687 | 0.700082 | 0.998684 | -0.00161 | 0.001082 | 0.999735 | 0.99839 | 1.001083 |
| GCST001456-Kawasaki disease | Inverse variance weighted | 2 | -0.01263 | 0.032807 | 0.700201 | 0.998684 | -0.07693 | 0.051669 | 0.987447 | 0.925951 | 1.053027 |
| GCST000364-QT interval | Inverse variance weighted | 9 | 0.001397 | 0.003635 | 0.700653 | 0.998684 | -0.00573 | 0.008522 | 1.001398 | 0.994289 | 1.008558 |
| GCST001158-Fibrinogen | Inverse variance weighted | 3 | 0.020652 | 0.054078 | 0.702535 | 0.998684 | -0.08534 | 0.126645 | 1.020867 | 0.9182 | 1.135014 |
| GCST002350-Chronic obstructive pulmonary disease \(severe\) | Inverse variance weighted | 2 | -0.01325 | 0.034728 | 0.702712 | 0.998684 | -0.08132 | 0.054812 | 0.986833 | 0.921898 | 1.056342 |
| GCST006284-Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease | Inverse variance weighted | 3 | 0.0725 | 0.189995 | 0.702768 | 0.998684 | -0.29989 | 0.44489 | 1.075192 | 0.740899 | 1.560318 |
| GCST001198-Multiple sclerosis | Inverse variance weighted | 39 | -0.0091 | 0.023916 | 0.703651 | 0.998684 | -0.05597 | 0.037778 | 0.990944 | 0.945564 | 1.038501 |
| GCST006625-Neonatal cytokine/chemokine levels \(maternal genetic effect\) | Inverse variance weighted | 2 | -0.01085 | 0.02857 | 0.704045 | 0.998684 | -0.06685 | 0.045145 | 0.989206 | 0.935335 | 1.046179 |
| GCST000051-Atrial fibrillation/atrial flutter | Inverse variance weighted | 2 | -0.01486 | 0.039134 | 0.704104 | 0.998684 | -0.09156 | 0.06184 | 0.985247 | 0.912502 | 1.063792 |
| GCST006366-Central corneal thickness | Inverse variance weighted | 6 | 0.001332 | 0.003507 | 0.704189 | 0.998684 | -0.00554 | 0.008206 | 1.001333 | 0.994473 | 1.00824 |
| GCST004861-Itch intensity from mosquito bite | Inverse variance weighted | 26 | 0.048019 | 0.127093 | 0.70556 | 0.998684 | -0.20108 | 0.29712 | 1.04919 | 0.817845 | 1.345977 |
| GCST003389-Bone mineral density \(hip\) | Inverse variance weighted | 3 | -0.05424 | 0.143561 | 0.705577 | 0.998684 | -0.33562 | 0.227142 | 0.947207 | 0.714896 | 1.255009 |
| GCST000056-Restless legs syndrome | Inverse variance weighted | 3 | 0.00794 | 0.021075 | 0.706379 | 0.998684 | -0.03337 | 0.049247 | 1.007971 | 0.967182 | 1.05048 |
| GCST004565-Waist circumference adjusted for BMI in inactive individuals | Inverse variance weighted | 2 | -0.13448 | 0.357242 | 0.706595 | 0.998684 | -0.83467 | 0.565717 | 0.874172 | 0.434016 | 1.76071 |
| GCST007932-Medication use \(thyroid preparations\) | Inverse variance weighted | 86 | -0.00807 | 0.021465 | 0.706991 | 0.998684 | -0.05014 | 0.034003 | 0.991964 | 0.951096 | 1.034588 |
| GCST006075-Hair color | Inverse variance weighted | 15 | 0.012421 | 0.033049 | 0.70704 | 0.998684 | -0.05235 | 0.077196 | 1.012498 | 0.948992 | 1.080254 |
| GCST001870-Bone mineral density | Inverse variance weighted | 4 | -0.02588 | 0.069128 | 0.708119 | 0.998684 | -0.16137 | 0.10961 | 0.974452 | 0.850976 | 1.115843 |
| GCST002667-Mammographic density \(dense area\) | Inverse variance weighted | 6 | 0.020197 | 0.0541 | 0.708899 | 0.998684 | -0.08584 | 0.126233 | 1.020403 | 0.917743 | 1.134547 |
| GCST002305-Breast cancer \(estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative\) | Inverse variance weighted | 2 | -0.02032 | 0.054784 | 0.710727 | 0.998684 | -0.1277 | 0.087059 | 0.979887 | 0.880121 | 1.090961 |
| GCST002840-Myeloproliferative neoplasms | Inverse variance weighted | 2 | 0.02515 | 0.06794 | 0.711242 | 0.998684 | -0.10801 | 0.158312 | 1.025469 | 0.897617 | 1.171532 |
| GCST003838-Morning vs. evening chronotype | Inverse variance weighted | 3 | 0.08024 | 0.217233 | 0.711852 | 0.998684 | -0.34554 | 0.506017 | 1.083547 | 0.70784 | 1.658671 |
| GCST006279-Cerebrospinal fluid -synuclein levels | Inverse variance weighted | 2 | -0.04245 | 0.11546 | 0.713116 | 0.998684 | -0.26875 | 0.183849 | 0.958437 | 0.764332 | 1.201835 |
| GCST001806-Corneal structure | Inverse variance weighted | 20 | 0.015693 | 0.042739 | 0.713476 | 0.998684 | -0.06808 | 0.099462 | 1.015817 | 0.93419 | 1.104577 |
| GCST000288-HDL cholesterol | Inverse variance weighted | 6 | 0.026527 | 0.072595 | 0.71481 | 0.998684 | -0.11576 | 0.168813 | 1.026881 | 0.890689 | 1.183898 |
| GCST005561-Aortic valve stenosis | Inverse variance weighted | 3 | -0.02087 | 0.057156 | 0.715016 | 0.998684 | -0.1329 | 0.091157 | 0.979347 | 0.875556 | 1.095441 |
| GCST000829-Waist-hip ratio | Inverse variance weighted | 8 | 0.076304 | 0.209027 | 0.715078 | 0.998684 | -0.33339 | 0.485998 | 1.079291 | 0.716491 | 1.625797 |
| GCST001217-Metabolic traits | Inverse variance weighted | 27 | -0.01069 | 0.029322 | 0.715507 | 0.998684 | -0.06816 | 0.046783 | 0.98937 | 0.934114 | 1.047895 |
| GCST004562-Waist circumference adjusted for body mass index | Inverse variance weighted | 78 | -0.02829 | 0.077783 | 0.716089 | 0.998684 | -0.18074 | 0.124166 | 0.972107 | 0.834649 | 1.132203 |
| GCST006613-Triglycerides | Inverse variance weighted | 82 | 0.0203 | 0.055962 | 0.716798 | 0.998684 | -0.08939 | 0.129985 | 1.020507 | 0.914493 | 1.138812 |
| GCST007576-Chronotype | Inverse variance weighted | 41 | -0.09667 | 0.266854 | 0.717168 | 0.998684 | -0.6197 | 0.426366 | 0.907858 | 0.538106 | 1.531682 |
| GCST000915-Primary sclerosing cholangitis | Inverse variance weighted | 2 | -0.01647 | 0.045458 | 0.717178 | 0.998684 | -0.10556 | 0.072631 | 0.983669 | 0.899818 | 1.075333 |
| GCST001072-Blood pressure | Inverse variance weighted | 4 | 0.003973 | 0.010998 | 0.717949 | 0.998684 | -0.01758 | 0.025529 | 1.00398 | 0.98257 | 1.025858 |
| GCST005845-Heart rate increase in response to exercise | Inverse variance weighted | 8 | -0.04672 | 0.129484 | 0.718239 | 0.998684 | -0.30051 | 0.207069 | 0.954355 | 0.740442 | 1.230068 |
| GCST006065-Glaucoma \(primary open-angle\) | Inverse variance weighted | 29 | 0.010539 | 0.029229 | 0.718417 | 0.998684 | -0.04675 | 0.067827 | 1.010595 | 0.954327 | 1.07018 |
| GCST007664-Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer | Inverse variance weighted | 2 | -0.01594 | 0.044319 | 0.719026 | 0.998684 | -0.10281 | 0.070921 | 0.984182 | 0.902299 | 1.073497 |
| GCST007837-Glycine levels | Inverse variance weighted | 4 | -0.01152 | 0.032092 | 0.719545 | 0.998684 | -0.07442 | 0.051377 | 0.988543 | 0.928279 | 1.05272 |
| GCST001579-Age-related macular degeneration \(choroidal neovascularisation\) | Inverse variance weighted | 2 | -0.0095 | 0.026502 | 0.71993 | 0.998684 | -0.06145 | 0.042441 | 0.990543 | 0.940404 | 1.043355 |
| GCST000286-Triglycerides | Inverse variance weighted | 7 | 0.022014 | 0.061691 | 0.721205 | 0.998684 | -0.0989 | 0.142929 | 1.022258 | 0.905833 | 1.153648 |
| GCST000181-Bone mineral density \(hip\) | Inverse variance weighted | 4 | -0.0288 | 0.08077 | 0.721402 | 0.998684 | -0.18711 | 0.129509 | 0.971609 | 0.829351 | 1.138269 |
| GCST003566-Multiple sclerosis | Inverse variance weighted | 3 | 0.025092 | 0.070387 | 0.721482 | 0.998684 | -0.11287 | 0.16305 | 1.025409 | 0.893269 | 1.177096 |
| GCST007241-Obesity \(extreme\) | Inverse variance weighted | 6 | -0.0138 | 0.038781 | 0.722048 | 0.998684 | -0.08981 | 0.062216 | 0.986299 | 0.914108 | 1.064192 |
| GCST005672-Cholesteryl ester transfer protein levels | Inverse variance weighted | 3 | -0.01293 | 0.03635 | 0.722104 | 0.998684 | -0.08417 | 0.058318 | 0.987155 | 0.919271 | 1.060052 |
| GCST002643-Follicular lymphoma | Inverse variance weighted | 4 | 0.023874 | 0.067313 | 0.722837 | 0.998684 | -0.10806 | 0.155808 | 1.024161 | 0.897574 | 1.168602 |
| GCST000117-Blue vs. green eyes | Inverse variance weighted | 2 | 0.007012 | 0.019849 | 0.723879 | 0.998684 | -0.03189 | 0.045915 | 1.007037 | 0.968612 | 1.046986 |
| GCST004599-Mean platelet volume | Inverse variance weighted | 136 | 0.012462 | 0.035481 | 0.725412 | 0.998684 | -0.05708 | 0.082004 | 1.01254 | 0.944519 | 1.08546 |
| GCST000283-LDL cholesterol | Inverse variance weighted | 2 | 0.030637 | 0.087384 | 0.725888 | 0.998684 | -0.14064 | 0.201909 | 1.031111 | 0.868806 | 1.223737 |
| GCST002678-Iron status biomarkers \(transferrin levels\) | Inverse variance weighted | 7 | 0.018243 | 0.05204 | 0.725919 | 0.998684 | -0.08375 | 0.120241 | 1.01841 | 0.919657 | 1.127768 |
| GCST000753-Metabolic syndrome | Inverse variance weighted | 2 | 0.072359 | 0.206416 | 0.725928 | 0.998684 | -0.33222 | 0.476935 | 1.075041 | 0.717331 | 1.611128 |
| GCST002765-Optic disc area | Inverse variance weighted | 2 | -0.05831 | 0.166466 | 0.726127 | 0.998684 | -0.38458 | 0.267964 | 0.943357 | 0.680734 | 1.307299 |
| GCST002697-Eosinophilic esophagitis | Inverse variance weighted | 3 | -0.01171 | 0.033499 | 0.726582 | 0.998684 | -0.07737 | 0.053944 | 0.988355 | 0.925546 | 1.055425 |
| GCST006922-Regular attendance at a religious group | Inverse variance weighted | 10 | -0.42154 | 1.211906 | 0.727968 | 0.998684 | -2.79687 | 1.953799 | 0.656037 | 0.061 | 7.05544 |
| GCST006482-Lung function \(FEV1/FVC\) | Inverse variance weighted | 11 | 0.789229 | 2.269799 | 0.728059 | 0.998684 | -3.65958 | 5.238035 | 2.201697 | 0.025743 | 188.2998 |
| GCST006067-Glaucoma \(primary open-angle\) | Inverse variance weighted | 5 | -0.01629 | 0.046876 | 0.72819 | 0.998684 | -0.10817 | 0.075586 | 0.983841 | 0.897477 | 1.078516 |
| GCST006258-Diastolic blood pressure | Inverse variance weighted | 31 | -0.00599 | 0.01724 | 0.728193 | 0.998684 | -0.03978 | 0.027799 | 0.994026 | 0.960999 | 1.028189 |
| GCST000542-Pulmonary function | Inverse variance weighted | 5 | 0.000177 | 0.000513 | 0.729728 | 0.998684 | -0.00083 | 0.001183 | 1.000177 | 0.999172 | 1.001183 |
| GCST000631-Activated partial thromboplastin time | Inverse variance weighted | 3 | -0.00969 | 0.028077 | 0.730081 | 0.998684 | -0.06472 | 0.045343 | 0.99036 | 0.937333 | 1.046387 |
| GCST006101-Cardiometabolic and hematological traits | Inverse variance weighted | 5 | -0.06475 | 0.187912 | 0.730396 | 0.998684 | -0.43306 | 0.303554 | 0.937298 | 0.64852 | 1.354665 |
| GCST005211-Nodular sclerosis Hodgkin lymphoma | Inverse variance weighted | 4 | 0.031981 | 0.092911 | 0.730686 | 0.998684 | -0.15012 | 0.214087 | 1.032498 | 0.860601 | 1.23873 |
| GCST007928-Medication use \(diuretics\) | Inverse variance weighted | 54 | -0.0128 | 0.037205 | 0.730773 | 0.998684 | -0.08572 | 0.060119 | 0.98728 | 0.917848 | 1.061963 |
| GCST003194-Fibrinogen levels | Inverse variance weighted | 26 | 0.132698 | 0.386489 | 0.731341 | 0.998684 | -0.62482 | 0.890216 | 1.141905 | 0.535358 | 2.435657 |
| GCST006230-Pulse pressure | Inverse variance weighted | 3 | -0.0166 | 0.04851 | 0.732163 | 0.998684 | -0.11168 | 0.078477 | 0.983534 | 0.894328 | 1.081639 |
| GCST005171-QT interval | Inverse variance weighted | 8 | -0.00234 | 0.006845 | 0.732422 | 0.998684 | -0.01576 | 0.011076 | 0.997662 | 0.984367 | 1.011137 |
| GCST002351-Chronic obstructive pulmonary disease \(moderate to severe\) | Inverse variance weighted | 2 | -0.01547 | 0.04555 | 0.734072 | 0.998684 | -0.10475 | 0.073803 | 0.984645 | 0.900549 | 1.076595 |
| GCST003125-Influenza A \(H1N1\) infection | Inverse variance weighted | 4 | 0.005213 | 0.015358 | 0.734306 | 0.998684 | -0.02489 | 0.035314 | 1.005226 | 0.975418 | 1.035945 |
| GCST001207-Butyrylcholinesterase levels | Inverse variance weighted | 3 | -0.00891 | 0.0263 | 0.734782 | 0.998684 | -0.06046 | 0.042638 | 0.99113 | 0.941334 | 1.04356 |
| GCST004615-Hemoglobin concentration | Inverse variance weighted | 64 | 0.02488 | 0.073643 | 0.735483 | 0.998684 | -0.11946 | 0.169219 | 1.025192 | 0.887399 | 1.18438 |
| GCST004419-Mucinous ovarian carcinoma | Inverse variance weighted | 2 | 0.018785 | 0.055913 | 0.736895 | 0.998684 | -0.0908 | 0.128374 | 1.018962 | 0.913197 | 1.136978 |
| GCST005781-Total cholesterol levels | Inverse variance weighted | 2 | 0.003888 | 0.011598 | 0.737451 | 0.998684 | -0.01884 | 0.026619 | 1.003895 | 0.981333 | 1.026976 |
| GCST001670-Vitiligo | Inverse variance weighted | 2 | -0.02304 | 0.069562 | 0.740497 | 0.998684 | -0.15938 | 0.113303 | 0.977225 | 0.852673 | 1.119971 |
| GCST001571-Age-related macular degeneration | Inverse variance weighted | 3 | -0.00413 | 0.012492 | 0.741024 | 0.998684 | -0.02861 | 0.020356 | 0.99588 | 0.971792 | 1.020565 |
| GCST008058-Estimated glomerular filtration rate | Inverse variance weighted | 169 | 0.168861 | 0.511404 | 0.741255 | 0.998684 | -0.83349 | 1.171213 | 1.183956 | 0.43453 | 3.225902 |
| GCST003367-circulating leptin levels | Inverse variance weighted | 2 | -0.12044 | 0.364894 | 0.741354 | 0.998684 | -0.83563 | 0.594755 | 0.886533 | 0.433601 | 1.812587 |
| GCST002043-HDL cholesterol | Inverse variance weighted | 4 | -0.09014 | 0.273302 | 0.741541 | 0.998684 | -0.62581 | 0.445533 | 0.913804 | 0.534828 | 1.561322 |
| GCST001718-Multiple cancers \(lung cancer, gastric cancer, and squamous cell carcinoma\) | Inverse variance weighted | 2 | 0.035915 | 0.109388 | 0.742661 | 0.998684 | -0.17848 | 0.250315 | 1.036568 | 0.836537 | 1.28443 |
| GCST002044-Triglycerides | Inverse variance weighted | 4 | 0.042161 | 0.128634 | 0.743094 | 0.998684 | -0.20996 | 0.294283 | 1.043062 | 0.810616 | 1.342164 |
| GCST006626-Pulse pressure | Inverse variance weighted | 22 | 0.008686 | 0.026532 | 0.743369 | 0.998684 | -0.04332 | 0.060689 | 1.008724 | 0.957609 | 1.062568 |
| GCST001965-Glycemic traits | Inverse variance weighted | 2 | 0.02264 | 0.069388 | 0.744209 | 0.998684 | -0.11336 | 0.15864 | 1.022898 | 0.892829 | 1.171916 |
| GCST005787-Heart rate response to exercise | Inverse variance weighted | 15 | 0.003116 | 0.009584 | 0.745124 | 0.998684 | -0.01567 | 0.0219 | 1.00312 | 0.984453 | 1.022142 |
| GCST004342-Vaccenic acid \(18:1n-7\) levels | Inverse variance weighted | 2 | 0.327802 | 1.009641 | 0.745429 | 0.998684 | -1.65109 | 2.306699 | 1.387915 | 0.19184 | 10.04123 |
| GCST004008-Red blood cell count | Inverse variance weighted | 2 | 0.516329 | 1.590589 | 0.745473 | 0.998684 | -2.60123 | 3.633884 | 1.675864 | 0.074183 | 37.85958 |
| GCST003378-Response to lithium treatment in bipolar disorder | Inverse variance weighted | 2 | 0.007042 | 0.021746 | 0.746069 | 0.998684 | -0.03558 | 0.049664 | 1.007067 | 0.965046 | 1.050917 |
| GCST004622-Reticulocyte count | Inverse variance weighted | 96 | 0.020408 | 0.063287 | 0.747098 | 0.998684 | -0.10363 | 0.144451 | 1.020618 | 0.901555 | 1.155405 |
| GCST006143-Bone mineral density \(total hip\) | Inverse variance weighted | 2 | -0.02084 | 0.064713 | 0.747386 | 0.998684 | -0.14768 | 0.105993 | 0.979373 | 0.862707 | 1.111815 |
| GCST007943-Medication use \(antihistamines for systemic use\) | Inverse variance weighted | 6 | -0.02704 | 0.084043 | 0.747676 | 0.998684 | -0.19176 | 0.137687 | 0.973325 | 0.825504 | 1.147617 |
| GCST004610-White blood cell count | Inverse variance weighted | 74 | 0.026547 | 0.082644 | 0.748045 | 0.998684 | -0.13544 | 0.188529 | 1.026902 | 0.873336 | 1.207472 |
| GCST000221-Type 2 diabetes | Inverse variance weighted | 3 | 0.017498 | 0.054522 | 0.748265 | 0.998684 | -0.08937 | 0.12436 | 1.017652 | 0.914512 | 1.132424 |
| GCST000028-Type 2 diabetes | Inverse variance weighted | 3 | 0.023073 | 0.072576 | 0.750551 | 0.998684 | -0.11918 | 0.165322 | 1.023341 | 0.887651 | 1.179773 |
| GCST008076-Triglyceride levels | Inverse variance weighted | 11 | 0.062043 | 0.195244 | 0.75066 | 0.998684 | -0.32064 | 0.444721 | 1.064008 | 0.725688 | 1.560055 |
| GCST005827-Estrone levels | Inverse variance weighted | 3 | 0.002444 | 0.007698 | 0.7509 | 0.998684 | -0.01264 | 0.017532 | 1.002447 | 0.987435 | 1.017686 |
| GCST001932-Hair color | Inverse variance weighted | 4 | 0.012242 | 0.038577 | 0.750988 | 0.998684 | -0.06337 | 0.087852 | 1.012317 | 0.938598 | 1.091826 |
| GCST000650-Systemic sclerosis | Inverse variance weighted | 2 | -0.01511 | 0.047802 | 0.751888 | 0.998684 | -0.10881 | 0.07858 | 0.985001 | 0.896905 | 1.08175 |
| GCST003021-Brown vs. non-brown hair color | Inverse variance weighted | 3 | 0.009605 | 0.030446 | 0.752391 | 0.998684 | -0.05007 | 0.06928 | 1.009652 | 0.951164 | 1.071736 |
| GCST003022-Light vs. dark hair color | Inverse variance weighted | 3 | 0.008013 | 0.025442 | 0.752794 | 0.998684 | -0.04185 | 0.05788 | 1.008045 | 0.95901 | 1.059587 |
| GCST003721-Migraine without aura | Inverse variance weighted | 3 | 0.022018 | 0.070166 | 0.753679 | 0.998684 | -0.11551 | 0.159544 | 1.022262 | 0.890913 | 1.172976 |
| GCST007278-Systemic seropositive rheumatic diseases \(Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies\) | Inverse variance weighted | 10 | 0.013829 | 0.044089 | 0.753785 | 0.998684 | -0.07259 | 0.100243 | 1.013925 | 0.929986 | 1.10544 |
| GCST005538-Sarcoidosis | Inverse variance weighted | 5 | -0.01726 | 0.055028 | 0.753793 | 0.998684 | -0.12511 | 0.090596 | 0.982889 | 0.882396 | 1.094827 |
| GCST006409-Allergic rhinitis | Inverse variance weighted | 21 | -0.02865 | 0.091443 | 0.754043 | 0.998684 | -0.20788 | 0.150577 | 0.971756 | 0.812306 | 1.162505 |
| GCST001251-Pulmonary function | Inverse variance weighted | 3 | -0.1378 | 0.44171 | 0.755062 | 0.998684 | -1.00355 | 0.727951 | 0.871272 | 0.366575 | 2.070833 |
| GCST000562-PR interval | Inverse variance weighted | 6 | -0.00093 | 0.00299 | 0.755401 | 0.998684 | -0.00679 | 0.00493 | 0.999069 | 0.99323 | 1.004942 |
| GCST000974-HDL cholesterol | Inverse variance weighted | 4 | 0.021462 | 0.069486 | 0.757429 | 0.998684 | -0.11473 | 0.157655 | 1.021693 | 0.891605 | 1.170762 |
| GCST003973-Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI | Inverse variance weighted | 2 | -0.00064 | 0.002057 | 0.757457 | 0.998684 | -0.00467 | 0.003397 | 0.999365 | 0.995343 | 1.003403 |
| GCST004604-Hematocrit | Inverse variance weighted | 62 | 0.019507 | 0.063512 | 0.758732 | 0.998684 | -0.10498 | 0.143991 | 1.019699 | 0.900346 | 1.154873 |
| GCST002110-Glycemic traits \(pregnancy\) | Inverse variance weighted | 6 | 0.026365 | 0.08601 | 0.759195 | 0.998684 | -0.14221 | 0.194946 | 1.026716 | 0.867435 | 1.215245 |
| GCST007838-Glycine levels | Inverse variance weighted | 5 | -0.01493 | 0.048747 | 0.759381 | 0.998684 | -0.11047 | 0.080613 | 0.98518 | 0.895409 | 1.083952 |
| GCST006288-Heel bone mineral density | Inverse variance weighted | 151 | -0.01289 | 0.042158 | 0.75982 | 0.998684 | -0.09552 | 0.069741 | 0.987194 | 0.908902 | 1.07223 |
| GCST002335-Bone properties \(heel\) | Inverse variance weighted | 7 | -0.02492 | 0.0817 | 0.760319 | 0.998684 | -0.18506 | 0.135209 | 0.975384 | 0.831058 | 1.144776 |
| GCST007103-QRS duration | Inverse variance weighted | 18 | 0.002758 | 0.009075 | 0.761207 | 0.998684 | -0.01503 | 0.020545 | 1.002762 | 0.985083 | 1.020757 |
| GCST004351-Bone ultrasound measurement \(broadband ultrasound attenuation\) | Inverse variance weighted | 4 | 0.025035 | 0.082547 | 0.76167 | 0.998684 | -0.13676 | 0.186827 | 1.025351 | 0.872183 | 1.205418 |
| GCST006701-Parental longevity \(father's attained age\) | Inverse variance weighted | 6 | 0.168792 | 0.562072 | 0.763945 | 0.998684 | -0.93287 | 1.270453 | 1.183874 | 0.393424 | 3.562465 |
| GCST002539-Schizophrenia | Inverse variance weighted | 55 | -0.01237 | 0.041311 | 0.764538 | 0.998684 | -0.09334 | 0.068596 | 0.987702 | 0.91088 | 1.071004 |
| GCST007721-Urinary potassium to creatinine ratio | Inverse variance weighted | 3 | 0.119369 | 0.398897 | 0.764751 | 0.998684 | -0.66247 | 0.901208 | 1.126786 | 0.515577 | 2.462576 |
| GCST008161-Waist circumference adjusted for body mass index | Inverse variance weighted | 3 | 0.075716 | 0.253692 | 0.765354 | 0.998684 | -0.42152 | 0.572952 | 1.078657 | 0.656049 | 1.773495 |
| GCST007554-Autism and educational attainment \(MTAG\) | Inverse variance weighted | 3 | -0.08065 | 0.271131 | 0.766117 | 0.998684 | -0.61207 | 0.450767 | 0.922517 | 0.542229 | 1.569515 |
| GCST003403-Vascular endothelial growth factor levels | Inverse variance weighted | 4 | 0.045006 | 0.15147 | 0.766367 | 0.998684 | -0.25188 | 0.341888 | 1.046035 | 0.777342 | 1.407603 |
| GCST007982-Sleep duration | Inverse variance weighted | 30 | -0.06756 | 0.227715 | 0.766716 | 0.998684 | -0.51388 | 0.378765 | 0.934675 | 0.598171 | 1.460479 |
| GCST008110-Insulinogenic index | Inverse variance weighted | 3 | -0.08256 | 0.278509 | 0.766909 | 0.998684 | -0.62843 | 0.463321 | 0.92076 | 0.533427 | 1.589344 |
| GCST003944-Hepcidin/ferritin ratio | Inverse variance weighted | 3 | 0.019783 | 0.066752 | 0.766945 | 0.998684 | -0.11105 | 0.150616 | 1.01998 | 0.894894 | 1.162551 |
| GCST007878-Urea levels | Inverse variance weighted | 2 | 0.04874 | 0.165428 | 0.768277 | 0.998684 | -0.2755 | 0.372979 | 1.049947 | 0.759193 | 1.452054 |
| GCST000463-Acute lymphoblastic leukemia \(childhood\) | Inverse variance weighted | 2 | -0.01017 | 0.034551 | 0.768418 | 0.998684 | -0.07789 | 0.057546 | 0.989878 | 0.925064 | 1.059234 |
| GCST002580-Intraocular pressure | Inverse variance weighted | 8 | 0.010633 | 0.036187 | 0.768873 | 0.998684 | -0.06029 | 0.081559 | 1.01069 | 0.941489 | 1.084977 |
| GCST007581-Carpal tunnel syndrome | Inverse variance weighted | 6 | -0.02283 | 0.077852 | 0.769311 | 0.998684 | -0.17542 | 0.129757 | 0.977427 | 0.839104 | 1.138552 |
| GCST001199-Iris characteristics | Inverse variance weighted | 2 | -0.02229 | 0.076027 | 0.769358 | 0.998684 | -0.17131 | 0.126721 | 0.977954 | 0.842564 | 1.1351 |
| GCST000210-Soluble ICAM-1 | Inverse variance weighted | 3 | -0.0002 | 0.000695 | 0.770454 | 0.998684 | -0.00156 | 0.001159 | 0.999797 | 0.998437 | 1.00116 |
| GCST007387-Insomnia symptoms \(never/rarely vs. sometimes/usually\) | Inverse variance weighted | 15 | 0.044162 | 0.151589 | 0.7708 | 0.998684 | -0.25295 | 0.341276 | 1.045152 | 0.776506 | 1.406741 |
| GCST007382-Plasma free amino acid levels \(adjusted for twenty other PFAAs\) | Inverse variance weighted | 24 | 0.00449 | 0.015455 | 0.771404 | 0.998684 | -0.0258 | 0.034781 | 1.0045 | 0.974529 | 1.035393 |
| GCST004772-Bone mineral density \(paediatric, total body less head\) | Inverse variance weighted | 5 | 0.025165 | 0.086624 | 0.771432 | 0.998684 | -0.14462 | 0.194949 | 1.025484 | 0.865352 | 1.215248 |
| GCST007638-Glycine levels | Inverse variance weighted | 13 | -0.01689 | 0.058327 | 0.772173 | 0.998684 | -0.13121 | 0.097433 | 0.983254 | 0.877035 | 1.102338 |
| GCST003770-Neuroticism | Inverse variance weighted | 5 | 0.097866 | 0.34343 | 0.77567 | 0.998684 | -0.57526 | 0.770989 | 1.102815 | 0.562561 | 2.161902 |
| GCST004015-Extraversion | Inverse variance weighted | 3 | -0.12637 | 0.443762 | 0.775827 | 0.998684 | -0.99614 | 0.743408 | 0.881292 | 0.369302 | 2.10309 |
| GCST003972-Visceral adipose tissue/subcutaneous adipose tissue ratio | Inverse variance weighted | 2 | -0.00055 | 0.001933 | 0.776103 | 0.998684 | -0.00434 | 0.003239 | 0.99945 | 0.995671 | 1.003244 |
| GCST007157-Corneal astigmatism | Inverse variance weighted | 2 | 0.048889 | 0.17212 | 0.776378 | 0.998684 | -0.28847 | 0.386244 | 1.050104 | 0.749413 | 1.471444 |
| GCST001220-Metabolite levels | Inverse variance weighted | 2 | 0.004836 | 0.017267 | 0.779429 | 0.998684 | -0.02901 | 0.038678 | 1.004847 | 0.97141 | 1.039436 |
| GCST000959-Parkinson's disease | Inverse variance weighted | 6 | -0.02095 | 0.075553 | 0.781558 | 0.998684 | -0.16903 | 0.127135 | 0.979268 | 0.844479 | 1.13557 |
| GCST007341-Well-being spectrum \(multivariate analysis\) | Inverse variance weighted | 152 | 0.063889 | 0.230688 | 0.781818 | 0.998684 | -0.38826 | 0.516039 | 1.065974 | 0.678236 | 1.675378 |
| GCST002331-Basal cell carcinoma | Inverse variance weighted | 6 | -0.01446 | 0.052225 | 0.781885 | 0.998684 | -0.11682 | 0.087902 | 0.985645 | 0.889745 | 1.091881 |
| GCST005306-Atrial fibrillation | Inverse variance weighted | 5 | 0.019235 | 0.069645 | 0.782408 | 0.998684 | -0.11727 | 0.155738 | 1.019421 | 0.889346 | 1.16852 |
| GCST004613-Sum neutrophil eosinophil counts | Inverse variance weighted | 68 | 0.023564 | 0.08535 | 0.782483 | 0.998684 | -0.14372 | 0.190851 | 1.023844 | 0.866128 | 1.210279 |
| GCST002033-Malaria | Inverse variance weighted | 2 | -0.00789 | 0.028794 | 0.784093 | 0.998684 | -0.06433 | 0.048547 | 0.992142 | 0.937699 | 1.049745 |
| GCST002811-Nonsyndromic cleft lip with or without cleft palate | Inverse variance weighted | 4 | -0.00968 | 0.035323 | 0.784136 | 0.998684 | -0.07891 | 0.059556 | 0.990371 | 0.924124 | 1.061366 |
| GCST005014-Tonsillectomy | Inverse variance weighted | 15 | -0.0197 | 0.072123 | 0.784704 | 0.998684 | -0.16107 | 0.121658 | 0.980489 | 0.851237 | 1.129368 |
| GCST000975-LDL cholesterol | Inverse variance weighted | 3 | -0.02267 | 0.083067 | 0.784918 | 0.998684 | -0.18548 | 0.140141 | 0.977585 | 0.830704 | 1.150436 |
| GCST004430-Interleukin-16 levels | Inverse variance weighted | 3 | -0.00945 | 0.034657 | 0.78515 | 0.998684 | -0.07738 | 0.05848 | 0.990596 | 0.925542 | 1.060224 |
| GCST006920-Regular attendance at a gym or sports club | Inverse variance weighted | 4 | 0.417114 | 1.531488 | 0.785346 | 0.998684 | -2.5846 | 3.418831 | 1.517576 | 0.075426 | 30.5337 |
| GCST001905-Hypertriglyceridemia | Inverse variance weighted | 2 | -0.00822 | 0.030214 | 0.785665 | 0.998684 | -0.06744 | 0.051004 | 0.991817 | 0.934787 | 1.052327 |
| GCST001785-Crohn's disease | Inverse variance weighted | 3 | -0.00898 | 0.033238 | 0.787002 | 0.998684 | -0.07413 | 0.056166 | 0.991059 | 0.928553 | 1.057773 |
| GCST007002-Cerebrospinal fluid t-tau levels in normal cognition | Inverse variance weighted | 2 | 0.006935 | 0.025678 | 0.787087 | 0.998684 | -0.04339 | 0.057264 | 1.00696 | 0.957535 | 1.058935 |
| GCST005109-Progranulin levels | Inverse variance weighted | 2 | -0.07244 | 0.268217 | 0.787111 | 0.998684 | -0.59814 | 0.453269 | 0.930126 | 0.549833 | 1.573448 |
| GCST007353-Generalized epilepsy | Inverse variance weighted | 6 | 0.00031 | 0.00115 | 0.787271 | 0.998684 | -0.00194 | 0.002564 | 1.00031 | 0.998059 | 1.002567 |
| GCST004348-Non-glioblastoma glioma | Inverse variance weighted | 7 | -0.011 | 0.040931 | 0.788102 | 0.998684 | -0.09123 | 0.069223 | 0.989059 | 0.912812 | 1.071675 |
| GCST002671-Toenail selenium levels | Inverse variance weighted | 3 | 0.092736 | 0.345136 | 0.788164 | 0.998684 | -0.58373 | 0.769204 | 1.097173 | 0.557813 | 2.158048 |
| GCST003184-Atopic dermatitis | Inverse variance weighted | 6 | 0.023249 | 0.086527 | 0.788169 | 0.998684 | -0.14634 | 0.192841 | 1.023521 | 0.863861 | 1.21269 |
| GCST004886-Alcohol consumption | Inverse variance weighted | 5 | -0.12149 | 0.452447 | 0.788303 | 0.998684 | -1.00828 | 0.765307 | 0.885601 | 0.364844 | 2.149653 |
| GCST004063-Waist circumference adjusted for body mass index | Inverse variance weighted | 57 | -0.02408 | 0.090322 | 0.789792 | 0.998684 | -0.20111 | 0.152953 | 0.976209 | 0.817823 | 1.16527 |
| GCST000495-Bone mineral density \(hip\) | Inverse variance weighted | 5 | -0.02455 | 0.092239 | 0.790159 | 0.998684 | -0.20533 | 0.156243 | 0.975754 | 0.814375 | 1.169111 |
| GCST001792-Colorectal cancer | Inverse variance weighted | 3 | 0.02344 | 0.088707 | 0.791591 | 0.998684 | -0.15043 | 0.197306 | 1.023717 | 0.860342 | 1.218117 |
| GCST000830-Body mass index | Inverse variance weighted | 23 | -0.0119 | 0.04508 | 0.791765 | 0.998684 | -0.10026 | 0.076454 | 0.988169 | 0.904604 | 1.079453 |
| GCST004824-P wave terminal force | Inverse variance weighted | 6 | 1.62E-05 | 6.20E-05 | 0.794309 | 0.998684 | -0.00011 | 0.000138 | 1.000016 | 0.999895 | 1.000138 |
| GCST007402-Factor VII activity or levels | Inverse variance weighted | 3 | -0.43083 | 1.655016 | 0.794617 | 0.998684 | -3.67467 | 2.812997 | 0.649967 | 0.025358 | 16.65976 |
| GCST002056-Osteosarcoma | Inverse variance weighted | 2 | -0.02402 | 0.092287 | 0.794627 | 0.998684 | -0.2049 | 0.156859 | 0.976263 | 0.814725 | 1.169831 |
| GCST006463-Urinary albumin excretion \(no hypertensive medication\) | Inverse variance weighted | 12 | 0.108916 | 0.418546 | 0.79469 | 0.998684 | -0.71143 | 0.929266 | 1.115069 | 0.49094 | 2.53265 |
| GCST004429-Stem cell factor levels | Inverse variance weighted | 2 | 0.065828 | 0.25314 | 0.794828 | 0.998684 | -0.43033 | 0.561984 | 1.068043 | 0.650296 | 1.754149 |
| GCST000532-Beta thalassemia/hemoglobin E disease | Inverse variance weighted | 2 | -0.00328 | 0.012705 | 0.796371 | 0.998684 | -0.02818 | 0.021623 | 0.996727 | 0.972214 | 1.021858 |
| GCST001876-Pubertal anthropometrics | Inverse variance weighted | 2 | -0.0314 | 0.122593 | 0.797854 | 0.998684 | -0.27168 | 0.208884 | 0.969089 | 0.762096 | 1.232302 |
| GCST005080-PR interval | Inverse variance weighted | 7 | 0.000653 | 0.002549 | 0.797859 | 0.998684 | -0.00434 | 0.005649 | 1.000653 | 0.995666 | 1.005665 |
| GCST000538-Adiponectin levels | Inverse variance weighted | 3 | 0.005446 | 0.02128 | 0.798012 | 0.998684 | -0.03626 | 0.047154 | 1.005461 | 0.964387 | 1.048283 |
| GCST004632-Lymphocyte percentage of white cells | Inverse variance weighted | 58 | -0.02126 | 0.083204 | 0.798288 | 0.998684 | -0.18434 | 0.141816 | 0.978961 | 0.83165 | 1.152365 |
| GCST007703-Systolic blood pressure | Inverse variance weighted | 69 | -0.00103 | 0.004055 | 0.798647 | 0.998684 | -0.00898 | 0.006914 | 0.998966 | 0.991058 | 1.006938 |
| GCST001006-Waist Circumference - Triglycerides \(WC-TG\) | Inverse variance weighted | 5 | 0.009873 | 0.03889 | 0.799595 | 0.998684 | -0.06635 | 0.086097 | 1.009922 | 0.935802 | 1.089912 |
| GCST004259-Mean arterial pressure \(long-term average\) | Inverse variance weighted | 3 | -0.0059 | 0.02336 | 0.800562 | 0.998684 | -0.05169 | 0.039884 | 0.994116 | 0.949627 | 1.04069 |
| GCST005952-Body mass index \(age&gt;50\) | Inverse variance weighted | 5 | 0.069029 | 0.275169 | 0.80192 | 0.998684 | -0.4703 | 0.60836 | 1.071468 | 0.624814 | 1.837415 |
| GCST002483-Lung function \(forced vital capacity\) | Inverse variance weighted | 4 | 0.000104 | 0.000417 | 0.802518 | 0.998684 | -0.00071 | 0.000921 | 1.000104 | 0.999288 | 1.000921 |
| GCST005328-Subjective well-being | Inverse variance weighted | 8 | 0.104986 | 0.42018 | 0.802696 | 0.998684 | -0.71857 | 0.92854 | 1.110695 | 0.48745 | 2.53081 |
| GCST003401-Glomerular filtration rate in non diabetics \(creatinine\) | Inverse variance weighted | 25 | 0.107918 | 0.431943 | 0.802708 | 0.998684 | -0.73869 | 0.954527 | 1.113957 | 0.477739 | 2.597441 |
| GCST008281-Hip bone size | Inverse variance weighted | 5 | -0.03285 | 0.131814 | 0.803202 | 0.998684 | -0.2912 | 0.225506 | 0.967685 | 0.747363 | 1.252957 |
| GCST005776-High density lipoprotein cholesterol levels | Inverse variance weighted | 6 | 0.000722 | 0.002915 | 0.804475 | 0.998684 | -0.00499 | 0.006436 | 1.000722 | 0.99502 | 1.006457 |
| GCST007159-Corneal astigmatism | Inverse variance weighted | 2 | -0.13296 | 0.537993 | 0.804798 | 0.998684 | -1.18743 | 0.921506 | 0.8755 | 0.305005 | 2.513072 |
| GCST002542-Electrocardiographic traits | Inverse variance weighted | 2 | -0.00112 | 0.004555 | 0.806582 | 0.998684 | -0.01004 | 0.007812 | 0.998885 | 0.990008 | 1.007843 |
| GCST004482-Peripheral arterial disease \(traffic-related air pollution interaction\) | Inverse variance weighted | 3 | -0.00108 | 0.004426 | 0.806615 | 0.998684 | -0.00976 | 0.007591 | 0.998917 | 0.990289 | 1.00762 |
| GCST001200-Graves' disease | Inverse variance weighted | 2 | -0.01838 | 0.075221 | 0.806921 | 0.998684 | -0.16582 | 0.129049 | 0.981784 | 0.847201 | 1.137746 |
| GCST005350-Total body bone mineral density \(age 45-60\) | Inverse variance weighted | 10 | -0.01601 | 0.065823 | 0.807838 | 0.998684 | -0.14502 | 0.113004 | 0.984118 | 0.865003 | 1.119636 |
| GCST006717-Alcohol use disorder \(dependence and problematic use scores\) | Inverse variance weighted | 2 | 1.197688 | 4.931302 | 0.808103 | 0.998684 | -8.46766 | 10.86304 | 3.312449 | 0.00021 | 52210.56 |
| GCST008087-Triglyceride levels in current drinkers | Inverse variance weighted | 15 | 0.038553 | 0.159691 | 0.80923 | 0.998684 | -0.27444 | 0.351548 | 1.039305 | 0.759996 | 1.421265 |
| GCST004571-Iron status biomarkers \(total iron binding capacity\) | Inverse variance weighted | 2 | 0.012807 | 0.053174 | 0.809674 | 0.998684 | -0.09141 | 0.117027 | 1.012889 | 0.91264 | 1.12415 |
| GCST001147-Prostate cancer | Inverse variance weighted | 6 | 0.018381 | 0.076425 | 0.809936 | 0.998684 | -0.13141 | 0.168174 | 1.018551 | 0.876856 | 1.183142 |
| GCST000396-Diastolic blood pressure | Inverse variance weighted | 3 | -0.00855 | 0.035614 | 0.810168 | 0.998684 | -0.07836 | 0.061249 | 0.991482 | 0.924632 | 1.063164 |
| GCST007706-Mean arterial pressure | Inverse variance weighted | 69 | -0.00139 | 0.005814 | 0.810551 | 0.998684 | -0.01279 | 0.010003 | 0.998607 | 0.987291 | 1.010053 |
| GCST002652-Cotinine glucuronidation | Inverse variance weighted | 2 | -0.16384 | 0.68401 | 0.8107 | 0.998684 | -1.5045 | 1.176823 | 0.848881 | 0.222129 | 3.244051 |
| GCST005958-Waist-to-hip ratio adjusted for BMI \(age &gt;50\) | Inverse variance weighted | 5 | -0.07899 | 0.330749 | 0.811235 | 0.998684 | -0.72726 | 0.569274 | 0.924046 | 0.48323 | 1.766984 |
| GCST002457-P wave duration | Inverse variance weighted | 2 | 0.002329 | 0.009794 | 0.812063 | 0.998684 | -0.01687 | 0.021526 | 1.002331 | 0.983273 | 1.021759 |
| GCST000588-Red blood cell count | Inverse variance weighted | 6 | -0.03274 | 0.138203 | 0.812717 | 0.998684 | -0.30362 | 0.238134 | 0.967787 | 0.738141 | 1.268879 |
| GCST002497-Blood pressure | Inverse variance weighted | 3 | 0.002305 | 0.009737 | 0.812874 | 0.998684 | -0.01678 | 0.021389 | 1.002308 | 0.983361 | 1.02162 |
| GCST007460-Smoking cessation | Inverse variance weighted | 13 | -0.04907 | 0.207476 | 0.813045 | 0.998684 | -0.45572 | 0.357585 | 0.952117 | 0.633991 | 1.429872 |
| GCST006483-Lung function \(FVC\) | Inverse variance weighted | 13 | \#\#\#\#\#\#\#\# | 0.000249 | 0.813573 | 0.998684 | -0.00055 | 0.00043 | 0.999941 | 0.999453 | 1.00043 |
| GCST000262-Intracranial aneurysm | Inverse variance weighted | 3 | -0.00949 | 0.040418 | 0.814402 | 0.998684 | -0.08871 | 0.069731 | 0.990557 | 0.915113 | 1.07222 |
| GCST004185-Lung function \(FEV1/FVC\) | Inverse variance weighted | 19 | 0.030259 | 0.130315 | 0.816386 | 0.998684 | -0.22516 | 0.285676 | 1.030721 | 0.798389 | 1.330662 |
| GCST005524-Autoimmune thyroid diseases \(Graves disease or Hashimoto's thyroiditis\) | Inverse variance weighted | 3 | 0.007923 | 0.034314 | 0.817382 | 0.998684 | -0.05933 | 0.075178 | 1.007955 | 0.942394 | 1.078076 |
| GCST004986-Idiopathic pulmonary fibrosis | Inverse variance weighted | 2 | -0.03645 | 0.15846 | 0.818068 | 0.998684 | -0.34703 | 0.27413 | 0.964206 | 0.706783 | 1.315386 |
| GCST005582-Coronary artery disease | Inverse variance weighted | 2 | 0.015861 | 0.06906 | 0.818349 | 0.998684 | -0.1195 | 0.151219 | 1.015987 | 0.887366 | 1.163252 |
| GCST007935-Medication use \(drugs affecting bone structure and mineralization\) | Inverse variance weighted | 5 | -0.0158 | 0.068858 | 0.818499 | 0.998684 | -0.15076 | 0.119161 | 0.984323 | 0.860051 | 1.126551 |
| GCST007131-Low density lipoprotein cholesterol levels | Inverse variance weighted | 6 | -0.1143 | 0.500339 | 0.819293 | 0.998684 | -1.09497 | 0.866359 | 0.891986 | 0.33455 | 2.378237 |
| GCST007045-PR interval | Inverse variance weighted | 27 | 0.000555 | 0.002457 | 0.821167 | 0.998684 | -0.00426 | 0.005372 | 1.000556 | 0.995748 | 1.005386 |
| GCST002773-Gout | Inverse variance weighted | 2 | 0.00673 | 0.030156 | 0.823413 | 0.998684 | -0.05238 | 0.065836 | 1.006752 | 0.948971 | 1.068052 |
| GCST008064-Chronic kidney disease | Inverse variance weighted | 13 | 0.014101 | 0.063254 | 0.823587 | 0.998684 | -0.10988 | 0.138079 | 1.014201 | 0.895945 | 1.148066 |
| GCST002304-Fractional exhaled nitric oxide \(childhood\) | Inverse variance weighted | 2 | 0.031767 | 0.1425 | 0.823594 | 0.998684 | -0.24753 | 0.311066 | 1.032277 | 0.780725 | 1.36488 |
| GCST000544-Pulmonary function | Inverse variance weighted | 4 | 0.035995 | 0.161775 | 0.823926 | 0.998684 | -0.28108 | 0.353074 | 1.03665 | 0.754964 | 1.423436 |
| GCST006408-Allergic sensitization | Inverse variance weighted | 6 | 0.010609 | 0.04778 | 0.824278 | 0.998684 | -0.08304 | 0.104258 | 1.010666 | 0.920315 | 1.109886 |
| GCST007227-QRS duration | Inverse variance weighted | 8 | -0.00171 | 0.007794 | 0.826144 | 0.998684 | -0.01699 | 0.013565 | 0.998289 | 0.983155 | 1.013657 |
| GCST001049-D-dimer levels | Inverse variance weighted | 3 | 0.000285 | 0.001307 | 0.827567 | 0.998684 | -0.00228 | 0.002847 | 1.000285 | 0.997725 | 1.002851 |
| GCST007930-Medication use \(agents acting on the renin-angiotensin system\) | Inverse variance weighted | 117 | 0.011 | 0.050783 | 0.82851 | 0.998684 | -0.08853 | 0.110535 | 1.011061 | 0.915271 | 1.116876 |
| GCST000240-HDL cholesterol | Inverse variance weighted | 3 | 0.001007 | 0.004648 | 0.828571 | 0.998684 | -0.0081 | 0.010117 | 1.001007 | 0.991929 | 1.010168 |
| GCST000394-Diastolic blood pressure | Inverse variance weighted | 3 | 0.012159 | 0.056181 | 0.828661 | 0.998684 | -0.09796 | 0.122274 | 1.012233 | 0.906688 | 1.130064 |
| GCST000430-C-reactive protein | Inverse variance weighted | 4 | -0.00012 | 0.000565 | 0.828737 | 0.998684 | -0.00123 | 0.000985 | 0.999878 | 0.998771 | 1.000986 |
| GCST004787-Coronary artery disease \(myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease\) | Inverse variance weighted | 27 | 0.020786 | 0.096127 | 0.828808 | 0.998684 | -0.16762 | 0.209196 | 1.021003 | 0.845672 | 1.232686 |
| GCST000847-Retinal vascular caliber | Inverse variance weighted | 3 | 0.002229 | 0.010337 | 0.829246 | 0.998684 | -0.01803 | 0.02249 | 1.002232 | 0.98213 | 1.022745 |
| GCST001137-White blood cell count | Inverse variance weighted | 5 | -0.08506 | 0.39443 | 0.829268 | 0.998684 | -0.85814 | 0.688029 | 0.918462 | 0.42395 | 1.989789 |
| GCST007857-Fasting blood insulin adjusted for BMI | Inverse variance weighted | 2 | -0.11216 | 0.52151 | 0.829718 | 0.998684 | -1.13432 | 0.910003 | 0.893904 | 0.321642 | 2.484329 |
| GCST002456-PR segment | Inverse variance weighted | 7 | 0.000751 | 0.003502 | 0.830088 | 0.998684 | -0.00611 | 0.007615 | 1.000752 | 0.993906 | 1.007644 |
| GCST006899-Thyroid stimulating hormone levels | Inverse variance weighted | 13 | -0.02696 | 0.126654 | 0.831439 | 0.998684 | -0.2752 | 0.221283 | 0.973401 | 0.759419 | 1.247677 |
| GCST000360-Warfarin maintenance dose | Inverse variance weighted | 2 | -0.00843 | 0.039742 | 0.831985 | 0.998684 | -0.08633 | 0.069463 | 0.991604 | 0.917296 | 1.071932 |
| GCST007472-Alcohol consumption \(drinks per week\) \(MTAG\) | Inverse variance weighted | 85 | 0.047764 | 0.225405 | 0.832183 | 0.998684 | -0.39403 | 0.489558 | 1.048923 | 0.674334 | 1.631595 |
| GCST000581-Urate levels | Inverse variance weighted | 4 | 0.019508 | 0.09317 | 0.834148 | 0.998684 | -0.16311 | 0.202122 | 1.0197 | 0.849502 | 1.223998 |
| GCST002078-Migraine without aura | Inverse variance weighted | 3 | -0.01446 | 0.069653 | 0.835492 | 0.998684 | -0.15098 | 0.122056 | 0.98564 | 0.859861 | 1.129817 |
| GCST000592-Systemic lupus erythematosus | Inverse variance weighted | 2 | 0.010927 | 0.053308 | 0.837584 | 0.998684 | -0.09356 | 0.115411 | 1.010987 | 0.910687 | 1.122334 |
| GCST000964-Ulcerative colitis | Inverse variance weighted | 29 | 0.005784 | 0.028806 | 0.840867 | 0.998684 | -0.05068 | 0.062243 | 1.005801 | 0.950587 | 1.064221 |
| GCST002322-Asthma and hay fever | Inverse variance weighted | 8 | -0.01631 | 0.081352 | 0.841067 | 0.998684 | -0.17576 | 0.143137 | 0.983819 | 0.838816 | 1.153888 |
| GCST002021-Body mass index | Inverse variance weighted | 4 | -0.02467 | 0.123131 | 0.841171 | 0.998684 | -0.26601 | 0.216663 | 0.975627 | 0.76643 | 1.241925 |
| GCST000703-Phosphorus levels | Inverse variance weighted | 3 | 0.09004 | 0.449789 | 0.841337 | 0.998684 | -0.79155 | 0.971627 | 1.094218 | 0.453143 | 2.64224 |
| GCST001103-Alcohol consumption \(transferrin glycosylation\) | Inverse variance weighted | 5 | 0.005189 | 0.026297 | 0.843563 | 0.998684 | -0.04635 | 0.056731 | 1.005203 | 0.954705 | 1.058371 |
| GCST001242-Schizophrenia | Inverse variance weighted | 5 | 0.007478 | 0.038279 | 0.84512 | 0.998684 | -0.06755 | 0.082505 | 1.007506 | 0.934682 | 1.086004 |
| GCST000296-Body mass index | Inverse variance weighted | 8 | -0.00031 | 0.001592 | 0.846009 | 0.998684 | -0.00343 | 0.00281 | 0.999691 | 0.996577 | 1.002814 |
| GCST008047-Platelet count | Inverse variance weighted | 5 | 0.00036 | 0.001867 | 0.847153 | 0.998684 | -0.0033 | 0.004019 | 1.00036 | 0.996706 | 1.004027 |
| GCST000872-QRS duration | Inverse variance weighted | 6 | 0.002477 | 0.012869 | 0.847379 | 0.998684 | -0.02275 | 0.0277 | 1.00248 | 0.97751 | 1.028088 |
| GCST001316-IgE levels | Inverse variance weighted | 4 | 0.021539 | 0.112061 | 0.847577 | 0.998684 | -0.1981 | 0.241179 | 1.021773 | 0.820288 | 1.272748 |
| GCST004093-Prostate-specific antigen levels | Inverse variance weighted | 13 | -0.01405 | 0.07331 | 0.848002 | 0.998684 | -0.15774 | 0.129636 | 0.986047 | 0.854073 | 1.138414 |
| GCST004399-Lipoprotein\(a\) levels adjusted for apolipoprotein\(a\) isoforms | Inverse variance weighted | 8 | -0.00077 | 0.004038 | 0.849655 | 0.998684 | -0.00868 | 0.00715 | 0.999235 | 0.991357 | 1.007176 |
| GCST004213-Resting heart rate | Inverse variance weighted | 2 | 0.003286 | 0.017341 | 0.849696 | 0.998684 | -0.0307 | 0.037275 | 1.003292 | 0.969764 | 1.037978 |
| GCST003154-Peripheral artery disease | Inverse variance weighted | 2 | -0.02301 | 0.122015 | 0.85039 | 0.998684 | -0.26216 | 0.216135 | 0.977248 | 0.769385 | 1.24127 |
| GCST001885-Height | Inverse variance weighted | 2 | 0.027751 | 0.148725 | 0.851982 | 0.998684 | -0.26375 | 0.319252 | 1.028139 | 0.768165 | 1.376099 |
| GCST005788-Heart rate response to recovery post exercise | Inverse variance weighted | 14 | -0.00207 | 0.011108 | 0.852002 | 0.998684 | -0.02384 | 0.019699 | 0.99793 | 0.976439 | 1.019894 |
| GCST004614-Granulocyte count | Inverse variance weighted | 68 | 0.016566 | 0.088932 | 0.85223 | 0.998684 | -0.15774 | 0.190873 | 1.016704 | 0.85407 | 1.210306 |
| GCST004288-Adolescent idiopathic scoliosis | Inverse variance weighted | 4 | -0.00567 | 0.030781 | 0.85382 | 0.998684 | -0.066 | 0.05466 | 0.994345 | 0.936128 | 1.056182 |
| GCST008129-Body mass index | Inverse variance weighted | 48 | -0.03174 | 0.172678 | 0.85414 | 0.998684 | -0.37019 | 0.306705 | 0.968754 | 0.6906 | 1.358939 |
| GCST007929-Medication use \(calcium channel blockers\) | Inverse variance weighted | 63 | 0.01151 | 0.063376 | 0.855881 | 0.998684 | -0.11271 | 0.135728 | 1.011577 | 0.893412 | 1.145371 |
| GCST002022-Testicular germ cell tumor | Inverse variance weighted | 11 | -0.0031 | 0.017144 | 0.856448 | 0.998684 | -0.0367 | 0.030501 | 0.996903 | 0.963961 | 1.030971 |
| GCST002601-Plasma plasminogen levels | Inverse variance weighted | 2 | -0.0857 | 0.476953 | 0.857405 | 0.998684 | -1.02053 | 0.849129 | 0.917871 | 0.360405 | 2.337611 |
| GCST000367-Homocysteine levels | Inverse variance weighted | 2 | 0.052682 | 0.296504 | 0.858977 | 0.998684 | -0.52847 | 0.633829 | 1.054094 | 0.589509 | 1.884813 |
| GCST004578-Waist-to-hip ratio adjusted for BMI in active individuals | Inverse variance weighted | 25 | 0.015797 | 0.088987 | 0.859102 | 0.998684 | -0.15862 | 0.190211 | 1.015922 | 0.853323 | 1.209504 |
| GCST003769-Depression | Inverse variance weighted | 3 | -0.0003 | 0.001718 | 0.859549 | 0.998684 | -0.00367 | 0.003064 | 0.999696 | 0.996335 | 1.003068 |
| GCST007858-Fasting blood glucose adjusted for BMI | Inverse variance weighted | 2 | -0.07454 | 0.426574 | 0.861274 | 0.998684 | -0.91063 | 0.76154 | 0.928166 | 0.402271 | 2.141572 |
| GCST006612-LDL cholesterol | Inverse variance weighted | 58 | 0.018651 | 0.107339 | 0.862052 | 0.998684 | -0.19173 | 0.229035 | 1.018826 | 0.825528 | 1.257386 |
| GCST003622-Systemic lupus erythematosus | Inverse variance weighted | 8 | 0.008011 | 0.046361 | 0.862815 | 0.998684 | -0.08286 | 0.098879 | 1.008043 | 0.920482 | 1.103933 |
| GCST000678-Breast cancer | Inverse variance weighted | 8 | -0.00613 | 0.035526 | 0.863109 | 0.998684 | -0.07576 | 0.063506 | 0.993893 | 0.927041 | 1.065566 |
| GCST008060-Estimated glomerular filtration rate | Inverse variance weighted | 17 | -0.14135 | 0.833328 | 0.865312 | 0.998684 | -1.77467 | 1.491976 | 0.868189 | 0.16954 | 4.445872 |
| GCST003124-Mild influenza \(H1N1\) infection | Inverse variance weighted | 8 | 0.001704 | 0.010099 | 0.866031 | 0.998684 | -0.01809 | 0.021497 | 1.001705 | 0.982073 | 1.02173 |
| GCST000502-Hematocrit | Inverse variance weighted | 7 | 0.005831 | 0.034721 | 0.866636 | 0.998684 | -0.06222 | 0.073885 | 1.005848 | 0.939673 | 1.076683 |
| GCST007992-Colorectal cancer | Inverse variance weighted | 50 | 0.004959 | 0.029604 | 0.866969 | 0.998684 | -0.05306 | 0.062982 | 1.004971 | 0.948319 | 1.065008 |
| GCST000270-Colorectal cancer | Inverse variance weighted | 4 | 0.013547 | 0.080996 | 0.867172 | 0.998684 | -0.14521 | 0.1723 | 1.013639 | 0.864844 | 1.188034 |
| GCST007406-Healthspan | Inverse variance weighted | 2 | 0.065058 | 0.389899 | 0.86748 | 0.998684 | -0.69914 | 0.829259 | 1.067221 | 0.497011 | 2.291621 |
| GCST001939-Tanning | Inverse variance weighted | 4 | -0.01011 | 0.061528 | 0.869466 | 0.998684 | -0.13071 | 0.110484 | 0.98994 | 0.877475 | 1.116819 |
| GCST007147-Lateral ventricular volume in normal aging | Inverse variance weighted | 4 | 0.000316 | 0.00194 | 0.870781 | 0.998684 | -0.00349 | 0.004118 | 1.000316 | 0.996519 | 1.004127 |
| GCST007338-Positive affect | Inverse variance weighted | 120 | 0.033978 | 0.210192 | 0.87158 | 0.998684 | -0.378 | 0.445955 | 1.034562 | 0.685231 | 1.561981 |
| GCST006131-Colorectal cancer | Inverse variance weighted | 16 | -0.00764 | 0.047332 | 0.871694 | 0.998684 | -0.10041 | 0.085126 | 0.992385 | 0.904462 | 1.088854 |
| GCST006614-Total cholesterol levels | Inverse variance weighted | 79 | 0.012383 | 0.076908 | 0.872083 | 0.998684 | -0.13836 | 0.163124 | 1.01246 | 0.870788 | 1.177182 |
| GCST001938-Ulcerative colitis | Inverse variance weighted | 2 | -0.00588 | 0.036977 | 0.873609 | 0.998684 | -0.07836 | 0.066593 | 0.994135 | 0.924634 | 1.068861 |
| GCST003129-Primary biliary cholangitis | Inverse variance weighted | 6 | 0.008594 | 0.05449 | 0.874677 | 0.998684 | -0.09821 | 0.115395 | 1.008631 | 0.906462 | 1.122317 |
| GCST005929-Severity of nausea and vomiting of pregnancy | Inverse variance weighted | 4 | -0.02098 | 0.134182 | 0.875725 | 0.998684 | -0.28398 | 0.242012 | 0.979234 | 0.75278 | 1.27381 |
| GCST005668-Delta-5 desaturase activity response to n3-polyunsaturated fat supplement | Inverse variance weighted | 3 | 0.00419 | 0.026959 | 0.876485 | 0.998684 | -0.04865 | 0.057029 | 1.004199 | 0.952516 | 1.058686 |
| GCST003683-Intracranial, abdominal aortic or thoracic aortic aneurysm \(pleiotropy\) | Inverse variance weighted | 2 | -0.01122 | 0.072577 | 0.877149 | 0.998684 | -0.15347 | 0.131032 | 0.988843 | 0.857726 | 1.140004 |
| GCST007702-Triglyceride levels | Inverse variance weighted | 3 | -0.00016 | 0.001012 | 0.877163 | 0.998684 | -0.00214 | 0.001827 | 0.999844 | 0.997862 | 1.001829 |
| GCST007096-Pulse pressure | Inverse variance weighted | 126 | 0.00133 | 0.00874 | 0.879025 | 0.998684 | -0.0158 | 0.018461 | 1.001331 | 0.984324 | 1.018632 |
| GCST002240-Bladder cancer | Inverse variance weighted | 6 | 0.01395 | 0.091896 | 0.879339 | 0.998684 | -0.16616 | 0.194066 | 1.014048 | 0.846907 | 1.214176 |
| GCST001337-Platelet count | Inverse variance weighted | 36 | 0.000162 | 0.00107 | 0.879629 | 0.998684 | -0.00194 | 0.00226 | 1.000162 | 0.998066 | 1.002263 |
| GCST000760-Cholesterol, total | Inverse variance weighted | 32 | -0.00032 | 0.002132 | 0.87979 | 0.998684 | -0.0045 | 0.003856 | 0.999678 | 0.995509 | 1.003864 |
| GCST004618-White blood cell count \(basophil\) | Inverse variance weighted | 37 | 0.013966 | 0.092497 | 0.879988 | 0.998684 | -0.16733 | 0.195259 | 1.014063 | 0.845922 | 1.215626 |
| GCST005526-Graves' disease | Inverse variance weighted | 2 | 0.006284 | 0.041652 | 0.880073 | 0.998684 | -0.07535 | 0.087923 | 1.006304 | 0.927415 | 1.091904 |
| GCST001128-Adiposity | Inverse variance weighted | 2 | 0.037247 | 0.24706 | 0.880164 | 0.998684 | -0.44699 | 0.521484 | 1.037949 | 0.63955 | 1.684526 |
| GCST007898-Fasting blood insulin | Inverse variance weighted | 5 | 0.059578 | 0.39558 | 0.880285 | 0.998684 | -0.71576 | 0.834914 | 1.061388 | 0.488821 | 2.304616 |
| GCST003322-Ischemic stroke \(large artery atherosclerosis\) | Inverse variance weighted | 2 | -0.00539 | 0.035831 | 0.880355 | 0.998684 | -0.07562 | 0.064835 | 0.994621 | 0.927167 | 1.066983 |
| GCST004300-Incident atrial fibrillation | Inverse variance weighted | 2 | 0.017016 | 0.113146 | 0.880458 | 0.998684 | -0.20475 | 0.238783 | 1.017162 | 0.81485 | 1.269703 |
| GCST000388-Bilirubin levels | Inverse variance weighted | 2 | -0.00445 | 0.029608 | 0.88063 | 0.998684 | -0.06248 | 0.053586 | 0.995564 | 0.939433 | 1.055048 |
| GCST001004-Triglycerides-Blood Pressure \(TG-BP\) | Inverse variance weighted | 6 | -0.00515 | 0.034436 | 0.881142 | 0.998684 | -0.07264 | 0.062346 | 0.994864 | 0.929931 | 1.064331 |
| GCST004785-Vitiligo | Inverse variance weighted | 30 | 0.002158 | 0.014602 | 0.882497 | 0.998684 | -0.02646 | 0.030777 | 1.002161 | 0.973886 | 1.031256 |
| GCST007411-Depressive symptoms x dependent stressful life events interaction \(2df test\) | Inverse variance weighted | 2 | -0.02512 | 0.171358 | 0.88343 | 0.998684 | -0.36099 | 0.310736 | 0.975188 | 0.696989 | 1.364429 |
| GCST008166-Mean corpuscular volume | Inverse variance weighted | 2 | -0.00303 | 0.020737 | 0.883712 | 0.998684 | -0.04368 | 0.037611 | 0.996972 | 0.957263 | 1.038327 |
| GCST004773-Type 2 diabetes | Inverse variance weighted | 8 | -0.02625 | 0.180139 | 0.884163 | 0.998684 | -0.37932 | 0.326828 | 0.974096 | 0.684328 | 1.386563 |
| GCST000042-Crohn's disease | Inverse variance weighted | 3 | 0.005238 | 0.036561 | 0.88607 | 0.998684 | -0.06642 | 0.076897 | 1.005252 | 0.935737 | 1.079931 |
| GCST008316-Corneal endothelial cell size variation coefficient | Inverse variance weighted | 3 | -0.01082 | 0.075796 | 0.886523 | 0.998684 | -0.15938 | 0.137744 | 0.989242 | 0.852675 | 1.147682 |
| GCST004256-Venous thromboembolism | Inverse variance weighted | 4 | 0.004799 | 0.03387 | 0.887329 | 0.998684 | -0.06159 | 0.071185 | 1.00481 | 0.940271 | 1.07378 |
| GCST004734-Heart rate variability traits \(SDNN\) | Inverse variance weighted | 10 | -0.02527 | 0.179941 | 0.888323 | 0.998684 | -0.37795 | 0.327416 | 0.975048 | 0.685263 | 1.387379 |
| GCST005906-Endometriosis or endometrial cancer \(pleiotropy\) | Inverse variance weighted | 2 | -0.01062 | 0.07567 | 0.888381 | 0.998684 | -0.15893 | 0.137693 | 0.989436 | 0.853052 | 1.147624 |
| GCST001439-Mean platelet volume | Inverse variance weighted | 2 | -0.01122 | 0.080005 | 0.888477 | 0.998684 | -0.16803 | 0.14559 | 0.988844 | 0.84533 | 1.156722 |
| GCST001093-C-reactive protein | Inverse variance weighted | 2 | 0.006278 | 0.04482 | 0.88861 | 0.998684 | -0.08157 | 0.094125 | 1.006297 | 0.921669 | 1.098697 |
| GCST007927-Medication use \(beta blocking agents\) | Inverse variance weighted | 40 | -0.00636 | 0.045598 | 0.889148 | 0.998684 | -0.09573 | 0.083017 | 0.993665 | 0.908711 | 1.08656 |
| GCST005042-Restless legs syndrome | Inverse variance weighted | 11 | 0.006257 | 0.045185 | 0.889861 | 0.998684 | -0.0823 | 0.094819 | 1.006277 | 0.920991 | 1.09946 |
| GCST001499-Atrial fibrillation | Inverse variance weighted | 5 | -0.0064 | 0.046275 | 0.890079 | 0.998684 | -0.09709 | 0.084303 | 0.993625 | 0.907471 | 1.087959 |
| GCST003837-Chronotype | Inverse variance weighted | 2 | -0.12215 | 0.885262 | 0.890256 | 0.998684 | -1.85726 | 1.612966 | 0.885017 | 0.156099 | 5.017671 |
| GCST007267-Systolic blood pressure | Inverse variance weighted | 194 | 0.000916 | 0.006692 | 0.891161 | 0.998684 | -0.0122 | 0.014032 | 1.000916 | 0.987874 | 1.014131 |
| GCST005902-Depression \(broad\) | Inverse variance weighted | 21 | -0.07068 | 0.522595 | 0.892414 | 0.998684 | -1.09497 | 0.953605 | 0.931759 | 0.334551 | 2.595047 |
| GCST007589-Intracranial volume | Inverse variance weighted | 3 | 0.000404 | 0.002988 | 0.892444 | 0.998684 | -0.00545 | 0.006261 | 1.000404 | 0.994562 | 1.00628 |
| GCST000039-Crohn's disease | Inverse variance weighted | 2 | -0.01062 | 0.078895 | 0.892876 | 0.998684 | -0.16526 | 0.144009 | 0.989432 | 0.847675 | 1.154895 |
| GCST001074-Blood pressure | Inverse variance weighted | 6 | -0.00212 | 0.015807 | 0.893532 | 0.998684 | -0.0331 | 0.028866 | 0.997887 | 0.967444 | 1.029287 |
| GCST001877-Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia \(combined\) | Inverse variance weighted | 3 | -0.02072 | 0.155471 | 0.89397 | 0.998684 | -0.32545 | 0.284002 | 0.979492 | 0.722206 | 1.328435 |
| GCST002421-Prostate cancer | Inverse variance weighted | 5 | 0.002978 | 0.022581 | 0.895078 | 0.998684 | -0.04128 | 0.047236 | 1.002982 | 0.95956 | 1.04837 |
| GCST003336-Waist circumference adjusted for body mass index | Inverse variance weighted | 3 | -0.04269 | 0.324216 | 0.895249 | 0.998684 | -0.67815 | 0.592776 | 0.95821 | 0.507554 | 1.809003 |
| GCST004505-Waist-to-hip ratio adjusted for BMI \(adjusted for smoking behaviour\) | Inverse variance weighted | 29 | 0.01432 | 0.109488 | 0.895944 | 0.998684 | -0.20028 | 0.228917 | 1.014423 | 0.818503 | 1.257238 |
| GCST007922-Medication use \(drugs for peptic ulcer and gastro-oesophageal reflux disease\) | Inverse variance weighted | 3 | -0.02536 | 0.196602 | 0.89735 | 0.998684 | -0.4107 | 0.359976 | 0.974955 | 0.663184 | 1.433295 |
| GCST001781-Mean corpuscular volume | Inverse variance weighted | 2 | -0.00341 | 0.026659 | 0.898171 | 0.998684 | -0.05566 | 0.048839 | 0.996594 | 0.945858 | 1.050052 |
| GCST000135-HDL cholesterol | Inverse variance weighted | 6 | 0.000501 | 0.003934 | 0.898682 | 0.998684 | -0.00721 | 0.008212 | 1.000501 | 0.992816 | 1.008245 |
| GCST003272-Systolic blood pressure | Inverse variance weighted | 5 | 0.001332 | 0.010557 | 0.899594 | 0.998684 | -0.01936 | 0.022023 | 1.001333 | 0.980827 | 1.022267 |
| GCST003303-LDL cholesterol | Inverse variance weighted | 4 | -0.01143 | 0.090647 | 0.899687 | 0.998684 | -0.1891 | 0.166242 | 0.988638 | 0.827708 | 1.180859 |
| GCST007344-Estimated glomerular filtration rate | Inverse variance weighted | 61 | -0.00086 | 0.006914 | 0.900551 | 0.998684 | -0.01442 | 0.012688 | 0.999136 | 0.985688 | 1.012768 |
| GCST004500-Waist circumference adjusted for BMI \(adjusted for smoking behaviour\) | Inverse variance weighted | 37 | 0.014092 | 0.114255 | 0.901838 | 0.998684 | -0.20985 | 0.238033 | 1.014192 | 0.810707 | 1.268751 |
| GCST006958-Length of menstrual cycle | Inverse variance weighted | 4 | 0.018729 | 0.153542 | 0.902916 | 0.998684 | -0.28221 | 0.319672 | 1.018905 | 0.754113 | 1.376675 |
| GCST002679-Iron status biomarkers \(iron levels\) | Inverse variance weighted | 2 | -0.01242 | 0.102393 | 0.903469 | 0.998684 | -0.21311 | 0.188271 | 0.987659 | 0.808069 | 1.207161 |
| GCST000583-Hematological and biochemical traits | Inverse variance weighted | 14 | -0.00471 | 0.039055 | 0.904068 | 0.998684 | -0.08125 | 0.07184 | 0.995304 | 0.921959 | 1.074483 |
| GCST005648-Serum metabolite concentrations in chronic kidney disease | Inverse variance weighted | 21 | -0.00147 | 0.012195 | 0.904132 | 0.998684 | -0.02537 | 0.022433 | 0.998532 | 0.974949 | 1.022686 |
| GCST004432-Platelet-derived growth factor BB levels | Inverse variance weighted | 6 | -0.00651 | 0.05413 | 0.90434 | 0.998684 | -0.1126 | 0.09959 | 0.993516 | 0.893507 | 1.104718 |
| GCST003968-Pericardial adipose tissue adjusted for height and weight | Inverse variance weighted | 3 | 0.000189 | 0.001582 | 0.904717 | 0.998684 | -0.00291 | 0.003291 | 1.000189 | 0.997093 | 1.003296 |
| GCST003400-Type 2 diabetes | Inverse variance weighted | 13 | 0.003707 | 0.031057 | 0.904993 | 0.998684 | -0.05716 | 0.064578 | 1.003714 | 0.944439 | 1.066709 |
| GCST000299-Weight | Inverse variance weighted | 8 | 0.000205 | 0.001718 | 0.904999 | 0.998684 | -0.00316 | 0.003572 | 1.000205 | 0.996843 | 1.003578 |
| GCST001248-Pulmonary function | Inverse variance weighted | 6 | 0.031148 | 0.263228 | 0.905805 | 0.998684 | -0.48478 | 0.547076 | 1.031638 | 0.615833 | 1.728192 |
| GCST003938-Carotenoid levels \(alpha-carotene\) | Inverse variance weighted | 2 | -0.00753 | 0.063712 | 0.905961 | 0.998684 | -0.1324 | 0.11735 | 0.992502 | 0.875988 | 1.124513 |
| GCST005191-Hair shape | Inverse variance weighted | 7 | -0.01457 | 0.127214 | 0.908819 | 0.998684 | -0.26391 | 0.23477 | 0.985536 | 0.768044 | 1.264618 |
| GCST003447-Neuroticism | Inverse variance weighted | 5 | 0.013383 | 0.117622 | 0.909413 | 0.998684 | -0.21716 | 0.243922 | 1.013473 | 0.804804 | 1.276245 |
| GCST002492-Bone mineral density \(paediatric, lower limb\) | Inverse variance weighted | 2 | -0.02762 | 0.244617 | 0.910092 | 0.998684 | -0.50707 | 0.451827 | 0.972755 | 0.602256 | 1.57118 |
| GCST004029-Angiotensin-converting enzyme inhibitor intolerance | Inverse variance weighted | 2 | -0.00345 | 0.030548 | 0.910206 | 0.998684 | -0.06332 | 0.056428 | 0.996561 | 0.938644 | 1.058051 |
| GCST007603-Smoking initiation | Inverse variance weighted | 26 | -0.03092 | 0.277034 | 0.911136 | 0.998684 | -0.57391 | 0.512068 | 0.969554 | 0.563321 | 1.668739 |
| GCST000144-Systemic lupus erythematosus | Inverse variance weighted | 2 | 0.007124 | 0.064517 | 0.912079 | 0.998684 | -0.11933 | 0.133576 | 1.007149 | 0.887516 | 1.142909 |
| GCST001799-Prostate-specific antigen levels | Inverse variance weighted | 2 | -0.02547 | 0.234342 | 0.913455 | 0.998684 | -0.48478 | 0.433841 | 0.974853 | 0.615833 | 1.543174 |
| GCST003275-Mean arterial pressure | Inverse variance weighted | 6 | -0.00168 | 0.015505 | 0.913667 | 0.998684 | -0.03207 | 0.028709 | 0.99832 | 0.968438 | 1.029125 |
| GCST008277-Corneal hysteresis | Inverse variance weighted | 3 | -0.00734 | 0.068905 | 0.915223 | 0.998684 | -0.14239 | 0.127719 | 0.992692 | 0.867283 | 1.136234 |
| GCST005649-Urinary metabolite ratios in chronic kidney disease | Inverse variance weighted | 2 | -0.00356 | 0.03349 | 0.915455 | 0.998684 | -0.0692 | 0.062085 | 0.996451 | 0.933144 | 1.064053 |
| GCST002890-Prostate cancer | Inverse variance weighted | 10 | 0.005253 | 0.05005 | 0.916416 | 0.998684 | -0.09285 | 0.103351 | 1.005267 | 0.911334 | 1.108881 |
| GCST004183-Lung function \(FEV1\) | Inverse variance weighted | 7 | 0.019126 | 0.182917 | 0.916722 | 0.998684 | -0.33939 | 0.377644 | 1.019311 | 0.712204 | 1.458843 |
| GCST001183-Asthma | Inverse variance weighted | 5 | -0.00555 | 0.05372 | 0.917757 | 0.998684 | -0.11084 | 0.099743 | 0.994468 | 0.895084 | 1.104887 |
| GCST002808-Venous thromboembolism | Inverse variance weighted | 5 | 0.003251 | 0.031514 | 0.917835 | 0.998684 | -0.05852 | 0.065019 | 1.003256 | 0.943162 | 1.067179 |
| GCST002533-QRS duration | Inverse variance weighted | 3 | 0.001582 | 0.015372 | 0.918021 | 0.998684 | -0.02855 | 0.031711 | 1.001583 | 0.971857 | 1.032219 |
| GCST004232-HDL cholesterol levels | Inverse variance weighted | 44 | 0.006227 | 0.060649 | 0.918224 | 0.998684 | -0.11265 | 0.1251 | 1.006246 | 0.893467 | 1.133261 |
| GCST001765-Red blood cell traits | Inverse variance weighted | 31 | 0.002179 | 0.021431 | 0.919023 | 0.998684 | -0.03983 | 0.044183 | 1.002181 | 0.960957 | 1.045173 |
| GCST002625-Chronic bronchitis and chronic obstructive pulmonary disease | Inverse variance weighted | 2 | 0.003741 | 0.038633 | 0.922851 | 0.998684 | -0.07198 | 0.079463 | 1.003748 | 0.93055 | 1.082705 |
| GCST002712-Red blood cell fatty acid levels | Inverse variance weighted | 5 | -0.00604 | 0.063516 | 0.924261 | 0.998684 | -0.13053 | 0.118454 | 0.99398 | 0.87763 | 1.125755 |
| GCST006881-Hippocampal tail volume \(corrected for total hippocampal volume\) | Inverse variance weighted | 7 | 0.000165 | 0.001735 | 0.924325 | 0.998684 | -0.00324 | 0.003565 | 1.000165 | 0.996769 | 1.003572 |
| GCST003239-Plasma omega-6 polyunsaturated fatty acid levels \(linoleic acid\) | Inverse variance weighted | 2 | -0.03273 | 0.347212 | 0.924888 | 0.998684 | -0.71327 | 0.647801 | 0.967795 | 0.490039 | 1.911334 |
| GCST005348-Total body bone mineral density | Inverse variance weighted | 101 | -0.00344 | 0.036446 | 0.92491 | 0.998684 | -0.07487 | 0.068 | 0.996571 | 0.927864 | 1.070365 |
| GCST002556-White blood cell count | Inverse variance weighted | 4 | -0.01502 | 0.159559 | 0.924994 | 0.998684 | -0.32776 | 0.297713 | 0.985091 | 0.720538 | 1.346776 |
| GCST005780-Triglyceride levels | Inverse variance weighted | 7 | -0.00011 | 0.001214 | 0.925456 | 0.998684 | -0.00249 | 0.002267 | 0.999886 | 0.997509 | 1.002269 |
| GCST005323-Depressive symptoms \(MTAG\) | Inverse variance weighted | 46 | -0.01898 | 0.203549 | 0.92569 | 0.998684 | -0.41794 | 0.379972 | 0.981194 | 0.658401 | 1.462244 |
| GCST004744-Lung adenocarcinoma | Inverse variance weighted | 14 | -0.00377 | 0.040804 | 0.926363 | 0.998684 | -0.08375 | 0.076205 | 0.996236 | 0.919663 | 1.079184 |
| GCST004428-Stem cell growth factor beta levels | Inverse variance weighted | 3 | 0.005786 | 0.062896 | 0.926698 | 0.998684 | -0.11749 | 0.129063 | 1.005803 | 0.889149 | 1.137762 |
| GCST003327-Squamous cell carcinoma | Inverse variance weighted | 7 | 0.004121 | 0.04588 | 0.928423 | 0.998684 | -0.0858 | 0.094046 | 1.00413 | 0.917775 | 1.09861 |
| GCST002785-Facial pigmentation | Inverse variance weighted | 3 | 9.76E-05 | 0.001099 | 0.929247 | 0.998684 | -0.00206 | 0.002252 | 1.000098 | 0.997945 | 1.002255 |
| GCST008259-Alcohol use disorder | Inverse variance weighted | 9 | -0.0001 | 0.001151 | 0.929363 | 0.998684 | -0.00236 | 0.002153 | 0.999898 | 0.997645 | 1.002156 |
| GCST003374-Chronic kidney disease | Inverse variance weighted | 3 | 0.005936 | 0.067427 | 0.929844 | 0.998684 | -0.12622 | 0.138093 | 1.005954 | 0.881421 | 1.148082 |
| GCST007226-PR interval | Inverse variance weighted | 12 | 0.000235 | 0.002694 | 0.930499 | 0.998684 | -0.00505 | 0.005516 | 1.000235 | 0.994967 | 1.005531 |
| GCST004258-Diastolic blood pressure \(long-term average\) | Inverse variance weighted | 3 | -0.00256 | 0.030051 | 0.932187 | 0.998684 | -0.06146 | 0.056343 | 0.997446 | 0.940394 | 1.05796 |
| GCST001605-C-reactive protein and white blood cell count | Inverse variance weighted | 6 | 0.003695 | 0.044311 | 0.933551 | 0.998684 | -0.08316 | 0.090544 | 1.003701 | 0.920208 | 1.09477 |
| GCST003061-Cutaneous malignant melanoma | Inverse variance weighted | 5 | -0.00604 | 0.072575 | 0.933619 | 0.998684 | -0.14829 | 0.136202 | 0.993973 | 0.862179 | 1.145914 |
| GCST000483-Folate pathway vitamin levels | Inverse variance weighted | 3 | -0.01014 | 0.122099 | 0.93384 | 0.998684 | -0.24945 | 0.229178 | 0.989915 | 0.779229 | 1.257566 |
| GCST003198-Inguinal hernia | Inverse variance weighted | 3 | -0.00699 | 0.092574 | 0.939837 | 0.998684 | -0.18843 | 0.174458 | 0.993037 | 0.828257 | 1.1906 |
| GCST001611-Myasthenia gravis | Inverse variance weighted | 3 | -0.00121 | 0.016163 | 0.940289 | 0.998684 | -0.03289 | 0.030468 | 0.99879 | 0.967646 | 1.030937 |
| GCST000777-Esophageal cancer and gastric cancer | Inverse variance weighted | 3 | 0.003948 | 0.053324 | 0.940974 | 0.998684 | -0.10057 | 0.108464 | 1.003956 | 0.904324 | 1.114565 |
| GCST000444-QT interval | Inverse variance weighted | 2 | 0.006473 | 0.087755 | 0.941202 | 0.998684 | -0.16553 | 0.178473 | 1.006494 | 0.847447 | 1.195391 |
| GCST006085-Prostate cancer | Inverse variance weighted | 72 | -0.00185 | 0.025706 | 0.942589 | 0.998684 | -0.05224 | 0.048533 | 0.99815 | 0.949105 | 1.04973 |
| GCST005212-Asthma | Inverse variance weighted | 13 | -0.00538 | 0.074878 | 0.942697 | 0.998684 | -0.15214 | 0.141379 | 0.994632 | 0.858865 | 1.151861 |
| GCST008226-Renal cell carcinoma | Inverse variance weighted | 3 | -0.004 | 0.0571 | 0.944194 | 0.998684 | -0.11591 | 0.107919 | 0.996011 | 0.890553 | 1.113957 |
| GCST008164-Free thyroxine concentration | Inverse variance weighted | 2 | 0.014237 | 0.203771 | 0.944297 | 0.998684 | -0.38515 | 0.413628 | 1.014339 | 0.680347 | 1.512294 |
| GCST001612-Sex hormone-binding globulin levels | Inverse variance weighted | 8 | 0.009751 | 0.143885 | 0.945971 | 0.998684 | -0.27226 | 0.291765 | 1.009798 | 0.761653 | 1.338789 |
| GCST003743-Hypertriglyceridemia | Inverse variance weighted | 3 | -0.00245 | 0.036292 | 0.946097 | 0.998684 | -0.07359 | 0.068678 | 0.997549 | 0.929057 | 1.071091 |
| GCST007691-Femoral neck bone mineral density | Inverse variance weighted | 18 | -0.0078 | 0.119385 | 0.947918 | 0.998684 | -0.24179 | 0.226196 | 0.992232 | 0.785219 | 1.253821 |
| GCST005166-GIP levels in response to oral glucose tolerance test \(120 minutes\) | Inverse variance weighted | 2 | -0.01372 | 0.212616 | 0.948551 | 0.998684 | -0.43045 | 0.403009 | 0.986374 | 0.650218 | 1.49632 |
| GCST007268-Diastolic blood pressure | Inverse variance weighted | 33 | 0.001093 | 0.017275 | 0.94955 | 0.998684 | -0.03277 | 0.034952 | 1.001094 | 0.967765 | 1.03557 |
| GCST000176-Height | Inverse variance weighted | 7 | 0.001242 | 0.020136 | 0.950818 | 0.998684 | -0.03822 | 0.040709 | 1.001243 | 0.962497 | 1.041549 |
| GCST004373-Atrial fibrillation | Inverse variance weighted | 8 | 0.00198 | 0.032291 | 0.951114 | 0.998684 | -0.06131 | 0.065271 | 1.001982 | 0.94053 | 1.067448 |
| GCST004236-LDL cholesterol levels | Inverse variance weighted | 5 | -0.00542 | 0.088496 | 0.951127 | 0.998684 | -0.17888 | 0.168029 | 0.994591 | 0.836209 | 1.182971 |
| GCST000366-Fibrinogen | Inverse variance weighted | 2 | -0.01129 | 0.190885 | 0.952846 | 0.998684 | -0.38542 | 0.362848 | 0.988776 | 0.680163 | 1.437417 |
| GCST008321-Corneal endothelial cell shape \(percentage of hexagonally shaped cells\) | Inverse variance weighted | 2 | 0.004482 | 0.076569 | 0.95332 | 0.998684 | -0.14559 | 0.154558 | 1.004492 | 0.864509 | 1.167142 |
| GCST004557-Body mass index | Inverse variance weighted | 70 | -0.00455 | 0.080132 | 0.95474 | 0.998684 | -0.16161 | 0.152512 | 0.995462 | 0.850775 | 1.164756 |
| GCST001929-Eye color | Inverse variance weighted | 2 | -0.00038 | 0.006814 | 0.955501 | 0.998684 | -0.01373 | 0.012975 | 0.99962 | 0.986359 | 1.013059 |
| GCST004902-Parkinson's disease | Inverse variance weighted | 28 | -0.00248 | 0.045002 | 0.955989 | 0.998684 | -0.09069 | 0.085721 | 0.997519 | 0.913303 | 1.089502 |
| GCST000132-LDL cholesterol | Inverse variance weighted | 3 | 0.000125 | 0.002287 | 0.956358 | 0.998684 | -0.00436 | 0.004608 | 1.000125 | 0.995651 | 1.004619 |
| GCST001146-Systemic sclerosis | Inverse variance weighted | 2 | -0.00278 | 0.050983 | 0.956545 | 0.998684 | -0.10271 | 0.097149 | 0.997226 | 0.902393 | 1.102025 |
| GCST000365-Breast cancer | Inverse variance weighted | 3 | -0.00275 | 0.050961 | 0.956943 | 0.998684 | -0.10264 | 0.097132 | 0.997252 | 0.902456 | 1.102006 |
| GCST002944-Prostate cancer | Inverse variance weighted | 16 | -0.00112 | 0.020929 | 0.95727 | 0.998684 | -0.04214 | 0.039899 | 0.998879 | 0.958734 | 1.040706 |
| GCST004966-Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease | Inverse variance weighted | 2 | 0.023161 | 0.432509 | 0.957293 | 0.998684 | -0.82456 | 0.870878 | 1.023432 | 0.43843 | 2.389008 |
| GCST003740-Barrett's esophagus  or Esophageal adenocarcinoma | Inverse variance weighted | 5 | -0.00321 | 0.0602 | 0.957435 | 0.998684 | -0.1212 | 0.114778 | 0.996792 | 0.885853 | 1.121625 |
| GCST001407-Ewing sarcoma | Inverse variance weighted | 3 | 0.001509 | 0.028683 | 0.958051 | 0.998684 | -0.05471 | 0.057728 | 1.00151 | 0.946759 | 1.059427 |
| GCST007553-Autism and major depressive disorder \(MTAG\) | Inverse variance weighted | 4 | 0.011232 | 0.216592 | 0.958641 | 0.998684 | -0.41329 | 0.435753 | 1.011296 | 0.661472 | 1.546126 |
| GCST000167-Type 2 diabetes | Inverse variance weighted | 7 | 0.005686 | 0.110233 | 0.958861 | 0.998684 | -0.21037 | 0.221742 | 1.005702 | 0.810284 | 1.24825 |
| GCST007281-HDL cholesterol x physical activity interaction \(1df test\) | Inverse variance weighted | 2 | -0.10089 | 1.98122 | 0.959388 | 0.998684 | -3.98408 | 3.782304 | 0.904035 | 0.01861 | 43.91711 |
| GCST008339-Corneal endothelial cell density | Inverse variance weighted | 4 | -0.00296 | 0.06076 | 0.961121 | 0.998684 | -0.12205 | 0.116128 | 0.997043 | 0.885102 | 1.12314 |
| GCST005953-Body mass index \(age &lt;50\) | Inverse variance weighted | 6 | -0.00673 | 0.13889 | 0.961381 | 0.998684 | -0.27895 | 0.2655 | 0.993297 | 0.756578 | 1.304083 |
| GCST003302-Cholesterol, total | Inverse variance weighted | 4 | -0.00419 | 0.087182 | 0.961627 | 0.998684 | -0.17507 | 0.166682 | 0.995814 | 0.839397 | 1.181379 |
| GCST006102-Interleukin-10 levels | Inverse variance weighted | 3 | 0.013058 | 0.271515 | 0.961643 | 0.998684 | -0.51911 | 0.545226 | 1.013143 | 0.595049 | 1.724998 |
| GCST007509-Cleft palate | Inverse variance weighted | 2 | -0.00016 | 0.00338 | 0.96195 | 0.998684 | -0.00679 | 0.006464 | 0.999839 | 0.993237 | 1.006485 |
| GCST007733-Serum uric acid levels | Inverse variance weighted | 19 | 0.003176 | 0.06739 | 0.962411 | 0.998684 | -0.12891 | 0.13526 | 1.003181 | 0.879055 | 1.144834 |
| GCST007090-Knee osteoarthritis | Inverse variance weighted | 5 | 0.008255 | 0.175785 | 0.962544 | 0.998684 | -0.33628 | 0.352793 | 1.008289 | 0.714421 | 1.423036 |
| GCST007942-Medication use \(glucocorticoids\) | Inverse variance weighted | 9 | -0.00283 | 0.063048 | 0.964174 | 0.998684 | -0.12641 | 0.120742 | 0.997172 | 0.881257 | 1.128333 |
| GCST002898-LDL cholesterol | Inverse variance weighted | 22 | -0.00262 | 0.058877 | 0.964484 | 0.998684 | -0.11802 | 0.112777 | 0.997382 | 0.888678 | 1.119383 |
| GCST007240-Obese vs. thin | Inverse variance weighted | 5 | -0.00245 | 0.055674 | 0.964896 | 0.998684 | -0.11157 | 0.10667 | 0.997553 | 0.894429 | 1.112567 |
| GCST001685-Primary biliary cholangitis | Inverse variance weighted | 4 | -0.00112 | 0.027529 | 0.967669 | 0.998909 | -0.05507 | 0.05284 | 0.998885 | 0.946417 | 1.054261 |
| GCST002701-Verbal declarative memory | Inverse variance weighted | 3 | 0.001082 | 0.029222 | 0.970457 | 0.998909 | -0.05619 | 0.058357 | 1.001083 | 0.945357 | 1.060093 |
| GCST000712-Type 2 diabetes | Inverse variance weighted | 13 | -0.00228 | 0.063198 | 0.971218 | 0.998909 | -0.12615 | 0.121588 | 0.997722 | 0.881484 | 1.129289 |
| GCST007385-Plasma free amino acid levels | Inverse variance weighted | 21 | 0.000521 | 0.014563 | 0.971458 | 0.998909 | -0.02802 | 0.029065 | 1.000521 | 0.972366 | 1.029491 |
| GCST000807-LDL cholesterol | Inverse variance weighted | 6 | 0.009977 | 0.281642 | 0.971741 | 0.998909 | -0.54204 | 0.561996 | 1.010027 | 0.58156 | 1.754171 |
| GCST004257-Systolic blood pressure \(long-term average\) | Inverse variance weighted | 3 | -0.00054 | 0.015524 | 0.972171 | 0.998946 | -0.03097 | 0.029885 | 0.999459 | 0.969507 | 1.030336 |
| GCST005194-Coronary artery disease | Inverse variance weighted | 76 | -0.00166 | 0.050143 | 0.973643 | 0.998946 | -0.09994 | 0.096623 | 0.998345 | 0.904895 | 1.101445 |
| GCST007328-Alcohol consumption \(drinks per week\) | Inverse variance weighted | 48 | -0.00618 | 0.192172 | 0.974363 | 0.998946 | -0.38283 | 0.370482 | 0.993843 | 0.681926 | 1.448433 |
| GCST005235-Hand grip strength | Inverse variance weighted | 12 | 0.001289 | 0.041495 | 0.975226 | 0.998946 | -0.08004 | 0.082619 | 1.001289 | 0.923078 | 1.086127 |
| GCST004238-Triglyceride levels | Inverse variance weighted | 6 | -0.00308 | 0.104406 | 0.976447 | 0.998946 | -0.20772 | 0.201553 | 0.996922 | 0.812437 | 1.2233 |
| GCST000833-Psoriasis | Inverse variance weighted | 5 | -0.00179 | 0.060824 | 0.976524 | 0.998946 | -0.121 | 0.117425 | 0.998212 | 0.88603 | 1.124597 |
| GCST002184-Mean platelet volume | Inverse variance weighted | 7 | -0.00123 | 0.045361 | 0.978323 | 0.998946 | -0.09014 | 0.087675 | 0.998768 | 0.913803 | 1.091634 |
| GCST004301-Prevalent atrial fibrillation | Inverse variance weighted | 6 | -0.00146 | 0.054371 | 0.978633 | 0.998946 | -0.10802 | 0.105111 | 0.998545 | 0.897607 | 1.110834 |
| GCST004280-Diastolic blood pressure | Inverse variance weighted | 31 | 0.000532 | 0.01991 | 0.978675 | 0.998946 | -0.03849 | 0.039556 | 1.000532 | 0.96224 | 1.040349 |
| GCST000510-Hematology traits | Inverse variance weighted | 2 | 0.002161 | 0.081682 | 0.978897 | 0.998946 | -0.15794 | 0.162257 | 1.002163 | 0.853905 | 1.176162 |
| GCST004129-White blood cell count \(monocyte\) | Inverse variance weighted | 2 | -0.01842 | 0.707197 | 0.979225 | 0.998946 | -1.40452 | 1.36769 | 0.981753 | 0.245485 | 3.92627 |
| GCST002023-Testicular germ cell tumor | Inverse variance weighted | 6 | 0.000458 | 0.019672 | 0.981413 | 0.998946 | -0.0381 | 0.039015 | 1.000458 | 0.962619 | 1.039786 |
| GCST006634-Hedonic well-being | Inverse variance weighted | 2 | -0.01427 | 0.618156 | 0.981578 | 0.998946 | -1.22586 | 1.197312 | 0.985828 | 0.293505 | 3.311205 |
| GCST003795-Age at first birth | Inverse variance weighted | 6 | -0.00209 | 0.094152 | 0.982283 | 0.998946 | -0.18663 | 0.182447 | 0.997911 | 0.829752 | 1.20015 |
| GCST004732-Heart rate variability traits \(pvRSA/HF\) | Inverse variance weighted | 5 | -0.00156 | 0.071471 | 0.982558 | 0.998946 | -0.14165 | 0.13852 | 0.998439 | 0.867929 | 1.148573 |
| GCST008282-Spine bone size | Inverse variance weighted | 3 | -0.00505 | 0.245162 | 0.983575 | 0.998946 | -0.48557 | 0.475471 | 0.994966 | 0.615349 | 1.608772 |
| GCST001893-Electrocardiographic conduction measures | Inverse variance weighted | 4 | 0.000236 | 0.011933 | 0.984212 | 0.998946 | -0.02315 | 0.023625 | 1.000236 | 0.977114 | 1.023906 |
| GCST003252-Systemic lupus erythematosus | Inverse variance weighted | 5 | -0.00054 | 0.027701 | 0.984513 | 0.998946 | -0.05483 | 0.053756 | 0.999462 | 0.946644 | 1.055227 |
| GCST007953-Glycated hemoglobin levels | Inverse variance weighted | 4 | 0.011766 | 0.609434 | 0.984597 | 0.998946 | -1.18272 | 1.206257 | 1.011836 | 0.306443 | 3.340956 |
| GCST000397-Renal function and chronic kidney disease | Inverse variance weighted | 2 | 0.002486 | 0.133535 | 0.985145 | 0.998946 | -0.25924 | 0.264215 | 1.002489 | 0.771636 | 1.302408 |
| GCST000750-Prostate cancer | Inverse variance weighted | 3 | -0.00127 | 0.069351 | 0.985397 | 0.998946 | -0.1372 | 0.134658 | 0.998731 | 0.871798 | 1.144146 |
| GCST001345-Ankylosing spondylitis | Inverse variance weighted | 2 | 0.002131 | 0.129895 | 0.98691 | 0.998946 | -0.25246 | 0.256724 | 1.002133 | 0.776886 | 1.292689 |
| GCST003764-Hirschsprung disease | Inverse variance weighted | 2 | -0.00042 | 0.026023 | 0.987008 | 0.998946 | -0.05143 | 0.050582 | 0.999576 | 0.949871 | 1.051883 |
| GCST002878-Creutzfeldt-Jakob disease \(sporadic\) | Inverse variance weighted | 2 | -0.00067 | 0.04377 | 0.987853 | 0.998946 | -0.08646 | 0.085123 | 0.999334 | 0.917176 | 1.088851 |
| GCST001798-End-stage coagulation | Inverse variance weighted | 16 | -0.00014 | 0.009701 | 0.98811 | 0.998946 | -0.01916 | 0.018869 | 0.999855 | 0.981025 | 1.019048 |
| GCST007836-Glycine levels | Inverse variance weighted | 7 | -0.00074 | 0.051225 | 0.988406 | 0.998946 | -0.10115 | 0.099658 | 0.999256 | 0.903801 | 1.104792 |
| GCST002376-Urinary uromodulin levels | Inverse variance weighted | 2 | -0.00085 | 0.058806 | 0.988529 | 0.998946 | -0.11611 | 0.114414 | 0.999155 | 0.890382 | 1.121216 |
| GCST007218-QT interval | Inverse variance weighted | 7 | \#\#\#\#\#\#\#\# | 0.004373 | 0.98909 | 0.998946 | -0.00863 | 0.008512 | 0.99994 | 0.991406 | 1.008548 |
| GCST005217-Insulin levels adjusted for BMI | Inverse variance weighted | 2 | -0.0021 | 0.154261 | 0.989146 | 0.998946 | -0.30445 | 0.300254 | 0.997904 | 0.737528 | 1.350202 |
| GCST006804-Red cell distribution width | Inverse variance weighted | 76 | -0.00076 | 0.057111 | 0.989415 | 0.998946 | -0.11269 | 0.111179 | 0.999243 | 0.893424 | 1.117595 |
| GCST007986-Ease of getting up in the morning | Inverse variance weighted | 41 | 0.003436 | 0.263026 | 0.989578 | 0.998946 | -0.5121 | 0.518967 | 1.003442 | 0.599238 | 1.680292 |
| GCST003023-Blond vs non-blond hair color | Inverse variance weighted | 2 | -0.00032 | 0.025003 | 0.989702 | 0.998946 | -0.04933 | 0.048684 | 0.999677 | 0.951868 | 1.049888 |
| GCST001301-Schizophrenia | Inverse variance weighted | 2 | 0.001401 | 0.110096 | 0.989847 | 0.998946 | -0.21439 | 0.21719 | 1.001402 | 0.807035 | 1.24258 |
| GCST000710-Eye color | Inverse variance weighted | 4 | \#\#\#\#\#\#\#\# | 0.007586 | 0.991158 | 0.999299 | -0.01495 | 0.014784 | 0.999916 | 0.985159 | 1.014894 |
| GCST003143-Lung disease severity in cystic fibrosis | Inverse variance weighted | 2 | -0.00107 | 0.124005 | 0.993142 | 0.999299 | -0.24412 | 0.241984 | 0.998935 | 0.783397 | 1.273773 |
| GCST007160-Refractive astigmatism | Inverse variance weighted | 2 | 0.004429 | 0.54507 | 0.993516 | 0.999299 | -1.06391 | 1.072767 | 1.004439 | 0.345104 | 2.923457 |
| GCST004302-Primary biliary cholangitis | Inverse variance weighted | 10 | 0.000176 | 0.021851 | 0.993555 | 0.999299 | -0.04265 | 0.043004 | 1.000177 | 0.958245 | 1.043942 |
| GCST002874-Psoriasis | Inverse variance weighted | 13 | -0.00019 | 0.025369 | 0.994006 | 0.999299 | -0.04991 | 0.049532 | 0.999809 | 0.951312 | 1.050779 |
| GCST007474-Smoking initiation \(ever regular vs never regular\) | Inverse variance weighted | 216 | -0.00052 | 0.071916 | 0.994182 | 0.999299 | -0.14148 | 0.140431 | 0.999476 | 0.868073 | 1.150769 |
| GCST000284-HDL cholesterol | Inverse variance weighted | 3 | -0.00097 | 0.155818 | 0.995009 | 0.999299 | -0.30638 | 0.304428 | 0.999026 | 0.736108 | 1.35585 |
| GCST004133-Ulcerative colitis | Inverse variance weighted | 3 | -0.00086 | 0.140742 | 0.995103 | 0.999299 | -0.27672 | 0.274991 | 0.999137 | 0.758268 | 1.316519 |
| GCST004449-Hepatocyte growth factor levels | Inverse variance weighted | 2 | 0.000481 | 0.087957 | 0.995635 | 0.999299 | -0.17191 | 0.172876 | 1.000481 | 0.842052 | 1.188719 |
| GCST001697-Telomere length | Inverse variance weighted | 4 | -0.00103 | 0.234505 | 0.99651 | 0.999495 | -0.46066 | 0.458604 | 0.998975 | 0.63087 | 1.581865 |
| GCST003122-Hemoglobin levels | Inverse variance weighted | 2 | -0.00017 | 0.039098 | 0.996569 | 0.999495 | -0.0768 | 0.076464 | 0.999832 | 0.926075 | 1.079463 |
| GCST002417-Plasma thyroid-stimulating hormone levels | Inverse variance weighted | 2 | -0.00022 | 0.086874 | 0.997984 | 0.999913 | -0.17049 | 0.170054 | 0.999781 | 0.843249 | 1.185369 |
| GCST000489-Prostate cancer | Inverse variance weighted | 5 | -0.00011 | 0.047922 | 0.998214 | 0.999913 | -0.09403 | 0.093819 | 0.999893 | 0.910252 | 1.098361 |
| GCST007551-Behcet's disease | Inverse variance weighted | 2 | 2.28E-05 | 0.023165 | 0.999215 | 1 | -0.04538 | 0.045426 | 1.000023 | 0.955634 | 1.046474 |
| GCST004862-Itch intensity from mosquito bite adjusted by bite size | Inverse variance weighted | 20 | -0.0001 | 0.144758 | 0.999432 | 1 | -0.28383 | 0.283622 | 0.999897 | 0.752896 | 1.327931 |

